"","Adenocarcinoma","Age.at.diagnosis","ALK","antipd1","antipdl1","ARID1A","Asian","Black","BRAF","CDKN2A","dataset","Date.of.diagnosis","Date.of.irAE.1","early_irae","EGFR","ERBB2","Grade.of.irAE.1","Histology","I.O.for.irAE.1","Immunotherapy..1.End.Date","Immunotherapy..1.Start.Date","Immunotherapy.1_DrugName","Immunotherapy.Class","irae_cat","irae_cat_1yr","irae_cat_6mo","irae_pos","irae_pos_1yr","irae_pos_6mo","irAE.1","irAE.1_EarlyLate","irAE.1_pos_neg","irAE.1.category","KRAS","Last.Visit","Line.of.immunotherapy..1","Line.of.therapy.TKI..1","LRP1B","male","MET","Molecular.test.performed","os_1yr_flag_surv","os_days_update","Packyear","PD..date..1","PD.Date.TKI..1","PD.L1.Range","PD.L1.Status","pdl1_149","pdl1_50100","pdl1_neg","pfs_6months_flag_surv","pfs_days","pfs_flag","PIK3CA","prior_tki","priortki","Race","Report.Date","Sex","SHADOW.ID","SMARCA4","Smoking","Squamous","Stage","StageIII","StageIorII","StageIV","STK11","survival_flag","TKI..1.Drug.Name","TKI..1.End.date","TKI..1.Start.date","TP53","VitalStatus","White"
"1",1,65,"",1,0,"",0,0,"","","NON-TKI",18556,NA,0,"","",NA,"adenocarcinoma","",18740,18740,"Nivolumab","anti-pd-1",0,0,0,0,0,0,"none reported",NA,"negative","No irae","",18782,2,NA,"",0,"","No Report",0,42,NA,18782,NA,"Not Reported","Not Reported",0,0,0,0,42,1,"","No Prior TKI",0,"Unknown or Other",NA,0,"AJ07793T","",0,0,"IV",0,0,1,"",1,"",NA,NA,"","Deceased",0
"2",1,85,"negative",0,1,"",0,0,"","","NON-TKI",18311,18612,1,"","",1,"adenocarcinoma","",18611,18611,"Atezolizumab","anti-pd-l1",0,0,0,1,1,1,"fatigue, body aches, decreased appetitie","Early irAE","positive","IRAE","g12d",18842,2,NA,"",1,"","Caris",0,231,50,18708,NA,"Not Reported","",0,0,0,0,97,1,"","No Prior TKI",0,"White",18353,1,"AJ11690U","a82*fs",1,0,"IV",0,0,1,"l282fs",1,"",NA,NA,"","Deceased",1
"3",1,61,"",1,0,"",1,0,"","","NON-TKI",17197,18478,1,"","",1,"adenocarcinoma","",18563,18416,"Pembrolizumab","anti-pd-1",0,0,0,1,1,1,"renal insufficiency","Early irAE","positive","IRAE","g13r",19058,3,NA,"",1,"","Foundation",1,642,40,18584,NA,">=50%","60%",0,1,0,0,168,1,"","No Prior TKI",0,"Asian",17448,1,"AJ12216R","",1,0,"IV",0,0,1,"",1,"",NA,NA,"h193r","Deceased",0
"4",0,66,"l1257v (vus)",0,1,"",0,1,"","","NON-TKI",18247,NA,0,"","r432w (vus)",NA,"large cell or nos nslc","",18418,18348,"Atezolizumab","anti-pd-l1",0,0,0,0,0,0,"none reported",NA,"negative","No irae","",18439,2,NA,"",0,"","Foundation",0,91,51,18436,NA,"1-49%","1%",1,0,0,0,88,1,"","No Prior TKI",0,"Black or African American",18327,0,"AJ28193V","",1,0,"IV",0,0,1,"splice site 598-23_609del35",0,"",NA,NA,"","Alive",0
"5",1,63,"",1,0,"",0,0,"","","NON-TKI",18180,18499,0,"","",NA,"adenocarcinoma","",18631,18332,"Pembrolizumab","anti-pd-1",0,0,0,1,1,1,"joint pain and numbness","Late irAE","positive","IRAE","",18660,1,NA,"",1,"","EGFR, ALK, ROS1 (All Negative)",0,328,NA,18660,NA,">=50%","91%",0,1,0,1,328,1,"","No Prior TKI",0,"Unknown or Other",18275,1,"AJ36478Q","",1,0,"IV",0,0,1,"",1,"",NA,NA,"","Deceased",0
"6",0,67,"negative",1,0,"",0,0,"","","NON-TKI",18124,18633,0,"negative","",NA,"squamous","",18676,18507,"Pembrolizumab","anti-pd-1",0,0,0,1,1,1,"fatigue","Late irAE","positive","IRAE","",18686,2,NA,"",1,"","GenPath",0,179,40,18686,NA,"Negative","Negative",0,0,1,0,179,1,"","No Prior TKI",0,"White",17988,1,"AJ63206T","",1,1,"III",1,0,0,"",1,"",NA,NA,"","Deceased",1
"7",1,81,"",1,0,"",0,0,"v600e","","NON-TKI",18614,NA,0,"","",NA,"adenocarcinoma","",19261,18683,"Pembrolizumab","anti-pd-1",0,0,0,0,0,0,"none reported",NA,"negative","No irae","",19289,1,NA,"",1,"","HopeSeq",1,606,NA,NA,NA,">=50%","60%",0,1,0,1,NA,0,"","No Prior TKI",0,"White",18675,1,"AJ83961S","",0,0,"IV",0,0,1,"",0,"",NA,NA,"q100ffs*50","Alive",1
"8",1,48,"",1,0,"",0,0,"","p16ink4a l65del, p14arf a79del","NON-TKI",18246,18296,1,"","",NA,"adenocarcinoma","",NA,18296,"Pembrolizumab","anti-pd-1",0,0,0,1,1,1,"fever","Early irAE","positive","IRAE","g12r",19296,1,NA,"h488y",1,"","Foundation",1,1000,29,NA,NA,">=50%","90%",0,1,0,1,NA,0,"","No Prior TKI",0,"White",18284,1,"AJ87336V","a322fs*65",1,0,"IV",0,0,1,"g56w",0,"",NA,NA,"c229fs*9","Alive",1
"9",1,48,"",1,0,"",0,0,"","","TKI",16858,NA,0,"","",NA,"adenocarcinoma","",17821,17707,"Pembrolizumab","anti-pd-1",0,0,0,0,0,0,"none reported",NA,"negative","No irae","",18207,4,7,"",0,"t1010i","Onco48",1,500,NA,17842,18047,"Not Reported","Not Reported",0,0,0,0,135,1,"","No Prior TKI",0,"White",17639,0,"AJ90696V","",0,0,"IV",0,0,1,"",1,"crizotinib",18047,17928,"","Deceased",1
"10",1,74,"",0,1,"",0,0,"","","NON-TKI",18457,NA,0,"","",NA,"adenocarcinoma","",18955,18487,"Atezolizumab","anti-pd-l1",0,0,0,0,0,0,"none reported",NA,"negative","No irae","g12a",19002,1,NA,"",0,"","Foundation",1,515,4,18975,NA,"Negative","Negative",0,0,1,1,488,1,"","No Prior TKI",0,"White",18507,0,"AK58337Z","",1,0,"I or II",0,1,0,"",1,"",NA,NA,"","Deceased",1
"11",1,67,"",0,1,"",0,0,"","","NON-TKI",18295,NA,0,"","",NA,"adenocarcinoma","",18730,18730,"Atezolizumab","anti-pd-l1",0,0,0,0,0,0,"none reported",NA,"negative","No irae","g12c",18773,2,NA,"",0,"","Foundation",0,43,30,18740,NA,"1-49%","1%",1,0,0,0,10,1,"","No Prior TKI",0,"White",18509,0,"AK61411S","",1,0,"IV",0,0,1,"",1,"",NA,NA,"r196p","Deceased",1
"12",0,58,"",1,0,"",1,0,"","","NON-TKI",17849,19271,0,"negative","",NA,"squamous","",NA,18507,"Nivolumab","anti-pd-1",1,0,0,0,0,0,"low tsh","Late irAE","positive","Endocrine","negative",19299,2,NA,"",1,"","Shanghai Jiaotong University Hospital molecular pathology report (EGFR, KRAS)",1,792,30,NA,NA,"Not Reported","",0,0,0,1,NA,0,"","No Prior TKI",0,"Asian",17849,1,"AK80128R","",1,1,"I or II",0,1,0,"",0,"",NA,NA,"","Alive",0
"13",1,81,"",1,0,"",0,0,"","","TKI",18723,NA,0,"amplification, m947t (vus)","",NA,"adenocarcinoma","",18845,18754,"Pembrolizumab","anti-pd-1",0,0,0,0,0,0,"none reported",NA,"negative","No irae","",18892,1,2,"",1,"","HopeSeq",0,138,1.25,18843,18887,">=50%","90%",0,1,0,0,89,1,"","No Prior TKI",0,"White",18831,1,"AK82032R","",1,0,"IV",0,0,1,"",1,"gefitinib",18887,18866,"q144*","Deceased",1
"14",1,56,"a1168a (syn)",0,1,"",0,0,"amplification","","NON-TKI",18178,NA,0,"amplification","",NA,"adenocarcinoma","",18647,18605,"Atezolizumab","anti-pd-l1",0,0,0,0,0,0,"none reported",NA,"negative","No irae","g12v, amplification",18680,2,NA,"",0,"amplification","Guardant360",0,75,30,18666,NA,"1-49%","4%",1,0,0,0,61,1,"","No Prior TKI",0,"White",18627,0,"AK86508Y","",1,0,"IV",0,0,1,"e57fs",1,"",NA,NA,"q100*, k101*","Deceased",1
"15",1,56,"",0,1,"",0,0,"","","NON-TKI",18178,NA,0,"","",NA,"adenocarcinoma","",18647,18605,"Atezolizumab","anti-pd-l1",0,0,0,0,0,0,"none reported",NA,"negative","No irae","",18680,2,NA,"",0,"","Paradigm  (ALK, ROS1: Neg, EGFR: Ins Spec.)",0,75,30,18666,NA,"1-49%","4%",1,0,0,0,61,1,"","No Prior TKI",0,"White",18201,0,"AK86508Y  ","",1,0,"IV",0,0,1,"",1,"",NA,NA,"","Deceased",1
"16",1,85,"",1,0,"",0,0,"","","NON-TKI",17590,NA,0,"negative","",NA,"adenocarcinoma","",18632,18487,"Nivolumab","anti-pd-1",0,0,0,0,0,0,"none reported",NA,"negative","No irae","",18671,2,NA,"",0,"","NeoGenomics",0,184,NA,18634,NA,"Not Reported","Not Reported",0,0,0,0,147,1,"","No Prior TKI",0,"White",17604,0,"AM24201U","",0,0,"No Staging Data",0,0,0,"",1,"",NA,NA,"","Deceased",1
"17",1,61,"",1,0,"",0,0,"","","NON-TKI",17821,17973,1,"","",2,"adenocarcinoma","",18906,17945,"Nivolumab","anti-pd-1",0,0,0,1,1,1,"fatigue","Early irAE","positive","IRAE","183a>c, q61h",19074,2,NA,"",1,"","OncoComplete",1,1129,30,18934,NA,">=50%","100%",0,1,0,1,989,1,"","No Prior TKI",0,"White",18297,1,"AM24398Q","",1,0,"IV",0,0,1,"",1,"",NA,NA,"","Deceased",1
"18",1,72,"",1,0,"",0,0,"","","NON-TKI",16035,NA,0,"","",NA,"adenocarcinoma","",18085,18043,"Nivolumab","anti-pd-1",0,0,0,0,0,0,"none reported",NA,"negative","No irae","",18146,1,NA,"",0,"","Onco48",0,103,NA,18096,NA,"Negative","Negative",0,0,1,0,53,1,"q546r","No Prior TKI",0,"White",17238,0,"AM86393W","",0,0,"IV",0,0,1,"",1,"",NA,NA,"","Deceased",1
"19",1,60,"",1,0,"",0,0,"","","NON-TKI",17889,18575,0,"","",NA,"adenocarcinoma","",18575,18263,"Nivolumab","anti-pd-1",1,1,0,0,0,0,"autoimmune hypothyroidism","Late irAE","positive","Endocrine","",18743,1,NA,"",1,"","Onco48",1,480,80,18666,NA,">=50%","90%",0,1,0,1,403,1,"","No Prior TKI",0,"White",17913,1,"AM89841U","",1,0,"IV",0,0,1,"",1,"",NA,NA,"","Deceased",1
"20",1,74,"",1,0,"",0,0,"","","NON-TKI",18122,NA,0,"","",NA,"adenocarcinoma","",NA,18731,"Nivolumab","anti-pd-1",0,0,0,0,0,0,"none reported",NA,"negative","No irae","",19305,3,NA,"",0,"","Foundation",1,574,15,NA,NA,"Negative","Negative",0,0,1,1,NA,0,"","No Prior TKI",0,"Unknown or Other",18197,0,"AN09251Z","",1,0,"IV",0,0,1,"",0,"",NA,NA,"","Alive",0
"21",1,61,"",1,0,"",0,0,"","","TKI",16808,NA,0,"g724s, s768i","",NA,"adenocarcinoma","",17879,17865,"Nivolumab","anti-pd-1",0,0,0,0,0,0,"none reported",NA,"negative","No irae","",17905,6,1,"",0,"","Onco48",0,40,NA,17897,17276,"Not Reported","Not Reported",0,0,0,0,32,1,"","Prior TKI",1,"White",17590,0,"AN70874Z","",0,0,"IV",0,0,1,"",1,"erlotinib",17276,16846,"","Deceased",1
"22",0,78,"",1,0,"",1,0,"","","NON-TKI",16637,17604,1,"","",2,"squamous","",17646,17562,"Nivolumab","anti-pd-1",1,1,1,0,0,0,"rash","Early irAE","positive","Skin","",18337,3,NA,"",1,"","No Report",1,775,40,17658,NA,"Not Reported","Not Reported",0,0,0,0,96,1,"","No Prior TKI",0,"Asian",NA,1,"AN76471W","",1,1,"IV",0,0,1,"",1,"",NA,NA,"","Deceased",0
"23",1,82,"negative",0,1,"",0,0,"negative","","NON-TKI",18319,18479,0,"negative","",2,"adenocarcinoma","",18863,18374,"Atezolizumab","anti-pd-l1",1,1,1,0,0,0,"dyspnea","Late irAE","positive","Respiratory","g12c",18955,2,NA,"",1,"","Integrated Oncology (EGFR, BRAF, KRAS, ROS1)",1,581,35,18884,NA,"1-49%","15%",1,0,0,1,510,1,"","No Prior TKI",0,"White",18295,1,"BJ11140X","",1,0,"IV",0,0,1,"",1,"",NA,NA,"","Deceased",1
"24",0,52,"",0,1,"",0,0,"","","NON-TKI",18029,NA,0,"s768_d770dup","",NA,"large cell or nos nslc","",18288,18183,"Atezolizumab","anti-pd-l1",0,0,0,0,0,0,"none reported",NA,"negative","No irae","",18767,3,NA,"",0,"","OncoComplete",1,584,NA,18320,NA,"1-49%","2%",1,0,0,0,137,1,"","No Prior TKI",0,"White",18172,0,"BJ31229X","",0,0,"IV",0,0,1,"",1,"",NA,NA,"r248g, h193r","Deceased",1
"25",1,79,"negative",0,1,"",0,0,"","","NON-TKI",17820,NA,0,"negative","",NA,"adenocarcinoma","",18739,18523,"Atezolizumab","anti-pd-l1",0,0,0,0,0,0,"none reported",NA,"negative","No irae","negative",18739,1,NA,"",1,"","GenPath EGFR, KRAS, ALK, ROS ",0,216,NA,18739,NA,"Negative","<10%",0,0,1,1,216,1,"","No Prior TKI",0,"White",17854,1,"BJ42537S","",0,0,"IV",0,0,1,"",1,"",NA,NA,"","Deceased",1
"26",1,67,"",1,0,"",0,0,"","p.e33*","NON-TKI",18513,18661,0,"","",NA,"adenocarcinoma","",18765,18586,"Pembrolizumab","anti-pd-1",0,0,0,1,1,1,"fatigue","Late irAE","positive","IRAE","",18785,1,NA,"",0,"","HopeSeq",0,199,20,18785,NA,"Negative","Negative",0,0,1,1,199,1,"","No Prior TKI",0,"Unknown or Other",18575,0,"BJ75540P","d1188y (vus)",1,0,"IV",0,0,1,"",1,"",NA,NA,"e62*","Deceased",0
"27",0,75,"",1,0,"",0,0,"","","NON-TKI",18571,18619,1,"","",NA,"squamous","",19201,18619,"Pembrolizumab","anti-pd-1",1,1,1,0,0,0,"keytruda induced pulmonary toxicity","Early irAE","positive","Respiratory","",19237,1,NA,"",0,"","Integrated Oncology EGFR, ALK, ROS1 (All Negative)",1,618,10,19222,NA,"1-49%","30%",1,0,0,1,603,1,"","No Prior TKI",0,"White",18600,0,"BJ87673T","",1,1,"IV",0,0,1,"",0,"",NA,NA,"","Alive",1
"28",0,73,"",0,1,"",1,0,"","h66r","NON-TKI",17360,18743,0,"","",NA,"squamous","",18848,18437,"Atezolizumab","anti-pd-l1",0,0,0,1,1,0,"fatigue","Late irAE","positive","IRAE","",18967,4,NA,"",1,"","Foundation",1,530,2,18862,NA,"Not Reported","",0,0,0,1,425,1,"e542k","No Prior TKI",0,"Asian",17757,1,"BJ88141Q","",1,1,"I or II",0,1,0,"",1,"",NA,NA,"","Deceased",0
"29",1,80,"",1,0,"",1,0,"","","TKI",17917,NA,0,"l858r","",NA,"adenocarcinoma","",18312,18043,"Nivolumab","anti-pd-1",0,0,0,0,0,0,"none reported",NA,"negative","No irae","",18696,2,3,"",1,"","FoundationACT",1,653,NA,18331,NA,"Not Reported","Not Reported",0,0,0,1,288,1,"","No Prior TKI",0,"Asian",18589,1,"BK36299Z","",0,0,"IV",0,0,1,"",1,"osimertinib",18683,18589,"a276g, v272m-equivocal","Deceased",0
"30",1,67,"negative",1,0,"",0,0,"","","NON-TKI",17360,18968,0,"","",NA,"adenocarcinoma","",18989,18582,"Pembrolizumab","anti-pd-1",0,0,0,1,0,0,"fatigue  (possibly related to pembrolizumab)","Late irAE","positive","IRAE","",19285,2,NA,"",0,"","ResponseDX Lung EGFR, ALK (Negative)",1,703,64,18989,NA,"Negative","Negative",0,0,1,1,407,1,"","No Prior TKI",0,"White",17416,0,"BK78518P","",1,0,"IV",0,0,1,"",0,"",NA,NA,"","Alive",1
"31",1,66,"",1,0,"",0,0,"","","NON-TKI",18570,NA,0,"","",NA,"adenocarcinoma","",18625,18570,"Pembrolizumab","anti-pd-1",0,0,0,0,0,0,"none reported",NA,"negative","No irae","",18646,1,NA,"",0,"","Clarient Diagnostic Services EGFR, KRAS, ALK (All Negative)",0,76,NA,18646,NA,">=50%","80%",0,1,0,0,76,1,"","No Prior TKI",0,"White",18549,0,"BK96094Q","",0,0,"IV",0,0,1,"",1,"",NA,NA,"","Deceased",1
"32",1,78,"",1,0,"",0,0,"","","NON-TKI",17667,18065,1,"","",NA,"adenocarcinoma","",18079,18051,"Nivolumab","anti-pd-1",0,0,0,1,1,1,"fatigue worsening","Early irAE","positive","IRAE","",18138,3,NA,"",1,"","Onco48",0,87,NA,18089,NA,"1-49%",">1%",1,0,0,0,38,1,"","No Prior TKI",0,"White",17835,1,"BL01023V","",0,0,"IV",0,0,1,"",1,"",NA,NA,"","Deceased",1
"33",1,70,"",1,0,"",0,0,"","","NON-TKI",18373,NA,0,"","r47h (vus)",NA,"adenocarcinoma","",18759,18404,"Pembrolizumab","anti-pd-1",0,0,0,0,0,0,"none reported",NA,"negative","No irae","",19229,1,NA,"p3215t (vus)",0,"","Foundation",1,825,24,18815,NA,"Negative","Negative",0,0,1,1,411,1,"","No Prior TKI",0,"White",18407,0,"BL05428Z","",1,0,"IV",0,0,1,"m1?",1,"",NA,NA,"p152fs*18","Deceased",1
"34",1,76,"",1,0,"p1169fs*25",0,0,"","loss","NON-TKI",18677,NA,0,"","a775_g776insyvma, amplification",NA,"adenocarcinoma","",NA,18736,"Pembrolizumab","anti-pd-1",0,0,0,0,0,0,"none reported",NA,"negative","No irae","",19303,1,NA,"",1,"","Foundation",1,567,NA,NA,NA,">=50%","70%",0,1,0,1,NA,0,"","No Prior TKI",0,"White",18731,1,"BL16199R","",0,0,"IV",0,0,1,"",0,"",NA,NA,"","Alive",1
"35",1,64,"",1,0,"",0,0,"l597r","","NON-TKI",18177,18456,1,"","",NA,"adenocarcinoma","",18480,18456,"Pembrolizumab","anti-pd-1",1,1,1,0,0,0,"postobstructive pneumonitis","Early irAE","positive","Respiratory","",18506,2,NA,"",1,"","OncoComplete",0,50,40,18493,NA,">=50%","50%",0,1,0,0,37,1,"e545k","No Prior TKI",0,"White",18416,1,"BL28358Y","",1,0,"IV",0,0,1,"",1,"",NA,NA,"p151s","Deceased",1
"36",1,62,"",0,1,"",0,0,"","","NON-TKI",18186,18373,1,"","",2,"adenocarcinoma","",18381,18360,"Atezolizumab","anti-pd-l1",1,1,1,0,0,0,"nausea, vomiting","Early irAE","positive","Gastrointestinal","g12v",18402,2,NA,"r2240l (vus)",1,"","Foundation",0,42,50,18394,NA,"1-49%","1%",1,0,0,0,34,1,"","No Prior TKI",0,"White",18214,1,"BL42206S","splice site 2860-2a>g",1,0,"IV",0,0,1,"g196v",1,"",NA,NA,"","Deceased",1
"37",1,62,"",1,0,"",0,0,"","","NON-TKI",18277,NA,0,"","",NA,"adenocarcinoma","",18540,18540,"Nivolumab","anti-pd-1",0,0,0,0,0,0,"none reported",NA,"negative","No irae","",18546,2,NA,"",1,"","Foundation",0,6,NA,18546,NA,"Not Reported","Not Reported",0,0,0,0,6,1,"","No Prior TKI",0,"Unknown or Other",18445,1,"BL45385S","",0,0,"IV",0,0,1,"",1,"",NA,NA,"r249s","Deceased",0
"38",1,47,"",1,0,"",1,0,"","","TKI",17728,NA,0,"l858r, t790m","",NA,"adenocarcinoma","",18543,18519,"Pembrolizumab","anti-pd-1",0,0,0,0,0,0,"none reported",NA,"negative","No irae","",18575,3,2,"",0,"","Cancer Genetics Incorporated EGFR ",0,56,NA,18547,18137,"1-49%","10%",1,0,0,0,28,1,"","Prior TKI",1,"Asian",18247,0,"BL55855X","",0,0,"IV",0,0,1,"",0,"erlotinib",18137,17833,"","Alive",0
"39",1,58,"",0,1,"",0,0,"","","NON-TKI",18635,18827,0,"","",2,"adenocarcinoma","",18813,18743,"Durvalumab","anti-pd-l1",1,1,1,0,0,0,"pneumonitis","Late irAE","positive","Respiratory","g12c",19283,2,NA,"",1,"","Foundation",1,540,25,NA,NA,"Negative","Negative",0,0,1,1,NA,0,"","No Prior TKI",0,"White",18668,1,"BL85903T","",1,0,"III",1,0,0,"k44fs*8",0,"",NA,NA,"h193y","Alive",1
"40",1,64,"",0,1,"",1,0,"","","NON-TKI",18103,18652,0,"","",3,"adenocarcinoma","",18781,18379,"Atezolizumab","anti-pd-l1",1,1,0,0,0,0,"rash","Late irAE","positive","Skin","",19194,2,NA,"v4561fs*16, g174e (vus)",1,"","Foundation",1,815,20,NA,NA,"Negative","Negative",0,0,1,1,NA,0,"","No Prior TKI",0,"Asian",18452,1,"BM36874R","",1,0,"I or II",0,1,0,"",0,"",NA,NA,"g244c","Alive",0
"41",0,45,"negative",1,0,"",1,0,"","","NON-TKI",17780,NA,0,"negative","",NA,"large cell or nos nslc","",18283,17903,"Pembrolizumab","anti-pd-1",0,0,0,0,0,0,"none reported",NA,"negative","No irae","",19165,2,NA,"",1,"","Huntington Hospital molecular analysis (ALK, EGFR, ROS1)",1,1262,30,18799,NA,"Not Reported","Not Reported",0,0,0,1,896,1,"","No Prior TKI",0,"Asian",17799,1,"BM48793T","",1,0,"III",1,0,0,"",0,"",NA,NA,"","Alive",0
"42",1,68,"",1,0,"",0,0,"","","NON-TKI",17974,18429,0,"","amplification  equivocal",NA,"adenocarcinoma","",18375,18116,"Nivolumab","anti-pd-1",1,1,0,0,0,0,"abnormal thyroid function","Late irAE","positive","Endocrine","",18499,2,NA,"",0,"","Foundation",1,383,15,18422,NA,"Not Reported","",0,0,0,1,306,1,"","No Prior TKI",0,"White",18458,0,"BM49651S","t910m",1,0,"IV",0,0,1,"",1,"",NA,NA,"r335fs*10","Deceased",1
"43",1,71,"",1,0,"",1,0,"","","NON-TKI",18620,NA,0,"","",NA,"adenocarcinoma","",18732,18691,"Pembrolizumab","anti-pd-1",0,0,0,0,0,0,"none reported",NA,"negative","No irae","",18744,1,NA,"",1,"","NeoGenomics EGFR, ALK, ROS1, BRAF (All Negative)",0,53,15,18744,NA,">=50%","100%",0,1,0,0,53,1,"","No Prior TKI",0,"Asian",18627,1,"BM82043W","",1,0,"IV",0,0,1,"",1,"",NA,NA,"","Deceased",0
"44",1,56,"",1,0,"",1,0,"","","TKI",18194,NA,0,"","",NA,"adenocarcinoma","",19046,18257,"Pembrolizumab","anti-pd-1",0,0,0,0,0,0,"none reported",NA,"negative","No irae","",19310,1,2,"",1,"","Caris",1,1053,NA,19074,NA,"Negative","Negative",0,0,1,1,817,1,"","No Prior TKI",0,"Asian",18177,1,"BM85639U","",0,0,"IV",0,0,1,"",0,"osimertinib",NA,19116,"","Alive",0
"45",1,67,"",1,0,"",0,1,"","","NON-TKI",18640,NA,0,"","",NA,"adenocarcinoma","",18696,18675,"Pembrolizumab","anti-pd-1",0,0,0,0,0,0,"none reported",NA,"negative","No irae","",19305,2,NA,"",0,"","HopeSeq",1,630,25,18738,NA,">=50%","100%",0,1,0,0,63,1,"","No Prior TKI",0,"Black or African American",18645,0,"BM98123S","",1,0,"IV",0,0,1,"p.a218lfs*69, c.652del",0,"",NA,NA,"p.r283p, c.848g>c","Alive",0
"46",1,60,"",1,0,"",0,0,"","","NON-TKI",16066,18101,0,"","",NA,"adenocarcinoma","",NA,17835,"Nivolumab","anti-pd-1",1,1,0,0,0,0,"increased tsh","Late irAE","positive","Endocrine","",19320,3,NA,"",0,"","Foundation",1,1485,NA,NA,NA,"Not Reported","",0,0,0,1,NA,0,"","No Prior TKI",0,"White",17247,0,"BN28051T","",1,0,"IV",0,0,1,"g251c (vus)",0,"",NA,NA,"","Alive",1
"47",0,65,"",0,1,"",0,0,"","","NON-TKI",18418,NA,0,"","",NA,"squamous","",18754,18564,"Atezolizumab","anti-pd-l1",0,0,0,0,0,0,"none reported",NA,"negative","No irae","",18887,1,NA,"",1,"","NeoGenomics (Only PD-L1)",0,323,100,18766,NA,">=50%","90%",0,1,0,1,202,1,"","No Prior TKI",0,"White",18361,1,"BN32732V","",1,1,"III",1,0,0,"",1,"",NA,NA,"","Deceased",1
"48",1,67,"",1,0,"",0,0,"","","NON-TKI",18326,NA,0,"","",NA,"adenocarcinoma","",NA,18397,"Nivolumab","anti-pd-1",0,0,0,0,0,0,"none reported",NA,"negative","No irae","",19318,2,NA,"",1,"","Foundation",1,921,NA,NA,NA,"Negative","Negative",0,0,1,1,NA,0,"","No Prior TKI",0,"White",18345,1,"BN40084Z","",0,0,"IV",0,0,1,"",0,"",NA,NA,"","Alive",1
"49",1,64,"eml4-alk fusion",1,0,"q379*",0,0,"","","NON-TKI",18227,NA,0,"","",NA,"adenocarcinoma","",18297,18276,"Pembrolizumab","anti-pd-1",0,0,0,0,0,0,"none reported",NA,"negative","No irae","",19286,6,NA,"",1,"","HopeSeq",1,1010,NA,18317,NA,">=50%","75%",0,1,0,0,41,1,"","No Prior TKI",0,"Unknown or Other",19013,1,"BN69618X","",0,0,"IV",0,0,1,"",0,"",NA,NA,"","Alive",0
"50",1,54,"",0,1,"q467h (vus)",0,0,"","","NON-TKI",18208,NA,0,"","amplification  equivocal, p523s (vus)",NA,"adenocarcinoma","",18332,18290,"Atezolizumab","anti-pd-l1",0,0,0,0,0,0,"none reported",NA,"negative","No irae","",18379,2,NA,"g418v",1,"","Foundation",0,89,30,18358,NA,"Negative","Negative",0,0,1,0,68,1,"","No Prior TKI",0,"White",18240,1,"BN75908T","e1573*",1,0,"IV",0,0,1,"",1,"",NA,NA,"s94*","Deceased",1
"51",1,75,"",1,0,"",0,0,"","","NON-TKI",17273,NA,0,"","",NA,"adenocarcinoma","",17967,17967,"Nivolumab","anti-pd-1",0,0,0,0,0,0,"none reported",NA,"negative","No irae","35g>a g12d",17988,7,NA,"",0,"","Onco48",0,21,10,17988,NA,"Not Reported","Not Reported",0,0,0,0,21,1,"","No Prior TKI",0,"White",17646,0,"CJ12812T","",1,0,"IV",0,0,1,"",1,"",NA,NA,"","Deceased",1
"52",1,72,"negative",0,1,"",0,0,"","","NON-TKI",18026,18221,1,"negative","",NA,"adenocarcinoma","",18221,18200,"Atezolizumab","anti-pd-l1",0,0,0,1,1,1,"diffuse body aches, fatigue","Early irAE","positive","IRAE","",18278,2,NA,"",1,"","Clarient Diagnostic Services (ALK, ROS1, EGFR)",0,78,75,18234,NA,"Not Reported","",0,0,0,0,34,1,"","No Prior TKI",0,"White",18227,1,"CJ17325Y","",1,0,"IV",0,0,1,"",1,"",NA,NA,"","Deceased",1
"53",1,65,"",1,0,"",0,1,"","d84y, a102v","NON-TKI",18110,19278,0,"","",NA,"adenocarcinoma","",NA,18296,"Pembrolizumab","anti-pd-1",0,0,0,1,0,0,"hyperkalemia","Late irAE","positive","IRAE","g12c",19312,1,NA,"",1,"","OncoComplete",1,1016,50,NA,NA,">=50%","60%",0,1,0,1,NA,0,"","No Prior TKI",0,"Black or African American",18235,1,"CJ90419P","",1,0,"IV",0,0,1,"",0,"",NA,NA,"v157f","Alive",0
"54",1,65,"",1,0,"",0,0,"","","NON-TKI",17772,17925,1,"","",1,"adenocarcinoma","",17925,17883,"Pembrolizumab","anti-pd-1",0,0,0,1,1,1,"arthralgias, myalgias, fatigue","Early irAE","positive","IRAE","35g>t, g12v",18104,2,NA,"",0,"","Foundation",0,221,15,17974,NA,"1-49%","10%",1,0,0,0,91,1,"","No Prior TKI",0,"White",17824,0,"CK19080Q","",1,0,"III",1,0,0,"y60fs*1",1,"",NA,NA,"q331*","Deceased",1
"55",0,66,"",1,0,"",0,0,"","","NON-TKI",17345,NA,0,"","",NA,"squamous","",18547,17627,"Nivolumab","anti-pd-1",0,0,0,0,0,0,"none reported",NA,"negative","No irae","",18550,2,NA,"",1,"","No Report",1,923,50,18550,NA,"Not Reported","Not Reported",0,0,0,1,923,1,"","No Prior TKI",0,"White",NA,1,"CK38232V","",1,1,"IV",0,0,1,"",1,"",NA,NA,"","Deceased",1
"56",1,62,"",1,0,"",0,0,"","","NON-TKI",18555,18647,1,"","",3,"adenocarcinoma","",18640,18619,"Pembrolizumab","anti-pd-1",1,1,1,0,0,0,"increase in alt","Early irAE","positive","Endocrine","",18842,1,NA,"",1,"","No Report",0,223,40,18660,NA,">=50%","90%",0,1,0,0,41,1,"","No Prior TKI",0,"Unknown or Other",NA,1,"CK58229U","",1,0,"IV",0,0,1,"",1,"",NA,NA,"","Deceased",0
"57",1,71,"",1,0,"",0,0,"","","NON-TKI",18222,18277,1,"","",NA,"adenocarcinoma","",18302,18277,"Pembrolizumab","anti-pd-1",0,0,0,1,1,1,"fever and chills","Early irAE","positive","IRAE","",18361,1,NA,"",0,"","EGFR, ALK, ROS1 (All Negative)",0,84,10,18326,NA,">=50%","80%",0,1,0,0,49,1,"","No Prior TKI",0,"White",18247,0,"CK69121Y","",1,0,"IV",0,0,1,"",1,"",NA,NA,"","Deceased",1
"58",1,65,"",1,0,"",0,0,"","","TKI",15736,17787,1,"d770_n771>asvdn","",NA,"adenocarcinoma","",17773,17773,"Nivolumab","anti-pd-1",0,0,0,1,1,1,"fatigue","Early irAE","positive","IRAE","",18117,5,2,"",0,"","Foundation",0,344,NA,17809,NA,"Not Reported","Not Reported",0,0,0,0,36,1,"","Prior TKI",1,"White",17155,0,"CK71200Z","",0,0,"I or II",0,1,0,"",1,"erlotinib",16919,16888,"","Deceased",1
"59",1,66,"",1,0,"",0,0,"","","NON-TKI",18502,18687,0,"","p625l (vus)",NA,"adenocarcinoma","",18886,18562,"Pembrolizumab","anti-pd-1",0,0,0,1,1,1,"anemia","Late irAE","positive","IRAE","",19296,1,NA,"",0,"","FoundationACT",1,734,NA,18907,NA,"Not Reported","Not Reported",0,0,0,1,345,1,"","No Prior TKI",0,"White",18788,0,"CL25673Q","",0,0,"III",1,0,0,"",0,"",NA,NA,"","Alive",1
"60",1,59,"",1,0,"p120s (vus)",0,1,"r444w","s73r (vus)","NON-TKI",17099,18666,1,"","",NA,"adenocarcinoma","",18639,18625,"Nivolumab","anti-pd-1",1,1,1,0,0,0,"autoimmune pneumonitis","Early irAE","positive","Respiratory","",18679,2,NA,"",0,"","Foundation",0,54,11,18666,NA,"1-49%","5%",1,0,0,0,41,1,"","No Prior TKI",0,"Black or African American",18271,0,"CL62692S","",1,0,"IV",0,0,1,"splice site 921-1g>t",1,"",NA,NA,"l194h","Deceased",0
"61",0,77,"",1,0,"",1,0,"","p16ink4a a102fs*44, p14arf r115fs*57","TKI",17205,NA,0,"","",NA,"squamous","",18605,18584,"Pembrolizumab","anti-pd-1",0,0,0,0,0,0,"none reported",NA,"negative","No irae","amplification",18745,6,5,"",1,"","Foundation",0,161,20,18626,18258,"Negative","Negative",0,0,1,0,42,1,"","Prior TKI",1,"Asian",18512,1,"CL67301P","",1,1,"IV",0,0,1,"",1,"erlotinib",18258,18137,"e271v","Deceased",0
"62",1,69,"",1,0,"",0,0,"","","NON-TKI",16676,NA,0,"","",NA,"adenocarcinoma","",18040,18040,"Pembrolizumab","anti-pd-1",0,0,0,0,0,0,"none reported",NA,"negative","No irae","",18136,4,NA,"",1,"","Onco48",0,96,40,18136,NA,"Negative","Negative",0,0,1,0,96,1,"","No Prior TKI",0,"Unknown or Other",17891,1,"CL87718V","",1,0,"IV",0,0,1,"",1,"",NA,NA,"596g>t g199v","Deceased",0
"63",0,72,"",1,0,"",0,0,"","","NON-TKI",16640,NA,0,"","",NA,"squamous","",NA,17570,"Nivolumab","anti-pd-1",0,0,0,0,0,0,"none reported",NA,"negative","No irae","",19312,5,NA,"",1,"","Foundation",1,1742,25,NA,NA,"Not Reported","Not Reported",0,0,0,1,NA,0,"amp+","No Prior TKI",0,"Unknown or Other",18829,1,"CL96943Q","",1,1,"IV",0,0,1,"",0,"",NA,NA,"r249s","Alive",0
"64",1,80,"",0,1,"",0,0,"","","NON-TKI",18451,19030,0,"","",NA,"adenocarcinoma","",19030,18597,"Durvalumab","anti-pd-l1",1,0,0,0,0,0,"itching","Late irAE","positive","Skin","",19205,1,NA,"",0,"","Integrated Oncology EGFR, ALK, ROS1, MET, RET (All Negative)",1,608,130,19205,NA,"1-49%","3%",1,0,0,1,608,1,"","No Prior TKI",0,"Unknown or Other",18540,0,"CM17462Z","",1,0,"IV",0,0,1,"",1,"",NA,NA,"","Deceased",0
"65",0,81,"",1,0,"",0,0,"","","NON-TKI",18190,NA,0,"","",NA,"squamous","",18681,18639,"Nivolumab","anti-pd-1",0,0,0,0,0,0,"none reported",NA,"negative","No irae","",18681,2,NA,"",1,"","No Report",0,42,15,NA,NA,"1-49%","10%",1,0,0,1,NA,0,"","No Prior TKI",0,"White",NA,1,"CM71581W","",1,1,"III",1,0,0,"",0,"",NA,NA,"","Alive",1
"66",0,81,"",0,1,"",1,0,"","","NON-TKI",18257,18638,0,"","",NA,"squamous","",18617,18554,"Atezolizumab","anti-pd-l1",1,1,1,0,0,0,"pneumonitis","Late irAE","positive","Respiratory","",19138,2,NA,"",1,"","No Report",1,584,100,18706,NA,"Not Reported","Not Reported",0,0,0,0,152,1,"","No Prior TKI",0,"Asian",NA,1,"CM80981S","",1,1,"I or II",0,1,0,"",1,"",NA,NA,"","Deceased",0
"67",1,80,"",1,0,"",0,0,"","","NON-TKI",18703,NA,0,"","",NA,"adenocarcinoma","",18872,18725,"Pembrolizumab","anti-pd-1",0,0,0,0,0,0,"none reported",NA,"negative","No irae","",18943,1,NA,"",0,"","No Report",0,218,NA,18883,NA,">=50%","80%",0,1,0,0,158,1,"","No Prior TKI",0,"Unknown or Other",NA,0,"CM97521V","",0,0,"IV",0,0,1,"",0,"",NA,NA,"","Alive",0
"68",1,57,"",1,0,"",0,0,"","","NON-TKI",17564,18191,0,"","",NA,"adenocarcinoma","",18722,18052,"Nivolumab","anti-pd-1",1,1,1,0,0,0,"rash","Late irAE","positive","Skin","",19306,2,NA,"",1,"","Foundation",1,1254,20,18960,NA,"Not Reported","Not Reported",0,0,0,1,908,1,"","No Prior TKI",0,"White",17672,1,"CN07184Y","",1,0,"IV",0,0,1,"",0,"",NA,NA,"s215i","Alive",1
"69",1,65,"",1,0,"",0,0,"","","NON-TKI",16622,18071,1,"","",NA,"adenocarcinoma","",18051,18009,"Pembrolizumab","anti-pd-1",1,1,1,0,0,0,"diarrhea","Early irAE","positive","Gastrointestinal","",19303,4,NA,"",1,"","Onco48",1,1294,60,18080,NA,">=50%","51%",0,1,0,0,71,1,"","No Prior TKI",0,"White",17242,1,"CN14047U","",1,0,"IV",0,0,1,"",0,"",NA,NA,"1045g>t e349*","Alive",1
"70",0,41,"",1,0,"",0,0,"","","NON-TKI",18093,NA,0,"","",NA,"squamous","",18593,18593,"Nivolumab","anti-pd-1",0,0,0,0,0,0,"none reported",NA,"negative","No irae","",18610,2,NA,"",0,"","No Report",0,17,NA,18607,NA,"Not Reported","Not Reported",0,0,0,0,14,1,"","No Prior TKI",0,"White",NA,0,"CN17754W","",1,1,"IV",0,0,1,"",0,"",NA,NA,"","Alive",1
"71",1,56,"negative",1,0,"",0,0,"","","NON-TKI",17889,18365,1,"negative","",NA,"adenocarcinoma","",NA,18337,"Nivolumab","anti-pd-1",0,0,0,1,1,1,"hypophosphatemia","Early irAE","positive","IRAE","",19317,2,NA,"",1,"","Harbor-UCLA molecular report (EGFR, ALK, ROS1)",1,980,20,NA,NA,"Not Reported","",0,0,0,1,NA,0,"","No Prior TKI",0,"Unknown or Other",17899,1,"CN19997Z","",1,0,"IV",0,0,1,"",0,"",NA,NA,"","Alive",0
"72",1,77,"",0,1,"",0,0,"","","TKI",17406,NA,0,"l747_p753delinss, t790m","",NA,"adenocarcinoma","",18225,18200,"Atezolizumab","anti-pd-l1",0,0,0,0,0,0,"none reported",NA,"negative","No irae","",18417,5,1,"",0,"","Onco48",0,217,10,18241,17833,"Not Reported","Not Reported",0,0,0,0,41,1,"","Prior TKI",1,"White",17856,0,"CN45852X","",1,0,"IV",0,0,1,"",0,"erlotinib",17833,17437,"","Alive",1
"73",1,99,"",1,0,"",0,0,"","","NON-TKI",18318,NA,0,"","",NA,"adenocarcinoma","",18395,18395,"Pembrolizumab","anti-pd-1",0,0,0,0,0,0,"none reported",NA,"negative","No irae","",18409,1,NA,"",1,"","NeoGenomics EGFR, ALK, ROS1, BRAF, KRAS, MET (All Negative)",0,14,30,18402,NA,">=50%","60%",0,1,0,0,7,1,"","No Prior TKI",0,"White",18365,1,"CN70633Q","",1,0,"IV",0,0,1,"",1,"",NA,NA,"","Deceased",1
"74",0,65,"",1,0,"",0,0,"","p16ink4a a21del","NON-TKI",18330,NA,0,"","amplification",NA,"squamous","",18862,18355,"Pembrolizumab","anti-pd-1",0,0,0,0,0,0,"none reported",NA,"negative","No irae","",18867,1,NA,"deletion exons 21-26, d3973e (vus)",1,"","Foundation",1,512,14,18867,NA,">=50%","70%",0,1,0,1,512,1,"","No Prior TKI",0,"White",18360,1,"CN76754W","",1,1,"IV",0,0,1,"",1,"",NA,NA,"r280i","Deceased",1
"75",0,74,"k194r (vus)",1,0,"",0,0,"","loss","NON-TKI",18715,18814,1,"","",1,"large cell or nos nslc","",NA,18751,"Pembrolizumab","anti-pd-1",0,0,0,1,1,1,"fatigue","Early irAE","positive","IRAE","g12v",19305,1,NA,"",1,"","Foundation",1,554,100,NA,NA,">=50%","90%",0,1,0,1,NA,0,"","No Prior TKI",0,"White",18764,1,"CN83085T","",1,0,"IV",0,0,1,"",0,"",NA,NA,"r213*","Alive",1
"76",0,72,"",0,1,"",0,0,"","","NON-TKI",18330,NA,0,"","",NA,"squamous","",18918,18619,"Atezolizumab","anti-pd-l1",0,0,0,0,0,0,"none reported",NA,"negative","No irae","",18964,2,NA,"",1,"","No Report",0,345,60,18925,NA,"1-49%","10%",1,0,0,1,306,1,"","No Prior TKI",0,"Unknown or Other",NA,1,"CN83886T","",1,1,"IV",0,0,1,"",0,"",NA,NA,"","Alive",0
"77",1,81,"",0,1,"",0,0,"","","NON-TKI",18639,NA,0,"","",NA,"adenocarcinoma","",18730,18708,"Atezolizumab","anti-pd-l1",0,0,0,0,0,0,"none reported",NA,"negative","No irae","",19213,1,NA,"",0,"","No Report",1,505,NA,18746,NA,"Negative","Negative",0,0,1,0,38,1,"","No Prior TKI",0,"White",NA,0,"DJ09962R","",0,0,"I or II",0,1,0,"",0,"",NA,NA,"","Alive",1
"78",0,82,"",0,1,"",0,0,"","","NON-TKI",18575,18842,0,"","",1,"squamous","",18821,18536,"Atezolizumab","anti-pd-l1",0,0,0,1,1,0,"thrombocytopenia","Late irAE","positive","IRAE","",19234,1,NA,"",1,"exon 14 splice site (3028+1g>a)","Foundation",1,698,18,NA,NA,">=50%","70%",0,1,0,1,NA,0,"e545k","No Prior TKI",0,"White",18515,1,"DJ24962Z","",1,1,"III",1,0,0,"",0,"",NA,NA,"","Alive",1
"79",1,73,"",0,1,"",0,0,"","","NON-TKI",18087,NA,0,"","",NA,"adenocarcinoma","",18213,18171,"Atezolizumab","anti-pd-l1",0,0,0,0,0,0,"none reported",NA,"negative","No irae","",18253,2,NA,"",1,"","Northwestern Memorial Healthcare (22 gene panel)",0,82,20,18253,NA,"1-49%","15%",1,0,0,0,82,1,"m1043i","No Prior TKI",0,"White",18064,1,"DJ25623Y","",1,0,"IV",0,0,1,"",1,"",NA,NA,"","Deceased",1
"80",1,69,"",0,1,"",0,1,"","","NON-TKI",18422,NA,0,"","",NA,"adenocarcinoma","",18625,18583,"Atezolizumab","anti-pd-l1",0,0,0,0,0,0,"none reported",NA,"negative","No irae","",18726,2,NA,"",1,"","HopeSeq",0,143,50,18635,NA,"Not Reported","Not Reported",0,0,0,0,52,1,"","No Prior TKI",0,"Black or African American",18542,1,"DJ26319T","",1,0,"IV",0,0,1,"",1,"",NA,NA,"","Deceased",0
"81",1,56,"",1,0,"",1,0,"","","NON-TKI",18409,NA,0,"","a775_g776insyvma, amplification- equivocal",NA,"adenocarcinoma","",18498,18452,"Pembrolizumab","anti-pd-1",0,0,0,0,0,0,"none reported",NA,"negative","No irae","",19082,1,NA,"",0,"","Foundation",1,630,NA,18514,NA,">=50%","60%",0,1,0,0,62,1,"","No Prior TKI",0,"Asian",18417,0,"DJ27084Q","",0,0,"IV",0,0,1,"",1,"",NA,NA,"r209fs*6","Deceased",0
"82",1,69,"",1,0,"",0,0,"","","NON-TKI",18008,18465,0,"","",1,"adenocarcinoma","",19030,18290,"Pembrolizumab","anti-pd-1",0,0,0,1,1,1,"dry mouth","Late irAE","positive","IRAE","g12c",19243,1,NA,"g2637v (vus)",1,"","Foundation",1,953,50,NA,NA,">=50%","100%",0,1,0,1,NA,0,"","No Prior TKI",0,"White",18027,1,"DJ54614P","",1,0,"IV",0,0,1,"",0,"",NA,NA,"","Alive",1
"83",0,70,"",1,0,"",0,0,"","","NON-TKI",17717,17848,1,"","",1,"squamous","",17848,17806,"Nivolumab","anti-pd-1",0,0,0,1,1,1,"hyponatremia","Early irAE","positive","IRAE","",19006,2,NA,"",1,"","Onco48",1,1200,NA,17858,NA,"Negative","Negative",0,0,1,0,52,1,"","No Prior TKI",0,"White",17781,1,"DJ56409V","",0,1,"No Staging Data",0,0,0,"",0,"",NA,NA,"1079g>c pg360a","Alive",1
"84",0,57,"",1,0,"",1,0,"","","NON-TKI",18310,NA,0,"amplification","",NA,"large cell or nos nslc","",NA,18613,"Pembrolizumab","anti-pd-1",0,0,0,0,0,0,"none reported",NA,"negative","No irae","",19318,2,NA,"d301fs*20, d3526n (vus)",1,"","Foundation",1,705,NA,NA,NA,">=50%","70%",0,1,0,1,NA,0,"h1047n","No Prior TKI",0,"Asian",18365,1,"DJ56671X","",0,0,"IV",0,0,1,"",0,"",NA,NA,"splice site 375g>t","Alive",0
"85",0,72,"",1,0,"",0,0,"","","NON-TKI",17582,NA,0,"","",NA,"squamous","",17815,17815,"Nivolumab","anti-pd-1",0,0,0,0,0,0,"none reported",NA,"negative","No irae","",17881,2,NA,"",1,"","No Report",0,66,40,17834,NA,"Not Reported","Not Reported",0,0,0,0,19,1,"","No Prior TKI",0,"Unknown or Other",NA,1,"DJ71546P","",1,1,"III",1,0,0,"",1,"",NA,NA,"","Deceased",0
"86",1,74,"",0,1,"",1,0,"","","NON-TKI",18043,19243,0,"","",NA,"adenocarcinoma","",19264,18312,"Atezolizumab","anti-pd-l1",1,0,0,0,0,0,"dm - type ii -gradually improving - possibly more difficult to control due to atezolizumab.","Late irAE","positive","Endocrine","",19319,2,NA,"",1,"","Onco48",1,1007,NA,NA,NA,"Not Reported","Not Reported",0,0,0,1,NA,0,"","No Prior TKI",0,"Asian",18064,1,"DJ78267X","",0,0,"IV",0,0,1,"",0,"",NA,NA,"","Alive",0
"87",0,69,"",0,1,"",0,0,"","loss","NON-TKI",18058,NA,0,"","",NA,"squamous","",18233,18166,"Atezolizumab","anti-pd-l1",0,0,0,0,0,0,"none reported",NA,"negative","No irae","",18496,2,NA,"",0,"","Foundation",0,330,NA,18256,NA,"Negative","Negative",0,0,1,0,90,1,"","No Prior TKI",0,"White",18103,0,"DJ80672U","",0,1,"IV",0,0,1,"",1,"",NA,NA,"r196q","Deceased",1
"88",0,68,"",0,1,"",0,0,"","","NON-TKI",18549,NA,0,"","",NA,"squamous","",19067,18621,"Atezolizumab","anti-pd-l1",0,0,0,0,0,0,"none reported",NA,"negative","No irae","",19097,1,NA,"",0,"","Integrated Oncology EGFR, ALK, ROS1, BRAF (All Negative)",1,476,NA,19097,NA,"Negative","0%",0,0,1,1,476,1,"","No Prior TKI",0,"Unknown or Other",18626,0,"DJ92109U","",1,1,"IV",0,0,1,"",0,"",NA,NA,"","Alive",0
"89",1,57,"",1,0,"",0,1,"","","NON-TKI",17406,18618,0,"","",1,"adenocarcinoma","",19221,17848,"Pembrolizumab","anti-pd-1",0,0,0,1,0,0,"fatigue","Late irAE","positive","IRAE","",19310,2,NA,"",1,"","No Report",1,1462,20,NA,NA,"Not Reported","Not Reported",0,0,0,1,NA,0,"","No Prior TKI",0,"Black or African American",NA,1,"DK05338X","",1,0,"IV",0,0,1,"",0,"",NA,NA,"","Alive",0
"90",1,60,"",0,1,"",0,1,"","","NON-TKI",18250,18626,0,"","",NA,"adenocarcinoma","",NA,18522,"Atezolizumab","anti-pd-l1",1,1,1,0,0,0,"hypothyroidism","Late irAE","positive","Endocrine","",19296,2,NA,"",1,"","No Report",1,774,45,NA,NA,"Not Reported","Not Reported",0,0,0,1,NA,0,"","No Prior TKI",0,"Black or African American",NA,1,"DK09826X","",1,0,"No Staging Data",0,0,0,"",0,"",NA,NA,"","Alive",0
"91",1,65,"",1,0,"",0,0,"","","NON-TKI",17598,NA,0,"","",NA,"adenocarcinoma","",17996,17954,"Nivolumab","anti-pd-1",0,0,0,0,0,0,"none reported",NA,"negative","No irae","g12c",18198,2,NA,"",0,"","Foundation",0,244,20,18003,NA,"1-49%","10%",1,0,0,0,49,1,"e454k","No Prior TKI",0,"White",17919,0,"DK17773X","",1,0,"III",1,0,0,"",1,"",NA,NA,"l194fs*13","Deceased",1
"92",0,76,"",0,1,"",0,0,"","","NON-TKI",17945,NA,0,"","",NA,"squamous","",18115,18115,"Atezolizumab","anti-pd-l1",0,0,0,0,0,0,"none reported",NA,"negative","No irae","",18153,2,NA,"",1,"","No Report",0,38,60,18118,NA,"Not Reported","",0,0,0,0,3,1,"","No Prior TKI",0,"White",NA,1,"DK35452U","",1,1,"IV",0,0,1,"",1,"",NA,NA,"","Deceased",1
"93",1,67,"negative",1,0,"",0,0,"","","NON-TKI",18325,NA,0,"negative","",NA,"adenocarcinoma","",18578,18430,"Nivolumab","anti-pd-1",0,0,0,0,0,0,"none reported",NA,"negative","No irae","",18613,2,NA,"",0,"","NeoGenomics",0,183,NA,18580,NA,"Negative","Negative",0,0,1,0,150,1,"","No Prior TKI",0,"White",18354,0,"DK38317Z","",0,0,"IV",0,0,1,"",1,"",NA,NA,"","Deceased",1
"94",1,54,"",1,0,"",1,0,"g596r","","NON-TKI",18088,18592,0,"","",NA,"adenocarcinoma","",18428,18362,"Pembrolizumab","anti-pd-1",1,1,0,0,0,0,"hypothyroidism","Late irAE","positive","Endocrine","",19227,1,NA,"d4407y (vus)",1,"","Foundation",1,865,30,NA,NA,">=50%","90%",0,1,0,1,NA,0,"","No Prior TKI",0,"Asian",18254,1,"DK44510T","",1,0,"IV",0,0,1,"",0,"",NA,NA,"r273l","Alive",0
"95",1,83,"",1,0,"",0,0,"","","NON-TKI",18620,18862,0,"","",NA,"adenocarcinoma","",18731,18682,"Pembrolizumab","anti-pd-1",0,0,0,1,1,1,"immune-related hepatitis","Late irAE","positive","IRAE","",18862,2,NA,"",0,"","Foundation",0,180,50,18862,NA,"1-49%","5%",1,0,0,0,180,1,"","No Prior TKI",0,"White",18579,0,"DK83664X","",1,0,"IV",0,0,1,"",1,"",NA,NA,"","Deceased",1
"96",1,72,"",0,1,"",0,0,"","","NON-TKI",17716,18580,1,"","",2,"adenocarcinoma","",18654,18570,"Atezolizumab","anti-pd-l1",1,1,1,0,0,0,"diarrhea, colitis","Early irAE","positive","Gastrointestinal","35 g>t g12v",19306,4,NA,"",0,"","Onco48",1,736,21,18851,NA,"Negative","Negative",0,0,1,1,281,1,"","No Prior TKI",0,"White",17760,0,"DK87652U","",1,0,"IV",0,0,1,"",0,"",NA,NA,"","Alive",1
"97",1,72,"",1,0,"",0,0,"","","NON-TKI",17218,NA,0,"negative","negative",NA,"adenocarcinoma","",17890,17821,"Nivolumab","anti-pd-1",0,0,0,0,0,0,"none reported",NA,"negative","No irae","g12v",18289,2,NA,"",1,"","University of Colorado NGS",1,468,40,17899,NA,"Not Reported","",0,0,0,0,78,1,"","No Prior TKI",0,"White",17218,1,"DL19826S","",1,0,"IV",0,0,1,"",1,"",NA,NA,"","Deceased",1
"98",0,79,"",0,1,"",0,0,"","","NON-TKI",18229,NA,0,"","",NA,"squamous","",18269,18269,"Atezolizumab","anti-pd-l1",0,0,0,0,0,0,"none reported",NA,"negative","No irae","",18319,2,NA,"",0,"","No Report",0,50,15,18305,NA,"1-49%","1%",1,0,0,0,36,1,"","No Prior TKI",0,"White",NA,0,"DL41390V","",1,1,"IV",0,0,1,"",1,"",NA,NA,"","Deceased",1
"99",1,56,"negative",1,0,"",0,1,"","","NON-TKI",17557,NA,0,"","",NA,"adenocarcinoma","",NA,18303,"Pembrolizumab","anti-pd-1",0,0,0,0,0,0,"none reported",NA,"negative","No irae","",19311,2,NA,"",1,"","Integrated Oncology EGFR, ALK, ROS1 (Negative)",1,1008,15,NA,NA,">=50%","80%",0,1,0,1,NA,0,"","No Prior TKI",0,"Black or African American",18268,1,"DL43287R","",1,0,"No Staging Data",0,0,0,"",0,"",NA,NA,"","Alive",0
"100",1,70,"",1,0,"",0,0,"","","TKI",18022,NA,0,"t710del","",NA,"adenocarcinoma","",18683,18572,"Nivolumab","anti-pd-1",0,0,0,0,0,0,"none reported",NA,"negative","No irae","",18690,2,1,"",0,"","NeoGenomics EGFR Seq.",0,118,NA,18690,18555,"Not Reported","Not Reported",0,0,0,0,118,1,"","Prior TKI",1,"White",18579,0,"DL99104W","",1,0,"No Staging Data",0,0,0,"",0,"erlotinib",18555,18036,"","Alive",1
"101",1,57,"",1,0,"",0,0,"","","NON-TKI",18348,18534,0,"","",NA,"adenocarcinoma","Pembrolizumab",18556,18386,"Pembrolizumab","anti-pd-1",0,0,0,1,1,1,"normochromic normocytic anemia","Late irAE","positive","IRAE","",18753,2,NA,"",0,"","NeoGenomics OnkoSight, FISH (All Negative)",1,367,NA,18571,NA,"1-49%","1%",1,0,0,1,185,1,"","No Prior TKI",0,"Unknown or Other",18368,0,"DM01131U","",0,0,"IV",0,0,1,"",1,"",NA,NA,"","Deceased",0
"102",1,90,"",1,0,"",0,0,"","","NON-TKI",18460,18562,1,"p281p (syn)","",NA,"adenocarcinoma","",18568,18547,"Pembrolizumab","anti-pd-1",0,0,0,1,1,1,"hypoadrenalism","Early irAE","positive","IRAE","",18586,1,NA,"",0,"","Guardant360",0,39,30,18586,NA,"Not Reported","Not Reported",0,0,0,0,39,1,"","No Prior TKI",0,"White",18520,0,"DM21976Q","",1,0,"IV",0,0,1,"t71_l72del (vus)",1,"",NA,NA,"","Deceased",1
"103",1,55,"",0,1,"",0,0,"v600e","","TKI",16646,NA,0,"","",NA,"adenocarcinoma","",18471,18433,"Atezolizumab","anti-pd-l1",0,0,0,0,0,0,"none reported",NA,"negative","No irae","",18653,7,3,"",1,"","Onco48",0,220,NA,18464,18430,"Negative","Negative",0,0,1,0,31,1,"","Prior TKI",1,"White",17792,1,"DM44061U","",0,0,"IV",0,0,1,"",1,"cobometinib",18430,18180,"","Deceased",1
"104",0,79,"",1,0,"",1,0,"","","NON-TKI",17394,NA,0,"","",NA,"squamous","",17939,17827,"Nivolumab","anti-pd-1",0,0,0,0,0,0,"none reported",NA,"negative","No irae","",18383,2,NA,"",1,"","No Report",1,556,60,17946,NA,"Not Reported","Not Reported",0,0,0,0,119,1,"","No Prior TKI",0,"Asian",NA,1,"DM82358X","",1,1,"III",1,0,0,"",1,"",NA,NA,"","Deceased",0
"105",1,46,"",1,0,"",0,0,"","","TKI",16857,NA,0,"e746_a750del","",NA,"adenocarcinoma","",17899,17841,"Nivolumab","anti-pd-1",0,0,0,0,0,0,"none reported",NA,"negative","No irae","",18173,3,1,"",0,"","Onco48",0,332,NA,17913,17655,"Not Reported","Not Reported",0,0,0,0,72,1,"e542k","Prior TKI",1,"White",17928,0,"DM87249S","",0,0,"IV",0,0,1,"",1,"erlotinib",17655,15093,"c135g","Deceased",1
"106",0,70,"",1,0,"",0,0,"","","NON-TKI",16432,18247,0,"","",NA,"squamous","",18626,17633,"Nivolumab","anti-pd-1",1,0,0,0,0,0,"endocrinopathies","Late irAE","positive","Endocrine","",19304,5,NA,"",1,"","No Report",1,1671,NA,NA,NA,"Not Reported","Not Reported",0,0,0,1,NA,0,"","No Prior TKI",0,"White",NA,1,"DM99167W","",0,1,"III",1,0,0,"",0,"",NA,NA,"","Alive",1
"107",1,68,"e310d (vus)",1,0,"",0,0,"","","NON-TKI",18359,18631,0,"","",2,"adenocarcinoma","",18925,18561,"Nivolumab","anti-pd-1",1,1,1,0,0,0,"hyperthyroidism","Late irAE","positive","Endocrine","g12d",19289,2,NA,"",0,"","Caris",1,728,23,NA,NA,">=50%","75%",0,1,0,1,NA,0,"","No Prior TKI",0,"White",18382,0,"DN14712Q","",1,0,"I or II",0,1,0,"",0,"",NA,NA,"","Alive",1
"108",1,81,"",0,1,"",0,0,"","","NON-TKI",18267,18568,0,"","",1,"adenocarcinoma","",18913,18358,"Atezolizumab","anti-pd-l1",1,1,0,0,0,0,"rash and pruritis","Late irAE","positive","Skin","g12a, t158i (vus)",19262,1,NA,"l1287f (vus)",1,"e83* (vus)","Foundation",1,904,57,NA,NA,">=50%","90%",0,1,0,1,NA,0,"q75e","No Prior TKI",0,"White",18305,1,"DN19021P","",1,0,"III",1,0,0,"",0,"",NA,NA,"","Alive",1
"109",0,66,"",0,1,"",0,0,"","","NON-TKI",18393,NA,0,"","",NA,"squamous","",NA,18649,"Durvalumab","anti-pd-l1",0,0,0,0,0,0,"none reported",NA,"negative","No irae","",19304,2,NA,"",1,"","No Report",1,655,90,NA,NA,"Not Reported","Not Reported",0,0,0,1,NA,0,"","No Prior TKI",0,"White",NA,1,"DN21773U","",1,1,"I or II",0,1,0,"",0,"",NA,NA,"","Alive",1
"110",0,59,"",1,0,"",0,0,"","loss","NON-TKI",18459,18620,1,"","",NA,"squamous","",18633,18614,"Nivolumab","anti-pd-1",0,0,0,1,1,1,"autoimmune neurological disorder (cidp)","Early irAE","positive","IRAE","",18656,3,NA,"",1,"","Foundation",0,42,NA,18639,NA,"Not Reported","Not Reported",0,0,0,0,25,1,"","No Prior TKI",0,"Unknown or Other",18485,1,"DN31619Q","",0,1,"IV",0,0,1,"",1,"",NA,NA,"s106del","Deceased",0
"111",1,54,"",1,0,"",0,0,"","","NON-TKI",14917,17934,1,"","",1,"adenocarcinoma","",18051,17892,"Nivolumab","anti-pd-1",1,1,1,0,0,0,"diarrhea, abdominal discomfort","Early irAE","positive","Gastrointestinal","q61h",18681,2,NA,"",1,"","Onco48",1,789,NA,18073,NA,"Negative","Negative",0,0,1,1,181,1,"","No Prior TKI",0,"White",17788,1,"DN45702P","",1,0,"IV",0,0,1,"",1,"",NA,NA,"r248q","Deceased",1
"112",1,53,"",1,0,"q611*",0,0,"","","NON-TKI",18660,18697,1,"","",1,"adenocarcinoma","",19112,18697,"Pembrolizumab","anti-pd-1",0,0,0,1,1,1,"fever","Early irAE","positive","IRAE","g12c",19297,1,NA,"",0,"","HopeSeq",1,600,23,NA,NA,">=50%","100%",0,1,0,1,NA,0,"","No Prior TKI",0,"White",18703,0,"DN88439W","",1,0,"IV",0,0,1,"",0,"",NA,NA,"s106r","Alive",1
"113",1,56,"",1,0,"q789*, n114k (vus)",0,0,"","p16ink4a t18fs*21","NON-TKI",18596,NA,0,"","",NA,"adenocarcinoma","",18743,18701,"Pembrolizumab","anti-pd-1",0,0,0,0,0,0,"none reported",NA,"negative","No irae","amplification, g12v",19174,1,NA,"",0,"","Foundation",1,473,30,18798,NA,">=50%","50%",0,1,0,0,97,1,"","No Prior TKI",0,"Unknown or Other",18688,0,"DN93397Z","",1,0,"IV",0,0,1,"",0,"",NA,NA,"y220c","Alive",0
"114",1,68,"",0,1,"",0,1,"","","NON-TKI",18200,NA,0,"","e645k",NA,"adenocarcinoma","",18487,18445,"Atezolizumab","anti-pd-l1",0,0,0,0,0,0,"none reported",NA,"negative","No irae","g12v",18736,2,NA,"",0,"","Guardant360",0,291,45,18492,NA,">=50%","80%",0,1,0,0,47,1,"","No Prior TKI",0,"Black or African American",18255,0,"EJ25452V","",1,0,"IV",0,0,1,"",1,"",NA,NA,"splice site snv","Deceased",0
"115",1,64,"k1518n (vus)",1,0,"",0,0,"","loss","NON-TKI",18093,NA,0,"","",NA,"adenocarcinoma","",18348,18135,"Pembrolizumab","anti-pd-1",0,0,0,0,0,0,"none reported",NA,"negative","No irae","g12c",18704,1,NA,"c503*, d703y (vus)",0,"","Foundation",1,569,25,18348,NA,">=50%","50%",0,1,0,1,213,1,"","No Prior TKI",0,"White",18124,0,"EJ34351Z","e1449*",1,0,"IV",0,0,1,"",1,"",NA,NA,"q167*","Deceased",1
"116",1,73,"",1,0,"",0,0,"","","TKI",18031,NA,0,"g719s","",NA,"adenocarcinoma","",18871,18521,"Pembrolizumab","anti-pd-1",0,0,0,0,0,0,"none reported",NA,"negative","No irae","",19062,2,1,"",1,"","NeoGenomics EGFR Seq.",1,541,NA,18941,18248,"1-49%","30%",1,0,0,1,420,1,"","Prior TKI",1,"Unknown or Other",18045,1,"EJ44348R","",0,0,"III",1,0,0,"",1,"erlotinib",18222,18078,"","Deceased",0
"117",1,71,"",1,0,"",0,0,"","","NON-TKI",18213,18773,0,"negative","",NA,"adenocarcinoma","",18773,18458,"Pembrolizumab","anti-pd-1",1,1,0,0,0,0,"hyperthyroidism","Late irAE","positive","Endocrine","negative",19198,2,NA,"",1,"","Cedars Sinai FISH and Gene Panel (KRAS, EGFR, ALK)",1,740,180,NA,NA,">=50%","50%",0,1,0,1,NA,0,"","No Prior TKI",0,"Unknown or Other",18338,1,"EJ47323Y","",1,0,"III",1,0,0,"",0,"",NA,NA,"","Alive",0
"118",1,70,"",1,0,"",0,0,"","","NON-TKI",17876,NA,0,"","",NA,"adenocarcinoma","",17976,17934,"Nivolumab","anti-pd-1",0,0,0,0,0,0,"none reported",NA,"negative","No irae","",18396,2,NA,"",1,"","Onco48",1,462,50,17985,NA,"Negative","Negative",0,0,1,0,51,1,"","No Prior TKI",0,"White",17917,1,"EJ55473S","",1,0,"IV",0,0,1,"",1,"",NA,NA,"","Deceased",1
"119",1,66,"",1,0,"",0,0,"","","NON-TKI",18179,NA,0,"negative","",NA,"adenocarcinoma","",18583,18415,"Pembrolizumab","anti-pd-1",0,0,0,0,0,0,"none reported",NA,"negative","No irae","",18752,2,NA,"",0,"","neogenomics: EGFR",0,337,60,18609,NA,"1-49%","25%",1,0,0,1,194,1,"","No Prior TKI",0,"White",18808,0,"EJ60367S","",1,0,"IV",0,0,1,"",1,"",NA,NA,"","Deceased",1
"120",0,63,"",0,1,"",0,0,"","","NON-TKI",18514,NA,0,"","",NA,"squamous","",18542,18521,"Atezolizumab","anti-pd-l1",0,0,0,0,0,0,"none reported",NA,"negative","No irae","",18953,1,NA,"",1,"","NeoGenomics EGFR, ALK, ROS1 (All Negative)",1,432,50,18677,NA,">=50%","60%",0,1,0,0,156,1,"","No Prior TKI",0,"Unknown or Other",18398,1,"EJ67795V","",1,1,"I or II",0,1,0,"",1,"",NA,NA,"","Deceased",0
"121",1,74,"",1,0,"",0,0,"","","NON-TKI",18283,18816,0,"","",NA,"adenocarcinoma","",18873,18724,"Pembrolizumab","anti-pd-1",1,1,1,0,0,0,"hyperthyroid","Late irAE","positive","Endocrine","",19146,1,NA,"",1,"","NeoType Analysis",1,422,80,18913,NA,"Negative","Negative",0,0,1,1,189,1,"","No Prior TKI",0,"Unknown or Other",18717,1,"EK03560P","",1,0,"I or II",0,1,0,"",0,"",NA,NA,"glu258glyfster6","Alive",0
"122",0,62,"",1,0,"",1,0,"","loss","NON-TKI",18256,18544,1,"","",NA,"large cell or nos nslc","",18775,18500,"Pembrolizumab","anti-pd-1",0,0,0,1,1,1,"allergic rhinitis","Early irAE","positive","IRAE","",18988,2,NA,"",1,"","Foundation",1,488,37,18794,NA,"1-49%","5%",1,0,0,1,294,1,"","No Prior TKI",0,"Asian",18297,1,"EK29684X","loss exons 2-29",1,0,"IV",0,0,1,"",0,"",NA,NA,"","Alive",0
"123",0,87,"",1,0,"",1,0,"","","NON-TKI",17725,NA,0,"","",NA,"squamous","",18101,18074,"Nivolumab","anti-pd-1",0,0,0,0,0,0,"none reported",NA,"negative","No irae","",18127,2,NA,"",1,"","Onco48",0,53,15,18114,NA,"Negative","Negative",0,0,1,0,40,1,"","No Prior TKI",0,"Asian",17969,1,"EK55210X","",1,1,"No Staging Data",0,0,0,"",1,"",NA,NA,"","Deceased",0
"124",1,66,"",1,0,"",0,0,"","","NON-TKI",18221,NA,0,"","",NA,"adenocarcinoma","",18877,18611,"Pembrolizumab","anti-pd-1",0,0,0,0,0,0,"none reported",NA,"negative","No irae","g12a",19206,2,NA,"",0,"","HopeSeq",1,595,400,18907,NA,"Negative","Negative",0,0,1,1,296,1,"","No Prior TKI",0,"White",18592,0,"EK55577X","",1,0,"IV",0,0,1,"r86*",0,"",NA,NA,"","Alive",1
"125",1,78,"",1,0,"",0,0,"","","NON-TKI",18263,NA,0,"","",NA,"adenocarcinoma","",18795,18303,"Pembrolizumab","anti-pd-1",0,0,0,0,0,0,"none reported",NA,"negative","No irae","g13d",18885,1,NA,"",0,"","NeoGenomics; EGFR, ALK, KRAS",1,582,50,18795,NA,">=50%","70%",0,1,0,1,492,1,"","No Prior TKI",0,"Unknown or Other",18286,0,"EK57990R","",1,0,"IV",0,0,1,"",1,"",NA,NA,"","Deceased",0
"126",1,73,"",1,0,"",0,0,"","","NON-TKI",18621,NA,0,"","y772_a775dup",NA,"adenocarcinoma","",18906,18660,"Pembrolizumab","anti-pd-1",0,0,0,0,0,0,"none reported",NA,"negative","No irae","",19109,1,NA,"",0,"","HopeSeq",1,449,NA,18912,NA,"1-49%","11%",1,0,0,1,252,1,"","No Prior TKI",0,"White",18654,0,"EK89683S","",0,0,"IV",0,0,1,"",1,"",NA,NA,"i195t","Deceased",1
"127",0,65,"",1,0,"",0,0,"","","NON-TKI",16857,NA,0,"","",NA,"squamous","",18806,18482,"Nivolumab","anti-pd-1",0,0,0,0,0,0,"none reported",NA,"negative","No irae","",19006,3,NA,"",1,"","No Report",1,524,NA,18843,NA,"Not Reported","Not Reported",0,0,0,1,361,1,"","No Prior TKI",0,"Unknown or Other",NA,1,"EL04240Z","",1,1,"III",1,0,0,"",0,"",NA,NA,"","Alive",0
"128",1,78,"",0,0,"",0,1,"","","TKI",16559,18054,0,"negative","",1,"adenocarcinoma","Pembrolizumab",17526,17379,"Atezolizumab","anti-pd-l1/ anti-pd-1",0,0,0,1,0,0,"peripheral neuropathy","Late irAE","positive","IRAE","gly12asp",18779,2,1,"",1,"","COH panel (KRAS, EGFR)",1,1400,12,17526,17353,"1-49%",">1%",1,0,0,0,147,1,"","Prior TKI",1,"Black or African American",17162,1,"EL09994V","",1,0,"IV",0,0,1,"",0,"crizotinib",17365,17173,"","Alive",0
"129",1,76,"",0,1,"",0,0,"","","NON-TKI",18515,NA,0,"","",NA,"adenocarcinoma","",18702,18666,"Atezolizumab","anti-pd-l1",0,0,0,0,0,0,"none reported",NA,"negative","No irae","p.g12c, c.34g>t",18715,2,NA,"",1,"","HopeSeq",0,49,63,18715,NA,">=50%","100%",0,1,0,0,49,1,"p.e545k, c.1633g>a","No Prior TKI",0,"Unknown or Other",18674,1,"EL46901X","p.q1230l, c3689a>t (vus)",1,0,"IV",0,0,1,"",1,"",NA,NA,"p.y163c, c.488a>g","Deceased",0
"130",1,52,"rearrangement",1,0,"",1,0,"","","TKI",18278,18357,1,"","",NA,"adenocarcinoma","",18345,18302,"Nivolumab","anti-pd-1",0,0,0,1,1,1,"pain to bilateral legs and back","Early irAE","positive","IRAE","",19235,2,3,"",1,"","COH ALK FISH",1,933,NA,18353,NA,"Negative","0%",0,0,1,0,51,1,"","No Prior TKI",0,"Asian",18303,1,"EL81228R","",0,0,"IV",0,0,1,"",0,"alectinib",18990,18362,"","Alive",0
"131",0,85,"",1,0,"",0,0,"","","NON-TKI",18388,NA,0,"","",NA,"squamous","",18549,18421,"Pembrolizumab","anti-pd-1",0,0,0,0,0,0,"none reported",NA,"negative","No irae","",18648,1,NA,"",1,"","NeoGenomics (Only PD-L1)",0,227,60,18648,NA,">=50%","99%",0,1,0,1,227,1,"","No Prior TKI",0,"White",18415,1,"EM01527S","",1,1,"IV",0,0,1,"",1,"",NA,NA,"","Deceased",1
"132",0,74,"",0,1,"",0,0,"","","NON-TKI",18765,NA,0,"","",NA,"squamous","",18817,18746,"Atezolizumab","anti-pd-l1",0,0,0,0,0,0,"none reported",NA,"negative","No irae","",18833,2,NA,"",0,"","No Report",0,87,30,18833,NA,"1-49%","30%",1,0,0,0,87,1,"","No Prior TKI",0,"White",NA,0,"EM31428Q","",1,1,"III",1,0,0,"",1,"",NA,NA,"","Deceased",1
"133",1,64,"",1,0,"",0,0,"","","NON-TKI",18397,18656,1,"","",NA,"adenocarcinoma","",18654,18626,"Nivolumab","anti-pd-1",0,0,0,1,1,1,"thrombocytopenia","Early irAE","positive","IRAE","",18768,2,NA,"",1,"","No Report",0,142,15,18656,NA,"Negative","Negative",0,0,1,0,30,1,"","No Prior TKI",0,"White",NA,1,"EM74289Q","",1,0,"IV",0,0,1,"",1,"",NA,NA,"","Deceased",1
"134",1,69,"",1,0,"",1,0,"","","NON-TKI",18625,NA,0,"","",NA,"adenocarcinoma","",18654,18654,"Pembrolizumab","anti-pd-1",0,0,0,0,0,0,"none reported",NA,"negative","No irae","q61h",18668,1,NA,"",1,"","Paradigm",0,14,50,NA,NA,">=50%","80%",0,1,0,1,NA,0,"","No Prior TKI",0,"Asian",18673,1,"EM85728X","",1,0,"IV",0,0,1,"",0,"",NA,NA,"","Alive",0
"135",1,49,"",1,0,"",0,0,"","","NON-TKI",18654,NA,0,"","",NA,"adenocarcinoma","",19271,18690,"Pembrolizumab","anti-pd-1",0,0,0,0,0,0,"none reported",NA,"negative","No irae","",19290,1,NA,"",1,"","Guardant360",1,600,NA,NA,NA,"Not Reported","Not Reported",0,0,0,1,NA,0,"","No Prior TKI",0,"White",18679,1,"EN18800R","",0,0,"IV",0,0,1,"",0,"",NA,NA,"r213fs","Alive",1
"136",1,71,"negative",0,1,"",0,0,"","","NON-TKI",17945,NA,0,"negative","",NA,"adenocarcinoma","",18128,18128,"Atezolizumab","anti-pd-l1",0,0,0,0,0,0,"none reported",NA,"negative","No irae","",18214,2,NA,"",1,"","Integrated Oncology (EGFR, ALK)",0,86,84,18200,NA,">=50%","80%",0,1,0,0,72,1,"","No Prior TKI",0,"White",17945,1,"EN34639U","",1,0,"IV",0,0,1,"",1,"",NA,NA,"","Deceased",1
"137",1,64,"",1,0,"",1,0,"","","TKI",16731,NA,0,"ala767_val769dup","",NA,"adenocarcinoma","",17921,17879,"Nivolumab","anti-pd-1",0,0,0,0,0,0,"none reported",NA,"negative","No irae","",18037,5,3,"",0,"","COH panel (EGFR, KRAS)",0,158,NA,17949,17604,"Negative","Negative",0,0,1,0,70,1,"","Prior TKI",1,"Asian",16828,0,"EN40687Z","",0,0,"IV",0,0,1,"",1,"erlotinib",17583,17562,"","Deceased",0
"138",0,64,"",1,0,"",0,0,"","","NON-TKI",16738,NA,0,"","",NA,"squamous","",18107,17969,"Nivolumab","anti-pd-1",0,0,0,0,0,0,"none reported",NA,"negative","No irae","",18149,3,NA,"",1,"","No Report",0,180,NA,18121,NA,"Not Reported","Not Reported",0,0,0,0,152,1,"","No Prior TKI",0,"White",NA,1,"EN42483V","",1,1,"No Staging Data",0,0,0,"",0,"",NA,NA,"","Alive",1
"139",0,65,"",0,1,"",0,0,"","","NON-TKI",18617,18759,1,"","",1,"squamous","",19278,18731,"Durvalumab","anti-pd-l1",1,1,1,0,0,0,"diarrhea","Early irAE","positive","Gastrointestinal","",19291,1,NA,"",1,"","GenPath OnkoSight",1,560,69,NA,NA,">=50%","60%",0,1,0,1,NA,0,"e542k","No Prior TKI",0,"Unknown or Other",18632,1,"EN46647U","",1,1,"III",1,0,0,"",0,"",NA,NA,"","Alive",0
"140",1,56,"",1,0,"s2249*",1,0,"","","NON-TKI",17603,NA,0,"","",NA,"adenocarcinoma","",17849,17849,"Nivolumab","anti-pd-1",0,0,0,0,0,0,"none reported",NA,"negative","No irae","",19303,3,NA,"",0,"","Foundation",1,1454,NA,17861,NA,"Not Reported","",0,0,0,0,12,1,"","No Prior TKI",0,"Asian",18550,0,"EN85658R","",0,0,"IV",0,0,1,"",0,"",NA,NA,"","Alive",0
"141",1,77,"",0,1,"",0,0,"","","NON-TKI",17989,NA,0,"","p.g776delinsvc",NA,"adenocarcinoma","",18480,18438,"Atezolizumab","anti-pd-l1",0,0,0,0,0,0,"none reported",NA,"negative","No irae","",19206,3,NA,"",1,"","OncoComplete",1,768,NA,18505,NA,">=50%","90%",0,1,0,0,67,1,"","No Prior TKI",0,"White",18074,1,"EN86497W","",0,0,"IV",0,0,1,"",1,"",NA,NA,"","Deceased",1
"142",1,57,"",1,0,"",0,0,"","loss","NON-TKI",18031,18480,0,"","",1,"adenocarcinoma","",18480,18410,"Nivolumab","anti-pd-1",0,0,0,1,1,1,"body aches","Late irAE","positive","IRAE","",18749,2,NA,"w2423l (vus)",0,"","Foundation",0,339,40,18491,NA,"Not Reported","Not Reported",0,0,0,0,81,1,"","No Prior TKI",0,"White",18054,0,"EN89556W","",1,0,"IV",0,0,1,"",1,"",NA,NA,"v157f","Deceased",1
"143",0,70,"",0,1,"",0,0,"","","NON-TKI",18416,NA,0,"","",NA,"large cell or nos nslc","",18596,18575,"Atezolizumab","anti-pd-l1",0,0,0,0,0,0,"none reported",NA,"negative","No irae","",18610,2,NA,"",1,"","Foundation",0,35,19.5,18610,NA,"Negative","Negative",0,0,1,0,35,1,"","No Prior TKI",0,"Unknown or Other",18510,1,"EN95861X","",1,0,"IV",0,0,1,"",1,"",NA,NA,"rearrangement exon 2","Deceased",0
"144",1,53,"",0,1,"",0,0,"","","NON-TKI",18394,18936,0,"","",NA,"adenocarcinoma","",18908,18551,"Durvalumab","anti-pd-l1",1,0,0,0,0,0,"hypothyroidism","Late irAE","positive","Endocrine","",19251,2,NA,"",1,"","No Report",1,700,10,NA,NA,"Not Reported","Not Reported",0,0,0,1,NA,0,"","No Prior TKI",0,"Unknown or Other",NA,1,"FJ08493V","",1,0,"No Staging Data",0,0,0,"",0,"",NA,NA,"","Alive",0
"145",0,75,"",1,0,"",0,0,"","","NON-TKI",18558,19228,0,"","",NA,"squamous","",19163,18591,"Pembrolizumab","anti-pd-1",1,0,0,0,0,0,"bilateral le edema and abdominal fullness","Late irAE","positive","Gastrointestinal","",19299,1,NA,"",0,"","Genoptix (ALK, BRAF, CD274, EGFR, ERBB2, KRAS, MET, RET, ROS1)",1,708,78,19297,NA,"1-49%","15%",1,0,0,1,706,1,"","No Prior TKI",0,"White",18562,0,"FJ33067W","",1,1,"IV",0,0,1,"",1,"",NA,NA,"","Deceased",1
"146",0,56,"negative",0,1,"",0,0,"","","NON-TKI",18215,18550,1,"","",NA,"squamous","",18926,18508,"Atezolizumab","anti-pd-l1",0,0,0,1,1,1,"fatigue","Early irAE","positive","IRAE","",19305,2,NA,"",1,"","OncoComplete",1,797,40,18988,NA,"Negative","Negative",0,0,1,1,480,1,"","No Prior TKI",0,"White",18249,1,"FJ38024S","",1,1,"IV",0,0,1,"",0,"",NA,NA,"e286k","Alive",1
"147",1,64,"",1,0,"",0,0,"","","NON-TKI",16715,NA,0,"","",NA,"adenocarcinoma","",17823,17823,"Nivolumab","anti-pd-1",0,0,0,0,0,0,"none reported",NA,"negative","No irae","34g>t g12c",17906,6,NA,"",1,"","Onco48",0,83,45,17837,NA,"Negative","Negative",0,0,1,0,14,1,"","No Prior TKI",0,"White",17514,1,"FJ39724R","",1,0,"IV",0,0,1,"",1,"",NA,NA,"","Deceased",1
"148",0,72,"",1,0,"",0,0,"","","NON-TKI",18471,NA,0,"","",NA,"squamous","",18690,18676,"Nivolumab","anti-pd-1",0,0,0,0,0,0,"none reported",NA,"negative","No irae","",18731,2,NA,"",1,"","NeoGenomics",0,55,NA,18731,NA,"Negative","Negative",0,0,1,0,55,1,"","No Prior TKI",0,"Unknown or Other",18466,1,"FJ45723V","",0,1,"IV",0,0,1,"",0,"",NA,NA,"","Alive",0
"149",1,72,"",1,0,"",0,0,"k601e","","TKI",18597,NA,0,"","",NA,"adenocarcinoma","",19040,18631,"Pembrolizumab","anti-pd-1",0,0,0,0,0,0,"none reported",NA,"negative","No irae","",19268,1,2,"",1,"","HopeSeq",1,637,6,19061,NA,">=50%","70%",0,1,0,1,430,1,"e726k","No Prior TKI",0,"White",18617,1,"FJ60602Q","",1,0,"IV",0,0,1,"",0,"dabrafenib, trametinib",NA,19092,"r213*, c.672+1g>t","Alive",1
"150",0,73,"",1,0,"",0,0,"","","NON-TKI",17771,NA,0,"","",NA,"large cell or nos nslc","",17914,17858,"Nivolumab","anti-pd-1",0,0,0,0,0,0,"none reported",NA,"negative","No irae","",17981,2,NA,"",0,"","Onco48",0,123,50,17921,NA,"Negative","Negative",0,0,1,0,63,1,"","No Prior TKI",0,"White",17835,0,"FK00192T","",1,0,"IV",0,0,1,"",1,"",NA,NA,"641a>g, h214r, 469g>t v157f","Deceased",1
"151",1,85,"",0,1,"",0,0,"","","NON-TKI",17850,NA,0,"","",NA,"adenocarcinoma","",18310,18205,"Atezolizumab","anti-pd-l1",0,0,0,0,0,0,"none reported",NA,"negative","No irae","",18705,2,NA,"",0,"","Guardant - TP53, Foundation One - QNS",1,500,60,18330,NA,"Negative","Negative",0,0,1,0,125,1,"","No Prior TKI",0,"White",NA,0,"FK22440Q","",1,0,"IV",0,0,1,"",1,"",NA,NA,"","Deceased",1
"152",1,72,"negative",1,0,"",1,0,"","","NON-TKI",18403,NA,0,"","",NA,"adenocarcinoma","",18856,18576,"Nivolumab","anti-pd-1",0,0,0,0,0,0,"none reported",NA,"negative","No irae","",19268,2,NA,"",0,"","Integrated Oncology (ALK)",1,692,NA,18876,NA,"Not Reported","Not Reported",0,0,0,1,300,1,"","No Prior TKI",0,"Asian",18397,0,"FK53713X","",0,0,"No Staging Data",0,0,0,"",0,"",NA,NA,"","Alive",0
"153",1,87,"",0,1,"",1,0,"k601e","","NON-TKI",18596,NA,0,"","",NA,"adenocarcinoma","",18655,18627,"Atezolizumab","anti-pd-l1",0,0,0,0,0,0,"none reported",NA,"negative","No irae","",18700,1,NA,"",1,"","HopeSeq",0,73,75,18676,NA,"Negative","0%",0,0,1,0,49,1,"","No Prior TKI",0,"Asian",18642,1,"FK53851U","",1,0,"IV",0,0,1,"",1,"",NA,NA,"r273l","Deceased",0
"154",1,81,"",0,1,"c.1324_1350+5delins",0,0,"","","NON-TKI",17875,18561,0,"","",NA,"adenocarcinoma","",18540,18389,"Atezolizumab","anti-pd-l1",0,0,0,1,1,1,"arthralgia","Late irAE","positive","IRAE","g12c",18892,2,NA,"",0,"","Guardant360",1,503,25,18553,NA,"Not Reported","Not Reported",0,0,0,0,164,1,"","No Prior TKI",0,"Unknown or Other",18874,0,"FK60351T","",1,0,"IV",0,0,1,"q112*, splice site snv",0,"",NA,NA,"k132n, r158h","Alive",0
"155",0,64,"",0,1,"",0,0,"","","NON-TKI",18529,NA,0,"","",NA,"squamous","",18775,18593,"Atezolizumab","anti-pd-l1",0,0,0,0,0,0,"none reported",NA,"negative","No irae","",18784,2,NA,"",1,"","No Report",0,191,80,18784,NA,"Not Reported","Not Reported",0,0,0,1,191,1,"","No Prior TKI",0,"Unknown or Other",NA,1,"FL11089S","",1,1,"IV",0,0,1,"",1,"",NA,NA,"","Deceased",0
"156",1,77,"",1,0,"",0,0,"","","TKI",18446,NA,0,"","",NA,"adenocarcinoma","",18575,18500,"Pembrolizumab","anti-pd-1",0,0,0,0,0,0,"none reported",NA,"negative","No irae","",19239,1,3,"",1,"exon 14 splice site (d1010y)","Foundation",1,739,55,18603,19228,"1-49%","1%",1,0,0,0,103,1,"","No Prior TKI",0,"White",18571,1,"FL25413V","",1,0,"I or II",0,1,0,"",1,"cabozantinib",19228,19174,"y126*","Deceased",1
"157",1,70,"",1,0,"",1,0,"","","TKI",15812,17724,1,"l858r","",NA,"adenocarcinoma","",17724,17724,"Nivolumab","anti-pd-1",1,1,1,0,0,0,"pneumonitis","Early irAE","positive","Respiratory","",17746,8,2,"",0,"","Onco48",0,22,NA,17745,16493,"Negative","Negative",0,0,1,0,21,1,"","Prior TKI",1,"Asian",17301,0,"FL35109Y","",0,0,"IV",0,0,1,"",1,"erlotinib",16462,16127,"","Deceased",0
"158",1,64,"",1,0,"",0,0,"","","NON-TKI",18330,NA,0,"","",NA,"adenocarcinoma","",18341,18341,"Pembrolizumab","anti-pd-1",0,0,0,0,0,0,"none reported",NA,"negative","No irae","",18349,1,NA,"",1,"","EGFR, ALK, ROS1 (All Negative)",0,8,30,18349,NA,"Not Reported","Not Reported",0,0,0,0,8,1,"","No Prior TKI",0,"White",18346,1,"FL54913W","",1,0,"IV",0,0,1,"",1,"",NA,NA,"","Deceased",1
"159",0,76,"",0,1,"",0,0,"","","NON-TKI",17604,18610,1,"p644p(syn)","",NA,"squamous","",18610,18610,"Atezolizumab","anti-pd-l1",0,0,0,1,1,1,"prolonged qt on ekg","Early irAE","positive","IRAE","",18834,4,NA,"",0,"r143*","Guardant360",0,224,55,18610,NA,"Not Reported","Not Reported",0,0,0,0,0,1,"","No Prior TKI",0,"White",18402,0,"FL56845P","",1,1,"No Staging Data",0,0,0,"",1,"",NA,NA,"q317*, v143m, p142p (syn)","Deceased",1
"160",1,82,"",1,0,"",1,0,"g469a","","NON-TKI",17927,18674,0,"","",NA,"adenocarcinoma","",18674,18054,"Pembrolizumab","anti-pd-1",0,0,0,1,0,0,"inflammatory arthritis","Late irAE","positive","IRAE","",19171,2,NA,"",0,"","Onco48",1,1117,NA,18695,NA,">=50%","90%",0,1,0,1,641,1,"h1047r","No Prior TKI",0,"Asian",17935,0,"FL67746S","",0,0,"IV",0,0,1,"",0,"",NA,NA,"e180d","Alive",0
"161",1,65,"",1,0,"",0,0,"","","NON-TKI",17771,NA,0,"","",NA,"adenocarcinoma","",18557,18536,"Pembrolizumab","anti-pd-1",0,0,0,0,0,0,"none reported",NA,"negative","No irae","",18831,2,NA,"",1,"","Guardant360",0,295,40,18579,NA,"Not Reported","",0,0,0,0,43,1,"","No Prior TKI",0,"Unknown or Other",18488,1,"FL79143R","",1,0,"IV",0,0,1,"",0,"",NA,NA,"c135w","Alive",0
"162",1,54,"",1,0,"",1,0,"","","TKI",17066,NA,0,"e746_a750del","",NA,"adenocarcinoma","",17914,17872,"Nivolumab","anti-pd-1",0,0,0,0,0,0,"none reported",NA,"negative","No irae","",17955,5,4,"",1,"","Onco48",0,83,NA,17928,NA,"Negative","Negative",0,0,1,0,56,1,"e545k","Prior TKI",1,"Asian",17785,1,"FL86705S","",0,0,"IV",0,0,1,"",1,"erlotinib",17928,17823,"","Deceased",0
"163",1,65,"negative",1,0,"",0,0,"","","NON-TKI",18453,NA,0,"negative","",NA,"adenocarcinoma","",18579,18493,"Pembrolizumab","anti-pd-1",0,0,0,0,0,0,"none reported",NA,"negative","No irae","negative",18639,2,NA,"",1,"","NeoGenomics",0,146,40,18639,NA,">=50%","90%",0,1,0,0,146,1,"","No Prior TKI",0,"Unknown or Other",18460,1,"FM03039U","",1,0,"IV",0,0,1,"",1,"",NA,NA,"","Deceased",0
"164",1,66,"",1,0,"",0,0,"","","TKI",17646,NA,0,"a767_v769dup","",NA,"adenocarcinoma","",17954,17898,"Nivolumab","anti-pd-1",0,0,0,0,0,0,"none reported",NA,"negative","No irae","",18064,2,3,"",0,"","Onco48",0,166,25,17953,18033,"Negative","Negative",0,0,1,0,55,1,"","No Prior TKI",0,"White",17681,0,"FM03433T","",1,0,"IV",0,0,1,"",1,"erlotinib",18022,17980,"l194r","Deceased",1
"165",0,79,"",0,1,"",0,0,"","","NON-TKI",18075,NA,0,"","",NA,"squamous","",18240,18197,"Atezolizumab","anti-pd-l1",0,0,0,0,0,0,"none reported",NA,"negative","No irae","",18340,2,NA,"",1,"","No Report",0,143,136,18260,NA,"Negative","Negative",0,0,1,0,63,1,"","No Prior TKI",0,"White",NA,1,"FM06678R","",1,1,"IV",0,0,1,"",0,"",NA,NA,"","Alive",1
"166",1,70,"",1,0,"",0,0,"","","NON-TKI",17931,18025,1,"","amplification  equivocal",1,"adenocarcinoma","",18068,17996,"Nivolumab","anti-pd-1",0,0,0,1,1,1,"nausea","Early irAE","positive","IRAE","g12a",18093,2,NA,"",1,"","Foundation",0,97,1,18087,NA,"Negative","Negative",0,0,1,0,91,1,"","No Prior TKI",0,"White",17971,1,"FM35767X","",1,0,"IV",0,0,1,"",1,"",NA,NA,"loss","Deceased",1
"167",1,58,"",0,0,"",0,0,"i755v (vus)","","NON-TKI",18116,18432,0,"","",NA,"adenocarcinoma","",18558,18313,"Atezolizumab,Nivolumab","anti-pd-l1/ anti-pd-1",0,0,0,1,1,1,"fever","Late irAE","positive","IRAE","",18684,2,NA,"w1397l, s3586t (vus)",1,"","Foundation",1,371,90,18579,NA,"1-49%","5%",1,0,0,1,266,1,"amplification","No Prior TKI",0,"White",18221,1,"FM62624T","",1,0,"IV",0,0,1,"rearrangement intron 4",1,"",NA,NA,"splice site 376-1g>a","Deceased",1
"168",1,65,"",0,1,"",0,0,"","","NON-TKI",18450,NA,0,"","",NA,"adenocarcinoma","",18652,18631,"Atezolizumab","anti-pd-l1",0,0,0,0,0,0,"none reported",NA,"negative","No irae","",18680,3,NA,"",1,"","Paradigm",0,49,60,18680,NA,"Negative","Negative",0,0,1,0,49,1,"","No Prior TKI",0,"White",18493,1,"FM64818X","",1,0,"IV",0,0,1,"",1,"",NA,NA,"","Deceased",1
"169",1,57,"",1,0,"",0,0,"","","NON-TKI",18016,NA,0,"","",NA,"adenocarcinoma","",18598,18274,"Nivolumab","anti-pd-1",0,0,0,0,0,0,"none reported",NA,"negative","No irae","g12d",18688,2,NA,"",1,"","Foundation",1,414,15,18640,NA,"1-49%","30%",1,0,0,1,366,1,"","No Prior TKI",0,"White",18543,1,"FM70257S","",1,0,"IV",0,0,1,"",1,"",NA,NA,"s127f","Deceased",1
"170",1,68,"",1,0,"",1,0,"v600e","","TKI",16296,18099,1,"","",1,"adenocarcinoma","",18114,18072,"Nivolumab","anti-pd-1",0,0,0,1,1,1,"hyponatremia","Early irAE","positive","IRAE","",18516,6,5,"",1,"","Onco48",1,444,NA,18128,18065,"Negative","0%",0,0,1,0,56,1,"e545k","Prior TKI",1,"Asian",17863,1,"FM74138T","",0,0,"IV",0,0,1,"",1,"rxdx-105-01 (ret tki)",18065,17891,"","Deceased",0
"171",1,57,"",1,0,"",0,0,"","","TKI",18108,NA,0,"exon 19 deletion","",NA,"adenocarcinoma","",18683,18586,"Pembrolizumab","anti-pd-1",0,0,0,0,0,0,"none reported",NA,"negative","No irae","",18865,3,2,"",0,"","Clarient EGFR Real-time PCR",0,279,NA,18713,18582,">=50%","75%",0,1,0,0,127,1,"","Prior TKI",1,"White",18121,0,"FM87555S","",0,0,"IV",0,0,1,"",0,"osimertinib",18582,18537,"","Alive",1
"172",0,57,"",1,0,"",0,0,"","","NON-TKI",17072,17833,0,"","",NA,"squamous","",18631,17763,"Nivolumab","anti-pd-1",1,1,1,0,0,0,"hypothyroidism","Late irAE","positive","Endocrine","",18732,3,NA,"",1,"","No Report",1,969,90,18654,NA,"Not Reported","Not Reported",0,0,0,1,891,1,"","No Prior TKI",0,"White",NA,1,"FN00404W","",1,1,"IV",0,0,1,"",0,"",NA,NA,"","Alive",1
"173",0,66,"",1,0,"",0,0,"","","NON-TKI",18422,NA,0,"","",NA,"squamous","",18520,18520,"Nivolumab","anti-pd-1",0,0,0,0,0,0,"none reported",NA,"negative","No irae","",18534,2,NA,"",0,"","No Report",0,14,35,18520,NA,"Not Reported","Not Reported",0,0,0,0,0,1,"","No Prior TKI",0,"White",NA,0,"FN02119T","",1,1,"IV",0,0,1,"",1,"",NA,NA,"","Deceased",1
"174",1,76,"",0,1,"",0,0,"","loss","NON-TKI",18228,NA,0,"","",NA,"adenocarcinoma","",18564,18564,"Atezolizumab","anti-pd-l1",0,0,0,0,0,0,"none reported",NA,"negative","No irae","g12v",18594,2,NA,"",1,"","Foundation",0,30,5,18583,NA,"Not Reported","",0,0,0,0,19,1,"","No Prior TKI",0,"White",18310,1,"FN03681W","",1,0,"IV",0,0,1,"",1,"",NA,NA,"splice site 376-2a>g","Deceased",1
"175",1,68,"",0,1,"",0,0,"","","NON-TKI",18520,NA,0,"","",NA,"adenocarcinoma","",18739,18668,"Durvalumab","anti-pd-l1",0,0,0,0,0,0,"none reported",NA,"negative","No irae","",18739,2,NA,"",0,"","No Report",0,71,NA,NA,NA,"Not Reported","Not Reported",0,0,0,1,NA,0,"","No Prior TKI",0,"Unknown or Other",NA,0,"FN08866R","",1,0,"III",1,0,0,"",0,"",NA,NA,"","Alive",0
"176",1,81,"l1404v (vus)",0,1,"",1,0,"","","NON-TKI",18141,18353,0,"","",1,"adenocarcinoma","",18466,18281,"Atezolizumab","anti-pd-l1",1,1,1,0,0,0,"rash, puritis","Late irAE","positive","Skin","k117n",18481,2,NA,"",1,"","Foundation",0,200,NA,18473,NA,"1-49%","30%",1,0,0,1,192,1,"","No Prior TKI",0,"Asian",18184,1,"FN45416Y","",0,0,"IV",0,0,1,"",1,"",NA,NA,"","Deceased",0
"177",1,65,"",1,0,"",0,0,"","g101w","NON-TKI",18157,18577,1,"","",3,"adenocarcinoma","",18571,18557,"Nivolumab","anti-pd-1",1,1,1,0,0,0,"diarrhea, colitis","Early irAE","positive","Gastrointestinal","q61l",18658,2,NA,"",0,"t1010i","OncoComplete",0,101,50,18620,NA,"Not Reported","Not Reported",0,0,0,0,63,1,"","No Prior TKI",0,"White",18180,0,"FN61345T","",1,0,"No Staging Data",0,0,0,"",1,"",NA,NA,"r110l","Deceased",1
"178",1,57,"",1,0,"",0,0,"","","NON-TKI",17583,18125,1,"e282k","",1,"adenocarcinoma","",19273,18124,"Nivolumab","anti-pd-1",1,1,1,0,0,0,"pruritis","Early irAE","positive","Skin","g12d",19283,3,NA,"",1,"","Onco48",1,1159,66,19273,NA,"Negative","0%",0,0,1,1,1149,1,"","No Prior TKI",0,"White",17619,1,"FN65518Q","",1,0,"III",1,0,0,"",1,"",NA,NA,"","Deceased",1
"179",0,75,"negative",1,0,"",0,0,"","","NON-TKI",18164,NA,0,"negative","",NA,"squamous","",18514,18514,"Pembrolizumab","anti-pd-1",0,0,0,0,0,0,"none reported",NA,"negative","No irae","",18537,2,NA,"",0,"","Neogenomics: EGFR, ROS1, ALK",0,23,NA,18519,NA,">=50%","50%",0,1,0,0,5,1,"","No Prior TKI",0,"White",18334,0,"FN92706Q","",1,1,"IV",0,0,1,"",1,"",NA,NA,"","Deceased",1
"180",1,75,"negative",1,0,"",1,0,"","","NON-TKI",16585,18046,0,"negative","",NA,"adenocarcinoma","",18033,17858,"Nivolumab","anti-pd-1",1,1,0,0,0,0,"pneumonitis","Late irAE","positive","Respiratory","",18293,3,NA,"",1,"","Clarient Diagnostic Services (EGFR, ALK)",1,435,20,18082,NA,"Not Reported","Not Reported",0,0,0,1,224,1,"","No Prior TKI",0,"Asian",16586,1,"GJ05191Q","",1,0,"IV",0,0,1,"",1,"",NA,NA,"","Deceased",0
"181",1,75,"neg",1,0,"",0,0,"","","NON-TKI",17212,NA,0,"negative","",NA,"adenocarcinoma","",17767,17767,"Nivolumab","anti-pd-1",0,0,0,0,0,0,"none reported",NA,"negative","No irae","gly12cys",17857,4,NA,"",1,"neg","ResponseDX lung (ALK, EGFR, KRAS. ROS1, MET, BRAF, FGFR1, RET, HER2, PI3K3CA)",0,90,64,17813,NA,"Not Reported","",0,0,0,0,46,1,"","No Prior TKI",0,"White",17308,1,"GJ48914T","",1,0,"IV",0,0,1,"",1,"",NA,NA,"","Deceased",1
"182",0,73,"",1,0,"",1,0,"","","NON-TKI",17562,17870,0,"","",NA,"squamous","Nivolumab",18227,17695,"Nivolumab","anti-pd-1",0,0,0,1,1,1,"sjogren syndrome","Late irAE","positive","IRAE","",18518,2,NA,"",0,"","Onco48",1,823,NA,18411,NA,"Not Reported","Not Reported",0,0,0,1,716,1,"","No Prior TKI",0,"Asian",17639,0,"GJ51265Y","",0,1,"No Staging Data",0,0,0,"",1,"",NA,NA,"","Deceased",0
"183",1,77,"",1,0,"",1,0,"","","NON-TKI",18662,NA,0,"","",NA,"adenocarcinoma","",18722,18701,"Pembrolizumab","anti-pd-1",0,0,0,0,0,0,"none reported",NA,"negative","No irae","",18735,1,NA,"",0,"","Foundation",0,34,NA,18735,NA,">=50%","85%",0,1,0,0,34,1,"","No Prior TKI",0,"Asian",18750,0,"GJ59224S","",0,0,"IV",0,0,1,"f354l (vus)",1,"",NA,NA,"s127f","Deceased",0
"184",1,69,"",1,0,"",0,0,"","","NON-TKI",17763,17995,1,"","",1,"adenocarcinoma","",19271,17982,"Pembrolizumab","anti-pd-1",0,0,0,1,1,1,"fever","Early irAE","positive","IRAE","g12c",19271,2,NA,"",0,"","GenPath OnkoSight",1,1289,NA,18878,NA,">=50%","60%",0,1,0,1,896,1,"","No Prior TKI",0,"White",18156,0,"GJ88917S","",0,0,"III",1,0,0,"",0,"",NA,NA,"","Alive",1
"185",1,70,"",1,0,"",0,0,"","","NON-TKI",18229,18752,0,"","",NA,"adenocarcinoma","",18822,18243,"Pembrolizumab","anti-pd-1",0,0,0,1,0,0,"syncopal episodes","Late irAE","positive","IRAE","amplification; g12c",18946,1,NA,"",0,"","Foundation",1,703,80,18921,NA,">=50%","70%",0,1,0,1,678,1,"","No Prior TKI",0,"White",18792,0,"GJ91520S","",1,0,"IV",0,0,1,"",1,"",NA,NA,"r248l","Deceased",1
"186",0,80,"negative",1,0,"",1,0,"","","NON-TKI",17623,17770,1,"negative","",NA,"squamous","",17840,17742,"Nivolumab","anti-pd-1",0,0,0,1,1,1,"elevated creatinine","Early irAE","positive","IRAE","",17928,2,NA,"",1,"","EGFR ALK  negative",0,186,10,17858,NA,"Not Reported","",0,0,0,0,116,1,"","No Prior TKI",0,"Asian",17683,1,"GK37896P","",1,1,"III",1,0,0,"",1,"",NA,NA,"","Deceased",0
"187",1,71,"",0,1,"",0,0,"","","NON-TKI",17821,NA,0,"","",NA,"adenocarcinoma","",18365,18365,"Atezolizumab","anti-pd-l1",0,0,0,0,0,0,"none reported",NA,"negative","No irae","182a>t, q61l",18459,2,NA,"",0,"","Onco48",0,94,20,18381,NA,"Not Reported","Not Reported",0,0,0,0,16,1,"","No Prior TKI",0,"White",17884,0,"GK49869Q","",1,0,"IV",0,0,1,"",1,"",NA,NA,"743g>a, r248q","Deceased",1
"188",1,63,"negative",1,0,"",0,0,"","","NON-TKI",17270,NA,0,"d770g insertion y exon 20","",NA,"adenocarcinoma","",17742,17721,"Pembrolizumab","anti-pd-1",0,0,0,0,0,0,"none reported",NA,"negative","No irae","",18243,4,NA,"",1,"","Quest Diagnostics  (EGFR, ALK)",1,522,NA,17764,NA,"Not Reported","Not Reported",0,0,0,0,43,1,"","No Prior TKI",0,"White",17225,1,"GK54396Y","",0,0,"IV",0,0,1,"",1,"",NA,NA,"","Deceased",1
"189",1,60,"",1,0,"",0,0,"","","NON-TKI",18666,18740,1,"","",1,"adenocarcinoma","",18983,18731,"Pembrolizumab","anti-pd-1",1,1,1,0,0,0,"diarrhea","Early irAE","positive","Gastrointestinal","p.g12s, c.34g>a",19291,2,NA,"",0,"","HopeSeq",1,560,40,NA,NA,">=50%","90%",0,1,0,1,NA,0,"","No Prior TKI",0,"Unknown or Other",18711,0,"GK55921W","",1,0,"IV",0,0,1,"",0,"",NA,NA,"p.r273l, c.818g>t","Alive",0
"190",1,71,"",0,1,"",0,1,"","","NON-TKI",18681,NA,0,"","a775_g776insyvma, amplification",NA,"adenocarcinoma","",18746,18725,"Atezolizumab","anti-pd-l1",0,0,0,0,0,0,"none reported",NA,"negative","No irae","",19145,1,NA,"",1,"","Foundation",1,420,6,18760,NA,"Negative","Negative",0,0,1,0,35,1,"","No Prior TKI",0,"Black or African American",18786,1,"GK59377Y","",1,0,"I or II",0,1,0,"",0,"",NA,NA,"tp53(nm_000546)-tekt1(nm_053285) fusion (t7;t7)","Alive",0
"191",1,57,"",1,0,"",0,0,"","","TKI",15537,NA,0,"e746_a750del","",NA,"adenocarcinoma","",17865,17739,"Nivolumab","anti-pd-1",0,0,0,0,0,0,"none reported",NA,"negative","No irae","",18134,8,2,"",0,"","Onco48",1,395,NA,17872,16934,"Negative","Negative",0,0,1,0,133,1,"","Prior TKI",1,"Unknown or Other",17316,0,"GK71748R","",0,0,"IV",0,0,1,"",1,"erlotinib",16934,15519,"r273h","Deceased",0
"192",1,65,"",1,0,"",0,0,"","","NON-TKI",18578,18656,1,"","",NA,"adenocarcinoma","",18908,18639,"Pembrolizumab","anti-pd-1",0,0,0,1,1,1,"neutropenia","Early irAE","positive","IRAE","",18935,1,NA,"",1,"","HopeSeq",0,296,12.5,18934,NA,"1-49%","15%",1,0,0,1,295,1,"","No Prior TKI",0,"Unknown or Other",18612,1,"GK83587W","",1,0,"IV",0,0,1,"",1,"",NA,NA,"c275*","Deceased",0
"193",0,46,"",1,0,"",0,0,"","a57v","NON-TKI",16443,NA,0,"","",NA,"squamous","",17842,17801,"Nivolumab","anti-pd-1",0,0,0,0,0,0,"none reported",NA,"negative","No irae","",18144,4,NA,"",0,"n375s","Onco48",0,343,14,17850,NA,"Not Reported","Not Reported",0,0,0,0,49,1,"","No Prior TKI",0,"White",17280,0,"GL00318P","",1,1,"IV",0,0,1,"",1,"",NA,NA,"a159v","Deceased",1
"194",1,61,"",1,0,"",0,0,"","p16ink4a r80*, p14arf p94l","NON-TKI",18313,NA,0,"","",NA,"adenocarcinoma","",18941,18471,"Pembrolizumab","anti-pd-1",0,0,0,0,0,0,"none reported",NA,"negative","No irae","amplification- equivocal, g12d",18955,1,NA,"",1,"","Foundation",1,484,NA,NA,NA,">=50%","80%",0,1,0,1,NA,0,"","No Prior TKI",0,"Unknown or Other",18557,1,"GL16835T","",0,0,"IV",0,0,1,"",0,"",NA,NA,"","Alive",0
"195",0,52,"",1,0,"",1,0,"","","NON-TKI",17225,18338,0,"negative","",NA,"squamous","",NA,17731,"Nivolumab","anti-pd-1",0,0,0,1,0,0,"autoimmune hepatitis","Late irAE","positive","IRAE","",19290,2,NA,"",0,"","Foundation",1,1559,NA,NA,NA,"Not Reported","Not Reported",0,0,0,1,NA,0,"","No Prior TKI",0,"Asian",17486,0,"GL29890Z","",0,1,"IV",0,0,1,"f354l",0,"",NA,NA,"","Alive",0
"196",1,33,"",1,0,"",1,0,"","","NON-TKI",18586,NA,0,"","",NA,"adenocarcinoma","",18673,18627,"Pembrolizumab","anti-pd-1",0,0,0,0,0,0,"none reported",NA,"negative","No irae","",18692,1,NA,"",1,"","Cancer Genetics Incorporated EGFR, ALK, ROS1 (All Negative)",0,65,7.5,18692,NA,"Negative","Negative",0,0,1,0,65,1,"","No Prior TKI",0,"Asian",18591,1,"GL40922R","",1,0,"IV",0,0,1,"",1,"",NA,NA,"","Deceased",0
"197",1,59,"negative",1,0,"",0,0,"negative","","NON-TKI",17351,18252,0,"negative","",2,"adenocarcinoma","",18324,18064,"Nivolumab","anti-pd-1",1,1,0,0,0,0,"abdominal discomfort, colitis","Late irAE","positive","Gastrointestinal","g12c",18904,2,NA,"",1,"","Clarient Diagnostic Services (HER2, ALK, EGFR, KRAS, BRAF)",1,840,NA,18577,NA,"Not Reported","",0,0,0,1,513,1,"","No Prior TKI",0,"White",17376,1,"GL68537V","",1,0,"IV",0,0,1,"",1,"",NA,NA,"","Deceased",1
"198",1,57,"",1,0,"",0,0,"","","NON-TKI",18138,18353,1,"","",1,"adenocarcinoma","",NA,18353,"Pembrolizumab","anti-pd-1",1,1,1,0,0,0,"nausea, vomiting, dizziness","Early irAE","positive","Gastrointestinal","amplification, g12c",19305,2,NA,"",0,"","Foundation",1,952,40,NA,NA,">=50%","80%",0,1,0,1,NA,0,"","No Prior TKI",0,"White",18366,0,"GL69497R","",1,0,"III",1,0,0,"",0,"",NA,NA,"","Alive",1
"199",0,77,"",1,0,"",0,0,"","","NON-TKI",18310,19101,0,"","",NA,"squamous","",19101,18365,"Pembrolizumab","anti-pd-1",0,0,0,1,0,0,"fatigue","Late irAE","positive","IRAE","",19119,1,NA,"",1,"","EGFR, ALK, ROS1 (All Negative)",1,754,50,19119,NA,">=50%","99%",0,1,0,1,754,1,"","No Prior TKI",0,"Unknown or Other",18331,1,"GL71170Y","",1,1,"III",1,0,0,"",1,"",NA,NA,"","Deceased",0
"200",1,68,"",0,1,"",1,0,"","loss","NON-TKI",17934,NA,0,"","",NA,"adenocarcinoma","",18397,18334,"Atezolizumab","anti-pd-l1",0,0,0,0,0,0,"none reported",NA,"negative","No irae","g12d",18547,2,NA,"",0,"","Foundation",0,213,NA,18407,NA,"Negative","Negative",0,0,1,0,73,1,"","No Prior TKI",0,"Asian",17997,0,"GL90558W","",0,0,"IV",0,0,1,"",1,"",NA,NA,"","Deceased",0
"201",1,68,"",1,0,"",1,0,"","h103fs","NON-TKI",18282,NA,0,"","",NA,"adenocarcinoma","",18941,18422,"Pembrolizumab","anti-pd-1",0,0,0,0,0,0,"none reported",NA,"negative","No irae","g12c",19291,1,NA,"",1,"t818h (vus)","Caris",1,869,75,NA,NA,"1-49%","35%",1,0,0,1,NA,0,"","No Prior TKI",0,"Asian",18317,1,"GL96988Y","",1,0,"IV",0,0,1,"",0,"",NA,NA,"e294fs","Alive",0
"202",1,64,"",1,0,"",0,0,"","","NON-TKI",17099,NA,0,"","",NA,"adenocarcinoma","",17799,17778,"Nivolumab","anti-pd-1",0,0,0,0,0,0,"none reported",NA,"negative","No irae","",17808,3,NA,"",1,"","Onco48",0,30,22,17806,NA,"Not Reported","Not Reported",0,0,0,0,28,1,"","No Prior TKI",0,"White",17484,1,"GM00704P","",1,0,"IV",0,0,1,"",1,"",NA,NA,"","Deceased",1
"203",1,74,"",1,0,"",0,0,"","","NON-TKI",18401,18570,0,"","",NA,"adenocarcinoma","",19073,18446,"Pembrolizumab","anti-pd-1",1,1,1,0,0,0,"hypothyroidism","Late irAE","positive","Endocrine","",19152,1,NA,"",0,"","Genpath (All Negative)",1,706,NA,19086,NA,"1-49%","40%",1,0,0,1,640,1,"","No Prior TKI",0,"Unknown or Other",18417,0,"GM03845Z","",0,0,"IV",0,0,1,"",1,"",NA,NA,"","Deceased",0
"204",0,66,"",1,0,"",1,0,"","","NON-TKI",16157,18394,0,"negative","",2,"squamous","Nivolumab",19068,18302,"Nivolumab","anti-pd-1",1,1,1,0,0,0,"hypothyroidism","Late irAE","positive","Endocrine","",19311,3,NA,"",0,"","COH EGFR panel",1,1009,NA,19080,NA,"Not Reported","Not Reported",0,0,0,1,778,1,"","No Prior TKI",0,"Asian",17865,0,"GM24570P","",0,1,"III",1,0,0,"",0,"",NA,NA,"","Alive",0
"205",1,70,"",1,0,"",0,0,"","","NON-TKI",18451,19009,0,"","",3,"adenocarcinoma","",18955,18493,"Pembrolizumab","anti-pd-1",1,0,0,0,0,0,"rash","Late irAE","positive","Skin","",19278,1,NA,"",0,"","Caris",1,785,NA,NA,NA,">=50%","100%",0,1,0,1,NA,0,"","No Prior TKI",0,"White",18479,0,"GM35768P","",0,0,"IV",0,0,1,"",0,"",NA,NA,"r273c","Alive",1
"206",0,79,"",1,0,"",0,0,"","","NON-TKI",18216,NA,0,"","",NA,"squamous","",19076,18523,"Pembrolizumab","anti-pd-1",0,0,0,0,0,0,"none reported",NA,"negative","No irae","",19120,2,NA,"",1,"","No Report",1,597,70,19110,NA,"Not Reported","Not Reported",0,0,0,1,587,1,"","No Prior TKI",0,"White",NA,1,"GM62038Q","",1,1,"No Staging Data",0,0,0,"",1,"",NA,NA,"","Deceased",1
"207",1,66,"negative",1,0,"",0,0,"","","NON-TKI",16157,17812,0,"negative","",2,"adenocarcinoma","",17868,17742,"Nivolumab","anti-pd-1",1,1,1,0,0,0,"autoimmune skin rash (hypertrophic lichen planus)","Late irAE","positive","Skin","g12v",19121,3,NA,"",0,"","responseDX lung (ALK, EGFR, KRAS. ROS1)",1,1379,NA,18269,NA,"1-49%","5%",1,0,0,1,527,1,"","No Prior TKI",0,"White",16764,0,"GM62546X","",0,0,"IV",0,0,1,"",0,"",NA,NA,"","Alive",1
"208",1,68,"",1,0,"",0,0,"","","NON-TKI",18199,18691,0,"","",NA,"adenocarcinoma","",18775,18250,"Pembrolizumab","anti-pd-1",0,0,0,1,0,0,"shoulder pain","Late irAE","positive","IRAE","",18967,1,NA,"r2609q, c490s (vus), s3063n (vus), v1067f (vus)",0,"","Foundation",1,717,NA,18792,NA,"Negative","Negative",0,0,1,1,542,1,"","No Prior TKI",0,"White",18234,0,"GM73383S","g1159fs*17, k997t (vus)",0,0,"IV",0,0,1,"g163f (vus)",1,"",NA,NA,"g244d","Deceased",1
"209",1,62,"",0,1,"",0,0,"","","TKI",15091,17598,0,"","",1,"adenocarcinoma","Atezolizumab",18498,17318,"Atezolizumab","anti-pd-l1",0,0,0,1,1,0,"fatigue","Late irAE","positive","IRAE","g12c",19306,7,1,"",0,"","Onco48",1,1988,32,18520,15789,"Not Reported","Not Reported",0,0,0,1,1202,1,"","Prior TKI",1,"White",17956,0,"GN33326V","",1,0,"IV",0,0,1,"",0,"erlotinib",15789,15154,"","Alive",1
"210",1,69,"",1,0,"",0,0,"","","NON-TKI",17658,NA,0,"","",NA,"adenocarcinoma","",17683,17683,"Nivolumab","anti-pd-1",0,0,0,0,0,0,"none reported",NA,"negative","No irae","",17713,4,NA,"",0,"","No Report",0,30,35,17684,NA,"Not Reported","",0,0,0,0,1,1,"","No Prior TKI",0,"White",NA,0,"GN36886Q","",1,0,"IV",0,0,1,"",1,"",NA,NA,"","Deceased",1
"211",1,61,"",1,0,"",0,0,"","","NON-TKI",18499,NA,0,"","",NA,"adenocarcinoma","",18626,18563,"Pembrolizumab","anti-pd-1",0,0,0,0,0,0,"none reported",NA,"negative","No irae","",18668,1,NA,"",0,"","Integrated Oncology EGFR, ALK, ROS1 (All Negative)",0,105,NA,18639,NA,"1-49%","1%",1,0,0,0,76,1,"","No Prior TKI",0,"Unknown or Other",18507,0,"GN40861U","",1,0,"IV",0,0,1,"",1,"",NA,NA,"","Deceased",0
"212",1,79,"",1,0,"s280fs*83",1,0,"","loss","NON-TKI",18453,NA,0,"","",NA,"adenocarcinoma","",18689,18626,"Nivolumab","anti-pd-1",0,0,0,0,0,0,"none reported",NA,"negative","No irae","",18714,2,NA,"e3g (vus)",0,"","Foundation",0,88,NA,18714,NA,"Negative","Negative",0,0,1,0,88,1,"","No Prior TKI",0,"Asian",18619,0,"GN42802W","",0,0,"IV",0,0,1,"",1,"",NA,NA,"","Deceased",0
"213",0,58,"",1,0,"",0,0,"","","TKI",17326,18036,1,"exon 19 deletion","",NA,"large cell or nos nslc","",18023,18023,"Nivolumab","anti-pd-1",0,0,0,1,1,1,"elevated bilirubin","Early irAE","positive","IRAE","",18209,3,1,"",0,"","Biodesix Genestrat EGFR",0,186,NA,18036,17468,"Not Reported","Not Reported",0,0,0,0,13,1,"","Prior TKI",1,"White",17354,0,"GN44534T","",0,0,"IV",0,0,1,"",1,"erlotinib",17468,17103,"","Deceased",1
"214",1,61,"r510w (vus)",1,0,"",1,0,"","","NON-TKI",18317,NA,0,"","",NA,"adenocarcinoma","",18439,18376,"Pembrolizumab","anti-pd-1",0,0,0,0,0,0,"none reported",NA,"negative","No irae","g12v",18537,1,NA,"",0,"","Foundation",0,161,NA,18439,NA,"Negative","Negative",0,0,1,0,63,1,"","No Prior TKI",0,"Asian",18388,0,"GN64490W","",0,0,"IV",0,0,1,"",0,"",NA,NA,"","Alive",0
"215",1,69,"",1,0,"",0,0,"","","NON-TKI",18508,NA,0,"","",NA,"adenocarcinoma","",18656,18530,"Pembrolizumab","anti-pd-1",0,0,0,0,0,0,"none reported",NA,"negative","No irae","",18837,1,NA,"",1,"","No Report",0,307,50,18670,NA,">=50%","80%",0,1,0,0,140,1,"","No Prior TKI",0,"White",NA,1,"GN79288Q","",1,0,"IV",0,0,1,"",0,"",NA,NA,"","Alive",1
"216",1,78,"",0,1,"",0,0,"","","NON-TKI",18402,NA,0,"","",NA,"adenocarcinoma","",18540,18477,"Atezolizumab","anti-pd-l1",0,0,0,0,0,0,"none reported",NA,"negative","No irae","",18554,2,NA,"",1,"","No Report",0,77,NA,18547,NA,"Not Reported","Not Reported",0,0,0,0,70,1,"","No Prior TKI",0,"White",NA,1,"GN83966S","",0,0,"IV",0,0,1,"",0,"",NA,NA,"","Alive",1
"217",1,61,"",1,0,"",0,0,"","","NON-TKI",17709,NA,0,"","",NA,"adenocarcinoma","",18051,17980,"Nivolumab","anti-pd-1",0,0,0,0,0,0,"none reported",NA,"negative","No irae","35 g>c g12a",18577,3,NA,"",0,"","Onco48",1,597,45,18061,NA,"Negative","Negative",0,0,1,0,81,1,"","No Prior TKI",0,"White",17771,0,"GN88582V","",1,0,"IV",0,0,1,"",1,"",NA,NA,"455 c>t p152l","Deceased",1
"218",1,72,"",1,0,"q479*",1,0,"","","NON-TKI",18338,NA,0,"","",NA,"adenocarcinoma","",18446,18383,"Pembrolizumab","anti-pd-1",0,0,0,0,0,0,"none reported",NA,"negative","No irae","g12c",19307,1,NA,"n4505s (vus)",1,"","Foundation",1,924,18,18460,NA,">=50%","60%",0,1,0,0,77,1,"","No Prior TKI",0,"Asian",18389,1,"GN95106Q","",1,0,"IV",0,0,1,"",0,"",NA,NA,"","Alive",0
"219",1,67,"",1,0,"",0,0,"","","NON-TKI",17325,NA,0,"","",NA,"adenocarcinoma","",18666,18386,"Nivolumab","anti-pd-1",0,0,0,0,0,0,"none reported",NA,"negative","No irae","g12d",19310,3,NA,"",1,"","Caris",1,924,NA,18676,NA,"Negative","Negative",0,0,1,1,290,1,"","No Prior TKI",0,"White",18042,1,"HJ36781W","",0,0,"IV",0,0,1,"",0,"",NA,NA,"","Alive",1
"220",1,78,"",1,0,"g846c (vus)",0,0,"","","NON-TKI",17893,18432,0,"","",1,"adenocarcinoma","",19060,18348,"Pembrolizumab","anti-pd-1",1,1,1,0,0,0,"dermatitis","Late irAE","positive","Skin","g13d",19300,2,NA,"",0,"","Foundation",1,952,30,NA,NA,">=50%","80%",0,1,0,1,NA,0,"","No Prior TKI",0,"White",18366,0,"HJ37208W","",1,0,"III",1,0,0,"",0,"",NA,NA,"","Alive",1
"221",1,76,"",0,1,"",0,0,"","","NON-TKI",17662,NA,0,"","",NA,"adenocarcinoma","",19060,18736,"Atezolizumab","anti-pd-l1",0,0,0,0,0,0,"none reported",NA,"negative","No irae","35g>a g12d",19157,3,NA,"",0,"","Paradigm",1,421,NA,19072,NA,"Not Reported","Not Reported",0,0,0,1,336,1,"1633g>a e545k","No Prior TKI",0,"Unknown or Other",18030,0,"HJ91176Q","",0,0,"IV",0,0,1,"",1,"",NA,NA,"","Deceased",0
"222",1,61,"",1,0,"",0,0,"","","NON-TKI",17275,17939,0,"","",1,"adenocarcinoma","",18276,17840,"Nivolumab","anti-pd-1",0,0,0,1,1,1,"arthralgias, myalgias","Late irAE","positive","IRAE","amplification  equivocal, g12c",18289,4,NA,"y345*, g3098r,h3296d (vus)",0,"","Foundation",1,449,40,18249,NA,"1-49%","5%",1,0,0,1,409,1,"","No Prior TKI",0,"White",17428,0,"HK29716X","e1211*",1,0,"IV",0,0,1,"",1,"",NA,NA,"c176f, v157l","Deceased",1
"223",1,81,"",0,1,"",0,0,"","","NON-TKI",17934,18583,1,"","",NA,"adenocarcinoma","",18584,18515,"Atezolizumab","anti-pd-l1",0,0,0,1,1,1,"mild anemia","Early irAE","positive","IRAE","",18584,2,NA,"",1,"","IntegratedOncology (MET, ALK, EGFR)",0,69,NA,NA,NA,"Not Reported","Not Reported",0,0,0,1,NA,0,"","No Prior TKI",0,"White",18018,1,"HK56156P","",1,0,"IV",0,0,1,"",0,"",NA,NA,"","Alive",1
"224",1,74,"",1,0,"",0,0,"","loss","NON-TKI",18379,NA,0,"","",NA,"adenocarcinoma","",18506,18485,"Pembrolizumab","anti-pd-1",0,0,0,0,0,0,"none reported",NA,"negative","No irae","g12c",18521,1,NA,"l3414i (vus)",0,"","Foundation",0,36,40,18521,NA,">=50%","80%",0,1,0,0,36,1,"","No Prior TKI",0,"White",18457,0,"HK64853U","",1,0,"IV",0,0,1,"",1,"",NA,NA,"","Deceased",1
"225",1,70,"",0,1,"",1,0,"","","NON-TKI",18528,NA,0,"","",NA,"adenocarcinoma","",18570,18551,"Atezolizumab","anti-pd-l1",0,0,0,0,0,0,"none reported",NA,"negative","No irae","g12d",19265,1,NA,"",1,"","HopeSeq",1,714,NA,NA,NA,"1-49%","5%",1,0,0,1,NA,0,"","No Prior TKI",0,"Asian",18614,1,"HK89856Q","",0,0,"III",1,0,0,"",0,"",NA,NA,"","Alive",0
"226",1,59,"",0,1,"",1,0,"","","NON-TKI",18627,NA,0,"","",NA,"adenocarcinoma","",18803,18740,"Atezolizumab","anti-pd-l1",0,0,0,0,0,0,"none reported",NA,"negative","No irae","p.g12c, c.34g>t",18901,2,NA,"",1,"","HopeSeq",0,161,41,18846,NA,"Not Reported","Not Reported",0,0,0,0,106,1,"","No Prior TKI",0,"Asian",18732,1,"HL50835V","p.g784v, c.2351g>t",1,0,"IV",0,0,1,"c.465-2a>t; p.f354l, c1062c>g (vus)",0,"",NA,NA,"p.p301qfs*44, c.902del","Alive",0
"227",1,77,"",1,0,"",0,0,"","","TKI",16559,17788,1,"","",1,"adenocarcinoma","",17801,17774,"Nivolumab","anti-pd-1",0,0,0,1,1,1,"arthralgia and myalgia","Early irAE","positive","IRAE","g12d",17953,7,5,"",0,"","COH KRAS Seq.",0,179,80,17821,17676,"Not Reported","Not Reported",0,0,0,0,47,1,"","Prior TKI",1,"White",16556,0,"HL74355Z","",1,0,"IV",0,0,1,"",1,"erlotinib",17662,17605,"","Deceased",1
"228",0,60,"equivocal",0,1,"",0,0,"","","NON-TKI",18466,NA,0,"negative","",NA,"squamous","",18641,18618,"Atezolizumab","anti-pd-l1",0,0,0,0,0,0,"none reported",NA,"negative","No irae","",18659,3,NA,"",1,"negative","COH Department of Anatomic Pathology (EGFR, ALK, ROS1, MET amp, ALK)",0,41,NA,18656,NA,"Negative","Negative",0,0,1,0,38,1,"","No Prior TKI",0,"Unknown or Other",18487,1,"HL74899V","",0,1,"IV",0,0,1,"",0,"",NA,NA,"","Alive",0
"229",1,70,"",0,1,"",0,0,"","","NON-TKI",18283,NA,0,"","",NA,"adenocarcinoma","",18520,18478,"Atezolizumab","anti-pd-l1",0,0,0,0,0,0,"none reported",NA,"negative","No irae","",18584,2,NA,"",0,"","No Report",0,106,NA,18529,NA,"Negative","Negative",0,0,1,0,51,1,"","No Prior TKI",0,"Unknown or Other",NA,0,"HM22880Q","",1,0,"IV",0,0,1,"",1,"",NA,NA,"","Deceased",0
"230",1,75,"",1,0,"q1332_q1334del (vus)",0,0,"","","TKI",15988,17811,0,"","",2,"adenocarcinoma","",17803,17732,"Nivolumab","anti-pd-1",1,1,1,0,0,0,"diarrhea, secondary to autoimmune colitis","Late irAE","positive","Gastrointestinal","g12c",17911,4,2,"",0,"","Foundation",0,179,NA,17830,16449,"Negative","Negative",0,0,1,0,98,1,"","Prior TKI",1,"White",17037,0,"HM33099V","",0,0,"IV",0,0,1,"",1,"erlotinib",16435,16435,"","Deceased",1
"231",1,78,"",1,0,"",0,0,"","","NON-TKI",17542,NA,0,"","",NA,"adenocarcinoma","",18085,18039,"Nivolumab","anti-pd-1",0,0,0,0,0,0,"none reported",NA,"negative","No irae","g12v",18428,2,NA,"",1,"","Foundation",1,389,19,18103,NA,"Not Reported","",0,0,0,0,64,1,"","No Prior TKI",0,"White",18144,1,"HM55201R","",1,0,"IV",0,0,1,"",0,"",NA,NA,"r273c","Alive",1
"232",1,65,"",1,0,"",0,0,"","","NON-TKI",15154,NA,0,"","her2 v797m (vus)",NA,"adenocarcinoma","",NA,18010,"Nivolumab","anti-pd-1",0,0,0,0,0,0,"none reported",NA,"negative","No irae","",19282,2,NA,"",0,"","Guardant360",1,1272,20,NA,NA,"Not Reported","Not Reported",0,0,0,1,NA,0,"","No Prior TKI",0,"Unknown or Other",19010,0,"HN11250Q","",1,0,"IV",0,0,1,"",0,"",NA,NA,"","Alive",0
"233",0,54,"",1,0,"",0,0,"","","NON-TKI",17975,NA,0,"","",NA,"squamous","",18087,18012,"Nivolumab","anti-pd-1",0,0,0,0,0,0,"none reported",NA,"negative","No irae","",18164,2,NA,"",0,"","No Report",0,152,NA,18099,NA,"Not Reported","",0,0,0,0,87,1,"","No Prior TKI",0,"White",NA,0,"HN14891V","",0,1,"IV",0,0,1,"",0,"",NA,NA,"","Alive",1
"234",1,68,"",0,1,"",1,0,"","","NON-TKI",17106,18218,1,"p772_h773insgdp","",NA,"adenocarcinoma","",18218,18176,"Atezolizumab","anti-pd-l1",0,0,0,1,1,1,"diffuse muscular body aches","Early irAE","positive","IRAE","",18322,2,NA,"",0,"","Foundation",0,146,NA,18236,NA,"Not Reported","Not Reported",0,0,0,0,60,1,"","No Prior TKI",0,"Asian",17648,0,"HN31684W","",0,0,"IV",0,0,1,"",1,"",NA,NA,"","Deceased",0
"235",0,63,"",0,1,"",0,0,"","p16ink4a r107fs*11, p14arf a121fs*38","NON-TKI",18509,NA,0,"","",NA,"squamous","",18737,18695,"Atezolizumab","anti-pd-l1",0,0,0,0,0,0,"none reported",NA,"negative","No irae","",18998,2,NA,"",1,"","Foundation",0,303,45,18752,NA,"1-49%","5%",1,0,0,0,57,1,"","No Prior TKI",0,"White",18583,1,"HN39243Q","",1,1,"IV",0,0,1,"",1,"",NA,NA,"splice site 673-1g>t","Deceased",1
"236",1,62,"negative",0,1,"",0,0,"","","NON-TKI",16462,18193,1,"negative","",NA,"adenocarcinoma","",18837,18193,"Atezolizumab","anti-pd-l1",1,1,1,0,0,0,"diarrhea","Early irAE","positive","Gastrointestinal","g12v",19264,2,NA,"",0,"","ResponseDX: Lung (KRAS, EGFR)",1,1071,30,18708,NA,"Negative","Negative",0,0,1,1,515,1,"","No Prior TKI",0,"Unknown or Other",16512,0,"HN47476P","",1,0,"IV",0,0,1,"",0,"",NA,NA,"","Alive",0
"237",1,66,"",1,0,"",0,0,"","a127p (vus)","NON-TKI",18661,NA,0,"t430t (syn)","",NA,"adenocarcinoma","",18946,18737,"Pembrolizumab","anti-pd-1",0,0,0,0,0,0,"none reported",NA,"negative","No irae","g12v",19313,1,NA,"",1,"","Guardant360",1,576,80,18960,NA,"Not Reported","Not Reported",0,0,0,1,223,1,"","No Prior TKI",0,"White",18744,1,"HN49889P","",1,0,"IV",0,0,1,"",0,"",NA,NA,"v157f, e287*","Alive",1
"238",0,66,"",0,1,"",0,0,"","","NON-TKI",18492,18785,1,"","",NA,"squamous","",18915,18739,"Durvalumab","anti-pd-l1",0,0,0,1,1,1,"autoimmune hepatitis","Early irAE","positive","IRAE","",19222,2,NA,"",1,"","No Report",1,483,28,NA,NA,"Not Reported","Not Reported",0,0,0,1,NA,0,"","No Prior TKI",0,"Unknown or Other",NA,1,"HN52031W","",1,1,"IV",0,0,1,"",0,"",NA,NA,"","Alive",0
"239",1,54,"",1,0,"",1,0,"","","TKI",17094,NA,0,"l747_t751del","",NA,"adenocarcinoma","",18892,18701,"Pembrolizumab","anti-pd-1",0,0,0,0,0,0,"none reported",NA,"negative","No irae","",19319,3,1,"",0,"","HopeSeq",1,618,10,18900,18179,">=50%","70%",0,1,0,1,199,1,"amplification","Prior TKI",1,"Asian",18523,0,"HN54933Q","",1,0,"IV",0,0,1,"",0,"erlotinib",18137,17103,"y327*","Alive",0
"240",1,71,"",1,0,"",0,0,"","","NON-TKI",18382,18787,0,"","",1,"adenocarcinoma","",19151,18409,"Pembrolizumab","anti-pd-1",0,0,0,1,0,0,"unsteady gait, blurred vision","Late irAE","positive","IRAE","g12v",18837,1,NA,"i4592t (vus)",0,"","Foundation",1,428,50,NA,NA,">=50%","70%",0,1,0,1,NA,0,"","No Prior TKI",0,"White",18408,0,"HN87096R","",1,0,"IV",0,0,1,"",0,"",NA,NA,"r273s","Alive",1
"241",0,65,"",0,1,"",0,0,"","e69*","NON-TKI",18333,NA,0,"amplificaiton low","",NA,"squamous","",18968,18725,"Durvalumab","anti-pd-l1",0,0,0,0,0,0,"none reported",NA,"negative","No irae","",19011,2,NA,"",1,"","Guardant360",0,286,35,18982,NA,"Not Reported","Not Reported",0,0,0,1,257,1,"amplification medium","No Prior TKI",0,"Unknown or Other",18978,1,"EJ16439X","",1,1,"I or II",0,1,0,"",0,"",NA,NA,"y234c","Alive",0
"242",1,54,"rearrangement",1,0,"",0,0,"","","TKI",15670,18015,1,"","",NA,"adenocarcinoma","",18085,18015,"Nivolumab","anti-pd-1",1,1,1,0,0,0,"immediate infusion reaction- 2 episodes of cough and spasm,  sob","Early irAE","positive","Respiratory","gly12val",18190,4,1,"",0,"","COH panel (EGFR, KRAS), ALK FISH",0,175,NA,18174,17011,"Negative","Negative",0,0,1,0,159,1,"","Prior TKI",1,"Unknown or Other",16839,0,"GL17857U","",0,0,"IV",0,0,1,"",1,"crizotinib",17011,16858,"","Deceased",0
"243",1,49,"",0,1,"",1,0,"","","TKI",17344,NA,0,"e746_a750del","",NA,"adenocarcinoma","",18514,18467,"Atezolizumab","anti-pd-l1",0,0,0,0,0,0,"none reported",NA,"negative","No irae","",18535,5,1,"",0,"","Onco48",0,68,NA,18528,17824,"Not Reported","Not Reported",0,0,0,0,61,1,"","Prior TKI",1,"Asian",17373,0,"AM78116V","",0,0,"IV",0,0,1,"",1,"erlotinib",17813,17376,"e258*","Deceased",0
"244",1,66,"",0,1,"",1,0,"","","TKI",17270,NA,0,"a763_y764insfqea","",NA,"adenocarcinoma","",18191,18148,"Atezolizumab","anti-pd-l1",0,0,0,0,0,0,"none reported",NA,"negative","No irae","",18879,3,2,"",1,"","Onco48",1,731,25,18215,18142,">=50%","68%",0,1,0,0,67,1,"","Prior TKI",1,"Asian",17484,1,"AN77012V","",1,0,"IV",0,0,1,"f354l",0,"erlotinib",18142,17579,"g245c","Alive",0
"245",1,47,"",1,0,"",0,0,"v600e","","TKI",15356,17728,1,"","",NA,"adenocarcinoma","",18274,17697,"Nivolumab","anti-pd-1",0,0,0,1,1,1,"encephalitis","Early irAE","positive","IRAE","",19290,7,2,"",0,"","Foundation",1,1593,10,18375,15731,">=50%","100%",0,1,0,1,678,1,"","Prior TKI",1,"White",16835,0,"AN98112Z","",1,0,"IV",0,0,1,"",0,"erlotinib",15731,15642,"","Alive",1
"246",1,43,"",1,0,"",0,0,"","","NON-TKI",16618,19254,0,"","",NA,"adenocarcinoma","",NA,18450,"Nivolumab","anti-pd-1",1,0,0,0,0,0,"endocrinopathy","Late irAE","positive","Endocrine","",19306,3,NA,"",0,"","UCLA Pathology (KRAS, EGFR, ALK)",1,856,NA,NA,NA,"Not Reported","Not Reported",0,0,0,1,NA,0,"","No Prior TKI",0,"Unknown or Other",16625,0,"BK34862Q","",1,0,"IV",0,0,1,"",0,"",NA,NA,"","Alive",0
"247",1,77,"",1,0,"",0,0,"","","NON-TKI",18367,NA,0,"l861q, p848l","",NA,"adenocarcinoma","",18723,18613,"Nivolumab","anti-pd-1",0,0,0,0,0,0,"none reported",NA,"negative","No irae","",19020,2,NA,"",1,"","NeoType Analysis",1,407,NA,NA,NA,"Negative","Negative",0,0,1,1,NA,0,"","No Prior TKI",0,"White",19079,1,"BK58428S","",0,0,"No Staging Data",0,0,0,"",0,"",NA,NA,"r248q","Alive",1
"248",1,78,"",1,0,"",1,0,"","","NON-TKI",18129,18220,1,"","",1,"adenocarcinoma","",18241,18178,"Pembrolizumab","anti-pd-1",0,0,0,1,1,1,"hyponatremia","Early irAE","positive","IRAE","g12c",18503,1,NA,"",1,"","OncoComplete",0,325,NA,18249,NA,">=50%","70%",0,1,0,0,71,1,"","No Prior TKI",0,"Asian",18276,1,"BN21120P","",0,0,"IV",0,0,1,"",1,"",NA,NA,"e258*","Deceased",0
"249",1,84,"",1,0,"",0,0,"","","NON-TKI",16814,18063,1,"","",NA,"adenocarcinoma","",18078,18008,"Nivolumab","anti-pd-1",0,0,0,1,1,1,"myalgias","Early irAE","positive","IRAE","",18102,6,NA,"",0,"","Foundation",0,94,NA,18089,NA,"Not Reported","Not Reported",0,0,0,0,81,1,"","No Prior TKI",0,"White",17037,0,"BN24593R","",0,0,"IV",0,0,1,"",1,"",NA,NA,"r273h, s215r","Deceased",1
"250",1,63,"",1,0,"",0,0,"","","NON-TKI",18164,NA,0,"","",NA,"adenocarcinoma","",18529,18515,"Nivolumab","anti-pd-1",0,0,0,0,0,0,"none reported",NA,"negative","No irae","",18866,2,NA,"",1,"","NeoGenomics (ALK)",0,351,45,18540,NA,">=50%","70%",0,1,0,0,25,1,"","No Prior TKI",0,"Unknown or Other",18863,1,"CJ08024V","",1,0,"IV",0,0,1,"",0,"",NA,NA,"","Alive",0
"251",1,53,"",0,1,"",1,0,"","","NON-TKI",17571,18305,1,"","",1,"adenocarcinoma","",18306,18283,"Atezolizumab","anti-pd-l1",0,0,0,1,1,1,"nausea, lower extemity edema","Early irAE","positive","IRAE","g12d",18390,2,NA,"",0,"","OncoComplete",0,107,NA,18312,NA,"1-49%","20%",1,0,0,0,29,1,"","No Prior TKI",0,"Asian",18271,0,"CJ75077Z","",0,0,"IV",0,0,1,"",0,"",NA,NA,"c176f","Alive",0
"252",1,61,"",1,0,"",1,0,"","","NON-TKI",18129,18360,0,"","",NA,"adenocarcinoma","",NA,18201,"Pembrolizumab","anti-pd-1",1,1,1,0,0,0,"facial hypopigmented patches","Late irAE","positive","Skin","",19313,1,NA,"",1,"","NeoGenomics (EGFR, ALK)",1,1112,2,NA,NA,">=50%","80%",0,1,0,1,NA,0,"","No Prior TKI",0,"Asian",18152,1,"CL57554S","",1,0,"IV",0,0,1,"",0,"",NA,NA,"","Alive",0
"253",0,71,"",1,0,"",0,0,"","","NON-TKI",18275,NA,0,"","",NA,"squamous","",18655,18318,"Pembrolizumab","anti-pd-1",0,0,0,0,0,0,"none reported",NA,"negative","No irae","",18760,1,NA,"s977g (vus)",0,"","Foundation",1,442,53,18675,NA,"Not Reported","Not Reported",0,0,0,1,357,1,"","No Prior TKI",0,"White",18317,0,"CM64544Z","",1,1,"IV",0,0,1,"",1,"",NA,NA,"g334v","Deceased",1
"254",1,89,"",1,0,"",0,1,"","","NON-TKI",18632,NA,0,"","",NA,"adenocarcinoma","",18646,18646,"Pembrolizumab","anti-pd-1",0,0,0,0,0,0,"none reported",NA,"negative","No irae","amplification",18686,1,NA,"",0,"exon 14 deletion","HopeSeq",0,40,NA,18686,NA,">=50%","70%",0,1,0,0,40,1,"h1047l","No Prior TKI",0,"Black or African American",18640,0,"CN66663X","",0,0,"IV",0,0,1,"",1,"",NA,NA,"","Deceased",0
"255",1,47,"",1,0,"",1,0,"","","TKI",14748,NA,0,"l858r, a955t (vus)","",NA,"adenocarcinoma","",18269,18227,"Nivolumab","anti-pd-1",0,0,0,0,0,0,"none reported",NA,"negative","No irae","",18307,5,2,"",0,"l211w (vus)","Foundation",0,80,NA,18283,17103,"Not Reported","Not Reported",0,0,0,0,56,1,"","Prior TKI",1,"Asian",18249,0,"DJ35663R","",0,0,"IV",0,0,1,"",1,"erlotinib",17103,15049,"e285k","Deceased",0
"256",1,79,"",1,0,"",0,0,"v600e","","TKI",18124,18334,1,"","",NA,"adenocarcinoma","",18348,18334,"Nivolumab","anti-pd-1",1,1,1,0,0,0,"pneumonitis","Early irAE","positive","Respiratory","",18637,3,2,"",0,"","OncoComplete",0,303,3,18348,18213,">=50%","60%",0,1,0,0,14,1,"","Prior TKI",1,"White",18142,0,"DK42164Z","",1,0,"IV",0,0,1,"",1,"dabrafenib, trametinib",18213,18150,"r213*","Deceased",1
"257",0,80,"",0,1,"",0,0,"","","NON-TKI",18256,18589,1,"","",1,"squamous","",18694,18568,"Atezolizumab","anti-pd-l1",0,0,0,1,1,1,"fatigue","Early irAE","positive","IRAE","",18774,2,NA,"",1,"","OncoComplete",0,206,30,18722,NA,"Negative","Negative",0,0,1,0,154,1,"","No Prior TKI",0,"White",18253,1,"DL58487Y","",1,1,"IV",0,0,1,"",1,"",NA,NA,"","Deceased",1
"258",1,72,"",0,1,"",0,0,"","","TKI",18395,NA,0,"","",NA,"adenocarcinoma","",18744,18697,"Atezolizumab","anti-pd-l1",0,0,0,0,0,0,"none reported",NA,"negative","No irae","",18995,3,1,"",0,"exon 14 splice site (d1010h)","Foundation",0,298,NA,18774,18642,"Not Reported","Not Reported",0,0,0,0,77,1,"","Prior TKI",1,"White",18428,0,"DN28487Q","",0,0,"IV",0,0,1,"",1,"crizotinib",18642,18452,"","Deceased",1
"259",1,61,"",1,0,"",0,0,"","","TKI",16966,NA,0,"e746_a750del","",NA,"adenocarcinoma","",18302,18253,"Pembrolizumab","anti-pd-1",0,0,0,0,0,0,"none reported",NA,"negative","No irae","",18712,6,1,"",0,"","COH panel (EGFR, KRAS)",1,459,6,18325,17420,"Not Reported","Not Reported",0,0,0,0,72,1,"","Prior TKI",1,"White",17003,0,"DN59126T","",1,0,"IV",0,0,1,"",1,"erlotinib",17420,17016,"","Deceased",1
"260",0,60,"",1,0,"",0,0,"","p14arf r64*","TKI",18110,19275,0,"l858r","",NA,"squamous","",19275,18449,"Nivolumab","anti-pd-1",1,0,0,0,0,0,"distal sigmoid wall thickening","Late irAE","positive","Gastrointestinal","",19303,3,1,"deletion exons 8-20",1,"s942l (vus)","Foundation",1,854,NA,NA,18320,">=50%","90%",0,1,0,1,NA,0,"","Prior TKI",1,"White",18124,1,"EJ87624S","",0,1,"IV",0,0,1,"",0,"afatinib",18278,18139,"v143m","Alive",1
"261",1,50,"",1,0,"",1,0,"","","TKI",17918,NA,0,"l858r, t790m","",NA,"adenocarcinoma","",18871,18341,"Pembrolizumab","anti-pd-1",0,0,0,0,0,0,"none reported",NA,"negative","No irae","",19279,2,1,"",0,"","HopeSeq",1,938,NA,18932,18124,">=50%","100%",0,1,0,1,591,1,"","Prior TKI",1,"Asian",18887,0,"EK09804S","",0,0,"IV",0,0,1,"f354l (vus)",0,"erlotinib",18124,17948,"","Alive",0
"262",1,66,"",1,0,"",1,0,"","","TKI",17967,NA,0,"l858r, t725m","",NA,"adenocarcinoma","",18792,18696,"Pembrolizumab","anti-pd-1",0,0,0,0,0,0,"none reported",NA,"negative","No irae","",18843,3,1,"",0,"","Foundation",0,147,5,18803,18640,">=50%","100%",0,1,0,0,107,1,"","Prior TKI",1,"Asian",17977,0,"EK79340W","",1,0,"IV",0,0,1,"",0,"erlotinib",18640,17983,"v272m","Alive",0
"263",1,57,"",1,0,"",0,0,"","","TKI",18061,NA,0,"l858r","",NA,"adenocarcinoma","",18612,18570,"Pembrolizumab","anti-pd-1",0,0,0,0,0,0,"none reported",NA,"negative","No irae","",19080,3,1,"",1,"","Esoterix Genetics Labs (EGFR, KRAS, ROS1, ALK)",1,510,NA,18633,18441,"1-49%","25%",1,0,0,0,63,1,"","Prior TKI",1,"White",18061,1,"EL03971W","",0,0,"IV",0,0,1,"",1,"erlotinib",18441,18097,"","Deceased",1
"264",1,63,"",0,1,"",0,0,"","","NON-TKI",17574,NA,0,"","",NA,"adenocarcinoma","",18359,18312,"Atezolizumab","anti-pd-l1",0,0,0,0,0,0,"none reported",NA,"negative","No irae","g12v",18474,4,NA,"i844m (vus)",1,"","Foundation",0,162,5,18424,NA,"Negative","Negative",0,0,1,0,112,1,"","No Prior TKI",0,"White",18136,1,"EL51031T","",1,0,"IV",0,0,1,"",0,"",NA,NA,"","Alive",1
"265",0,60,"",1,0,"",1,0,"","","TKI",18003,18596,0,"n746_a750del","",NA,"squamous","",18612,18444,"Nivolumab","anti-pd-1",1,1,1,0,0,0,"elevated tsh","Late irAE","positive","Endocrine","",18836,3,2,"",0,"","NeoGenomics EGFR Seq.",1,392,NA,18613,18408,"Not Reported","Not Reported",0,0,0,0,169,1,"","Prior TKI",1,"Asian",18386,0,"FJ20533X","",0,1,"III",1,0,0,"",0,"erlotinib",18408,18226,"","Alive",0
"266",1,65,"",1,0,"",0,0,"","","TKI",15413,18408,1,"e746_a750del, t790m","",NA,"adenocarcinoma","",18409,18388,"Pembrolizumab","anti-pd-1",1,1,1,0,0,0,"constipation","Early irAE","positive","Gastrointestinal","",18607,5,2,"",1,"","OncoComplete",0,219,3,18435,18199,">=50%","50%",0,1,0,0,47,1,"","Prior TKI",1,"White",18191,1,"FJ55688S","",1,0,"IV",0,0,1,"",1,"erlotinib",18199,14758,"r249m","Deceased",1
"267",1,50,"",1,0,"",0,0,"","","TKI",17834,NA,0,"exon 19 deletion, t790m","",NA,"adenocarcinoma","",18816,18548,"Pembrolizumab","anti-pd-1",0,0,0,0,0,0,"none reported",NA,"negative","No irae","",18841,3,1,"",0,"","Quest Diagnostics  (EGFR, ALK)",0,293,NA,18838,18227,"1-49%","25%",1,0,0,1,290,1,"","Prior TKI",1,"White",18261,0,"FL22988Z","",0,0,"IV",0,0,1,"",1,"erlotinib",18227,17862,"","Deceased",1
"268",1,59,"",0,0,"",1,0,"","","TKI",18285,18787,1,"amplification, l861q","",NA,"adenocarcinoma","",18750,18750,"Nivolumab,Ipilimumab","anti-pd-1/anti-ctla-4",1,1,1,0,0,0,"diarrhea","Early irAE","positive","Gastrointestinal","",18801,3,1,"",1,"","HopeSeq",0,51,30,18788,18684,"Not Reported","Not Reported",0,0,0,0,38,1,"c420r","Prior TKI",1,"Asian",18627,1,"FM05011X","",1,0,"IV",0,0,1,"",0,"erlotinib",18472,18292,"r283p","Alive",0
"269",1,79,"rearrangement",1,0,"",1,0,"","","TKI",17809,17900,1,"","",3,"adenocarcinoma","",17872,17872,"Pembrolizumab","anti-pd-1",1,1,1,0,0,0,"elevated lfts","Early irAE","positive","Endocrine","",19147,1,1,"",0,"","NeoGenomics ALK FISH",1,1275,NA,19145,18201,"Not Reported","Not Reported",0,0,0,1,1273,1,"","Prior TKI",1,"Asian",17829,0,"FM24107Z","",0,0,"IV",0,0,1,"",1,"crizotinib",18201,17849,"","Deceased",0
"270",1,59,"",1,0,"",1,0,"","","TKI",18163,NA,0,"l858r, t790m","",NA,"adenocarcinoma","",18627,18627,"Pembrolizumab","anti-pd-1",0,0,0,0,0,0,"none reported",NA,"negative","No irae","",18641,4,1,"",0,"","Foundation",0,14,NA,NA,18478,"1-49%","2%",1,0,0,1,NA,0,"","Prior TKI",1,"Asian",18465,0,"FN38153R","",0,0,"IV",0,0,1,"",1,"erlotinib",18478,18200,"p190l","Deceased",0
"271",1,74,"",1,0,"",0,0,"","","NON-TKI",18270,18401,0,"","",NA,"adenocarcinoma","",18612,18313,"Pembrolizumab","anti-pd-1",1,1,1,0,0,0,"fatigue and skin rash","Late irAE","positive","Skin","",18664,1,NA,"",0,"","Cedars Sinai FISH and Gene Panel (KRAS, EGFR, ALK< ROS1, BRAF, CDKN2A, ERBB2, NRAS, PIK3CA, PTEN)",0,351,63,18664,NA,"1-49%","5%",1,0,0,1,351,1,"","No Prior TKI",0,"White",18271,0,"GK96561Z","",1,0,"IV",0,0,1,"",1,"",NA,NA,"","Deceased",1
"272",0,56,"",1,0,"",0,0,"","d14_e27del","NON-TKI",18698,18741,1,"","",3,"large cell or nos nslc","",18761,18713,"Pembrolizumab","anti-pd-1",0,0,0,1,1,1,"fever","Early irAE","positive","IRAE","g12d",18844,1,NA,"",1,"","Tempus Sequencing",0,131,NA,18780,NA,"Negative","Negative",0,0,1,0,67,1,"","No Prior TKI",0,"Unknown or Other",18731,1,"GL41089Q","loss",0,0,"IV",0,0,1,"c.291-2a>t",1,"",NA,NA,"","Deceased",0
"273",1,65,"",0,1,"",0,0,"","","NON-TKI",18298,NA,0,"","",NA,"adenocarcinoma","",18498,18452,"Atezolizumab","anti-pd-l1",0,0,0,0,0,0,"none reported",NA,"negative","No irae","",18655,3,NA,"",0,"","Integrated Oncology (EGFR, ALK)",0,203,NA,18519,NA,"Not Reported","Not Reported",0,0,0,0,67,1,"","No Prior TKI",0,"White",17298,0,"GL86566W","",0,0,"IV",0,0,1,"",1,"",NA,NA,"","Deceased",1
"274",1,82,"",1,0,"",1,0,"l597r, i617v, amplification","","NON-TKI",18627,NA,0,"","",NA,"adenocarcinoma","",18649,18649,"Pembrolizumab","anti-pd-1",0,0,0,0,0,0,"none reported",NA,"negative","No irae","",18667,1,NA,"",1,"amplification","HopeSeq",0,18,5,18667,NA,">=50%","50%",0,1,0,0,18,1,"","No Prior TKI",0,"Asian",18652,1,"GM04540X","r1243w",1,0,"IV",0,0,1,"",1,"",NA,NA,"","Deceased",0
"275",1,48,"",0,1,"",0,0,"rearrangement intron 9","","TKI",17704,NA,0,"e746_a750del, t790m","",NA,"adenocarcinoma","",18248,18248,"Atezolizumab","anti-pd-l1",0,0,0,0,0,0,"none reported",NA,"negative","No irae","",18293,5,1,"",0,"","Foundation",0,45,NA,18265,17862,"Not Reported","Not Reported",0,0,0,0,17,1,"","Prior TKI",1,"White",18205,0,"GN25741R","",0,0,"IV",0,0,1,"",1,"erlotinib",17862,15884,"q331*","Deceased",1
"276",1,47,"",1,0,"",0,0,"","","TKI",17704,18570,0,"exon 19 deletion","",NA,"adenocarcinoma","",18542,18467,"Pembrolizumab","anti-pd-1",0,0,0,1,1,1,"severe lactic acidosis","Late irAE","positive","IRAE","",18615,3,1,"",1,"","Clarient EGFR Real-time PCR",0,148,NA,18570,18107,"Not Reported","Not Reported",0,0,0,0,103,1,"","Prior TKI",1,"White",17709,1,"GN63207T","",0,0,"IV",0,0,1,"",1,"erlotinib",18107,17710,"","Deceased",1
"277",1,46,"",1,0,"",0,0,"","","NON-TKI",18260,18418,1,"","",NA,"adenocarcinoma","",18439,18376,"Pembrolizumab","anti-pd-1",0,0,0,1,1,1,"thrombophlebitis migrans","Early irAE","positive","IRAE","",19298,1,NA,"",0,"","Quest Diagnostics  (EGFR, ALK, ROS1, BRAF)",1,922,45,NA,NA,">=50%","100%",0,1,0,1,NA,0,"","No Prior TKI",0,"White",18276,0,"HK23500V","",1,0,"III",1,0,0,"",0,"",NA,NA,"","Alive",1
"278",1,74,"",1,0,"",0,0,"","","NON-TKI",18724,18796,1,"","",1,"adenocarcinoma","",NA,18753,"Pembrolizumab","anti-pd-1",1,1,1,0,0,0,"lichenoid drug eruption","Early irAE","positive","Skin","g12c",19286,1,NA,"",1,"amplification","Foundation",1,533,NA,NA,NA,">=50%","90%",0,1,0,1,NA,0,"","No Prior TKI",0,"White",18744,1,"HK46592V","",1,0,"IV",0,0,1,"",0,"",NA,NA,"k132r","Alive",1
"279",0,74,"",1,0,"",0,0,"","","NON-TKI",18249,NA,0,"","",NA,"squamous","",18684,18621,"Pembrolizumab","anti-pd-1",0,0,0,0,0,0,"none reported",NA,"negative","No irae","",18710,2,NA,"",0,"exon 14 deletion","HopeSeq",0,89,NA,18710,NA,">=50%","60%",0,1,0,0,89,1,"","No Prior TKI",0,"White",18626,0,"HL09354X","",1,1,"IV",0,0,1,"",1,"",NA,NA,"","Deceased",1
"280",1,41,"",1,0,"",0,0,"","","TKI",18346,18703,0,"exon 19 deletion (t751_i759>n)","",1,"adenocarcinoma","",18703,18430,"Pembrolizumab","anti-pd-1",1,1,0,0,0,0,"transaminitis","Late irAE","positive","Endocrine","",19286,2,3,"",0,"","Foundation",1,856,4,18731,NA,"Negative","0%",0,0,1,1,301,1,"","No Prior TKI",0,"White",18369,0,"HM11652R","",1,0,"IV",0,0,1,"y166*",0,"erlotinib",NA,18730,"g302fs*4","Alive",1
"281",1,57,"",0,1,"",0,0,"","","TKI",17674,NA,0,"e746_a750del","",NA,"adenocarcinoma","",18746,18725,"Atezolizumab","anti-pd-l1",0,0,0,0,0,0,"none reported",NA,"negative","No irae","",18777,7,1,"",0,"","Onco48",0,52,NA,18760,18150,"Negative","Negative",0,0,1,0,35,1,"","Prior TKI",1,"White",17682,0,"HM25634T","",0,0,"IV",0,0,1,"",1,"afatinib",18150,17700,"y234*","Deceased",1
"282",1,49,"",1,0,"",0,0,"","","TKI",17777,NA,0,"","",NA,"adenocarcinoma","",18092,18064,"Nivolumab","anti-pd-1",0,0,0,0,0,0,"none reported",NA,"negative","No irae","",18115,5,2,"",1,"","Onco48",0,51,20,18108,17892,"Not Reported","Not Reported",0,0,0,0,44,1,"","Prior TKI",1,"White",17849,1,"HN44896X","",1,0,"IV",0,0,1,"",1,"crizotinib",17892,17864,"q192*","Deceased",1
"283",1,79,"",1,0,"",0,0,"","","NON-TKI",18565,18983,0,"","",NA,"adenocarcinoma","",NA,18619,"Pembrolizumab","anti-pd-1",1,1,0,0,0,0,"pruritus","Late irAE","positive","Respiratory","",19272,2,NA,"",1,"amplification","HopeSeq",1,653,80,NA,NA,">=50%","100%",0,1,0,1,NA,0,"","No Prior TKI",0,"Unknown or Other",18611,1,"HN83199Q","",1,0,"IV",0,0,1,"",0,"",NA,NA,"g245c, c238t","Alive",0
"284",1,73,"",1,0,"",0,0,"","","NON-TKI",17913,18018,1,"","",NA,"adenocarcinoma",NA,18032,18004,"Nivolumab","anti-pd-1",1,1,1,0,0,0,"infusion reaction: sob, desaturation, htn, chills, tachycardia","Early irAE","positive","Respiratory","G12C",18175,2,NA,"",1,"","OncoComplete",0,171,120,18046,NA,"Not Reported","",0,0,0,0,42,1,"","No Prior TKI",0,"White",18044,1,"AK03181U","",1,0,"IV",0,0,1,"",1,"",NA,NA,"","Deceased",1
"285",0,80,"",0,1,"",1,0,"","","NON-TKI",18453,NA,0,"","",NA,"squamous",NA,19013,18621,"Atezolizumab","anti-pd-l1",0,0,0,0,0,0,"none reported",NA,"negative","No irae","",19277,2,NA,"",1,"","OncoComplete",1,656,30,19034,NA,"Not Reported","Not Reported",0,0,0,1,413,1,"","No Prior TKI",0,"Asian",18488,1,"AK32849P","",1,1,"IV",0,0,1,"",0,"",NA,NA,"","Alive",0
"286",1,52,"",1,0,"",0,0,"","","TKI",18037,18732,0,"E746_A750del","",NA,"adenocarcinoma",NA,18705,18311,"Nivolumab","anti-pd-1",0,0,0,1,0,0,"acute renal failure","Late irAE","positive","IRAE","",18732,2,3,"",0,"","Foundation ACT",1,421,NA,18732,18688,"Not Reported","Not Reported",0,0,0,1,421,1,"","No Prior TKI",0,"Unknown or Other",18309,0,"AK40469X","",1,0,"IV",0,0,1,"",0,"osimertinib",18688,18611,"","Alive",0
"287",1,68,"",1,0,"",0,0,"","p16INK4a D108Y, p14ARF R122L","NON-TKI",18396,NA,0,"amplification","",NA,"adenocarcinoma",NA,18479,18479,"Pembrolizumab","anti-pd-1",0,0,0,0,0,0,"none reported",NA,"negative","No irae","",18493,1,NA,"",0,"","FoundationOne",0,14,50,18493,NA,">=50%","90%",0,1,0,0,14,1,"","No Prior TKI",0,"White",18471,0,"AK50895Z","",1,0,"IV",0,0,1,"",1,"",NA,NA,"R156G","Deceased",1
"288",1,69,"",1,0,"",0,0,"","","TKI",15964,NA,0,"E746_A750del, T790M","",NA,"adenocarcinoma",NA,18045,17954,"Nivolumab","anti-pd-1",0,0,0,0,0,0,"none reported",NA,"negative","No irae","",18181,5,1,"",0,"","Onco48",0,227,25,18059,17142,"Not Reported","Not Reported",0,0,0,0,105,1,"","Prior TKI",1,"White",17317,0,"AM05028X","",1,0,"IV",0,0,1,"",1,"erlotinib",17142,15945,"","Deceased",1
"289",1,60,"",0,1,"",0,0,"","","NON-TKI",17199,NA,0,"","",NA,"adenocarcinoma",NA,18913,18556,"Atezolizumab","anti-pd-l1",0,0,0,0,0,0,"none reported",NA,"negative","No irae","",19138,2,NA,"",1,"","Foundation",1,582,10,18913,NA,"1-49%","1%",1,0,0,1,357,1,"","No Prior TKI",0,"White",19087,1,"AN02340S","",1,0,"IV",0,0,1,"",0,"",NA,NA,"R282W","Alive",1
"290",1,51,"",0,1,"",0,1,"negative","","NON-TKI",18022,NA,0,"negative","",NA,"adenocarcinoma",NA,19150,18520,"Atezolizumab","anti-pd-l1",0,0,0,0,0,0,"none reported",NA,"negative","No irae","negative",19296,2,NA,"",0,"","Paradigm ",1,776,15,19170,NA,"Not Reported","",0,0,0,1,650,1,"","No Prior TKI",0,"Black or African American",18134,0,"AN35486R","",1,0,"IV",0,0,1,"",0,"",NA,NA,"","Alive",0
"291",1,66,"",1,0,"",1,0,"","","NON-TKI",18491,NA,0,"","",NA,"adenocarcinoma",NA,18614,18572,"Pembrolizumab","anti-pd-1",0,0,0,0,0,0,"none reported",NA,"negative","No irae","G12R",19025,1,NA,"",1,"","HopeSeq",1,453,40,18640,NA,">=50%","90%",0,1,0,0,68,1,"","No Prior TKI",0,"Asian",18564,1,"AN86077W","",1,0,"IV",0,0,1,"",1,"",NA,NA,"Y205C","Deceased",0
"292",1,77,"",1,0,"",0,0,"","","NON-TKI",18710,18723,1,"","",4,"adenocarcinoma",NA,18869,18722,"Pembrolizumab","anti-pd-1",0,0,0,1,1,1,"fatigue","Early irAE","positive","IRAE","",18885,1,NA,"",0,"","Paradigm  (ALK, ROS1: Neg, EGFR: Ins Spec.)",0,163,78,18885,NA,">=50%","90%",0,1,0,0,163,1,"","No Prior TKI",0,"White",18702,0,"AN88592U","",1,0,"IV",0,0,1,"",1,"",NA,NA,"","Deceased",1
"293",1,67,"rearrangement intron 19",1,0,"P239A (VUS)",0,0,"","2","TKI",17911,NA,0,"","",NA,"adenocarcinoma",NA,18243,18201,"Pembrolizumab","anti-pd-1",0,0,0,0,0,0,"none reported",NA,"negative","No irae","",18253,3,1,"",1,"S794P (VUS)","Foundation",0,52,NA,18253,18003,"1-49%","5%",1,0,0,0,52,1,"","Prior TKI",1,"White",18164,1,"BJ41053Y","loss exons 31-35",0,0,"IV",0,0,1,"loss exons 7-10, rearrangement (VUS)",1,"crizotinib",18003,17934,"","Deceased",1
"294",1,66,"V1405L (VUS)",1,0,"",0,0,"","","NON-TKI",17862,17996,1,"","",1,"adenocarcinoma",NA,18165,17982,"Nivolumab","anti-pd-1",0,0,0,1,1,1,"hyponatremia","Early irAE","positive","IRAE","G12C",18418,1,NA,"",0,"A347T (VUS)","Foundation",1,436,50,18176,NA,"Negative","Negative",0,0,1,1,194,1,"","No Prior TKI",0,"White",17925,0,"BJ81291Y","P169fs*134",1,0,"IV",0,0,1,"E165*",1,"",NA,NA,"","Deceased",1
"295",1,76,"",0,1,"",1,0,"","","NON-TKI",17969,18400,0,"","",NA,"adenocarcinoma",NA,19031,18313,"Atezolizumab","anti-pd-l1",1,1,1,0,0,0,"hypothyroidism","Late irAE","positive","Endocrine","",19276,2,NA,"",1,"","ONCOMUTATIONS",1,963,13,19052,NA,"Not Reported","",0,0,0,1,739,1,"","No Prior TKI",0,"Asian",18024,1,"BJ89714Q","",1,0,"IV",0,0,1,"Y36Ffs*16",0,"",NA,NA,"","Alive",0
"296",1,54,"",1,0,"",0,0,"","","NON-TKI",18626,NA,0,"","",NA,"adenocarcinoma",NA,18869,18673,"Pembrolizumab","anti-pd-1",0,0,0,0,0,0,"none reported",NA,"negative","No irae","",19158,1,NA,"",1,"","Cedars Comprehensive Cancer Panel",1,485,31.5,18935,NA,"Not Reported","Not Reported",0,0,0,1,262,1,"","No Prior TKI",0,"Unknown or Other",19080,1,"BK02431X","",1,0,"IV",0,0,1,"",1,"",NA,NA,"V143G","Deceased",0
"297",1,64,"",0,1,"",0,0,"","","NON-TKI",18568,18815,0,"","",2,"adenocarcinoma",NA,18801,18703,"Durvalumab","anti-pd-l1",1,1,1,0,0,0,"pneumonitis","Late irAE","positive","Respiratory","p.G12C, c.34G>T",19186,2,NA,"",1,"","HopeSeq",1,483,40,18815,NA,"1-49%","35%",1,0,0,0,112,1,"","No Prior TKI",0,"White",18607,1,"BL12750Z","",1,0,"III",1,0,0,"",0,"",NA,NA,"","Alive",1
"298",1,66,"",1,0,"",0,0,"","","NON-TKI",18659,NA,0,"","",NA,"adenocarcinoma",NA,18767,18711,"Pembrolizumab","anti-pd-1",0,0,0,0,0,0,"none reported",NA,"negative","No irae","G12V",18793,1,NA,"",1,"","Guardant360",0,82,22.5,NA,NA,"Negative","Negative",0,0,1,1,NA,0,"","No Prior TKI",0,"Unknown or Other",18721,1,"BN46666W","",1,0,"IV",0,0,1,"",0,"",NA,NA,"","Alive",0
"299",1,62,"",1,0,"",0,0,"","","NON-TKI",18254,18408,0,"","",NA,"adenocarcinoma",NA,18388,18281,"Pembrolizumab","anti-pd-1",1,1,1,0,0,0,"colitis","Late irAE","positive","Gastrointestinal","G12R",19305,1,NA,"",1,"","GEMExtra",1,1024,30,18407,NA,">=50%","50%",0,1,0,0,126,1,"","No Prior TKI",0,"White",19243,1,"BN83404P","",1,0,"IV",0,0,1,"",0,"",NA,NA,"","Alive",1
"300",1,81,"",1,0,"",0,0,"","","NON-TKI",18619,18723,1,"","",2,"adenocarcinoma",NA,19152,18718,"Pembrolizumab","anti-pd-1",1,1,1,0,0,0,"rash","Early irAE","positive","Skin","G12C",19310,1,NA,"",0,"","HopeSeq",1,592,60,19152,NA,">=50%","80%",0,1,0,1,434,1,"","No Prior TKI",0,"Unknown or Other",18691,0,"CJ01823V","",1,0,"IV",0,0,1,"",0,"",NA,NA,"","Alive",0
"301",0,58,"",1,0,"",0,0,"","","NON-TKI",16157,18668,1,"","",NA,"squamous",NA,18843,18647,"Pembrolizumab","anti-pd-1",0,0,0,1,1,1,"mild anemia","Early irAE","positive","IRAE","",18845,1,NA,"",1,"","Paradigm (ALK, ROS1)",0,198,NA,18845,NA,"Negative","Negative",0,0,1,1,198,1,"","No Prior TKI",0,"Unknown or Other",18670,1,"CJ70673T","",0,1,"IV",0,0,1,"",1,"",NA,NA,"","Deceased",0
"302",1,56,"negative",1,0,"",0,0,"","","NON-TKI",18015,18506,0,"negative","",NA,"adenocarcinoma",NA,18534,18093,"Nivolumab","anti-pd-1",0,0,0,1,0,0,"arthralgia","Late irAE","positive","IRAE","",18709,2,NA,"",1,"","Huntington Hospital molecular analysis (ALK, ROS1, EGFR)",1,616,40,18540,NA,"Not Reported","",0,0,0,1,447,1,"","No Prior TKI",0,"White",18026,1,"CJ71910X","",1,0,"IV",0,0,1,"",1,"",NA,NA,"","Deceased",1
"303",1,74,"",0,1,"",0,0,"","","NON-TKI",18227,NA,0,"","",NA,"adenocarcinoma",NA,18397,18332,"Atezolizumab","anti-pd-l1",0,0,0,0,0,0,"none reported",NA,"negative","No irae","",18457,2,NA,"A1260G (VUS)",1,"","Foundation",0,125,30,18418,NA,"1-49%","30%",1,0,0,0,86,1,"E545K","No Prior TKI",0,"White",18214,1,"CJ86013R","",1,0,"IV",0,0,1,"",1,"",NA,NA,"P151R","Deceased",1
"304",1,61,"",1,0,"",0,0,"","","NON-TKI",18639,18830,0,"","",1,"adenocarcinoma",NA,19213,18669,"Pembrolizumab","anti-pd-1",0,0,0,1,1,1,"fatigue","Late irAE","positive","IRAE","G12C",19304,1,NA,"",1,"","LabCorp (KRAS, EGFR, ALK)",1,635,80,NA,NA,">=50%","90%",0,1,0,1,NA,0,"","No Prior TKI",0,"White",18659,1,"CL21089P","",1,0,"IV",0,0,1,"",0,"",NA,NA,"","Alive",1
"305",1,63,"",1,0,"",0,0,"","","NON-TKI",17603,NA,0,"","",NA,"adenocarcinoma",NA,17751,17737,"Nivolumab","anti-pd-1",0,0,0,0,0,0,"none reported",NA,"negative","No irae","G12V",17775,2,NA,"",1,"","Foundation",0,38,NA,17775,NA,"Not Reported","Not Reported",0,0,0,0,38,1,"","No Prior TKI",0,"White",18045,1,"CL42993U","",0,0,"IV",0,0,1,"",1,"",NA,NA,"R273L","Deceased",1
"306",1,53,"",1,0,"",0,0,"","","NON-TKI",18556,18604,1,"","",NA,"adenocarcinoma",NA,19041,18603,"Pembrolizumab","anti-pd-1",0,0,0,1,1,1,"headaches","Early irAE","positive","IRAE","G12C",19293,1,NA,"H3992D (VUS), P1735T (VUS)",0,"","Foundation",1,690,7,NA,NA,">=50%","50%",0,1,0,1,NA,0,"","No Prior TKI",0,"Unknown or Other",18589,0,"CL67952S","",1,0,"IV",0,0,1,"truncation exon 4",0,"",NA,NA,"","Alive",0
"307",1,65,"",0,1,"",1,0,"","","NON-TKI",18353,NA,0,"","",NA,"adenocarcinoma",NA,18421,18400,"Atezolizumab","anti-pd-l1",0,0,0,0,0,0,"none reported",NA,"negative","No irae","G12V",19138,1,NA,"",1,"","HopeSeq",1,738,25,18488,NA,"1-49%","1%",1,0,0,0,88,1,"","No Prior TKI",0,"Asian",18648,1,"CL77438S","P1527S (VUS)",1,0,"III",1,0,0,"E199*",0,"",NA,NA,"","Alive",0
"308",1,64,"",1,0,"",0,0,"","","TKI",16552,17877,1,"E746_A750del, T790M","",NA,"adenocarcinoma",NA,17891,17828,"Nivolumab","anti-pd-1",0,0,0,1,1,1,"joint pain","Early irAE","positive","IRAE","",17964,5,2,"",0,"","Onco48",0,136,NA,17905,17158,"Not Reported","Not Reported",0,0,0,0,77,1,"","Prior TKI",1,"White",17344,0,"CM00092X","",0,0,"IV",0,0,1,"",0,"erlotinib",17158,16673,"A276G","Alive",1
"309",1,68,"negative",1,0,"",0,0,"","","NON-TKI",18038,NA,0,"negative","",NA,"adenocarcinoma",NA,18726,18386,"Nivolumab","anti-pd-1",0,0,0,0,0,0,"none reported",NA,"negative","No irae","",19247,2,NA,"",0,"","Genoptix (EGFR, ALK)",1,861,20,18729,NA,">=50%","80%",0,1,0,1,343,1,"","No Prior TKI",0,"White",18060,0,"CM05463W","",1,0,"No Staging Data",0,0,0,"",0,"",NA,NA,"","Alive",1
"310",0,71,"",1,0,"",1,0,"","","NON-TKI",17877,NA,0,"negative","",NA,"squamous",NA,17975,17975,"Nivolumab","anti-pd-1",0,0,0,0,0,0,"none reported",NA,"negative","No irae","negative",17991,2,NA,"",1,"","Cancer Hotspot Genotyping",0,16,NA,17980,NA,"Not Reported","",0,0,0,0,5,1,"","No Prior TKI",0,"Asian",17896,1,"CM09112V","",0,1,"IV",0,0,1,"",1,"",NA,NA,"R342* (VUS)","Deceased",0
"311",0,73,"",1,0,"G277fs",0,0,"","","NON-TKI",17788,NA,0,"","",NA,"squamous",NA,18816,17975,"Nivolumab","anti-pd-1",0,0,0,0,0,0,"none reported",NA,"negative","No irae","",18932,2,NA,"",1,"","Guardant360",1,957,NA,18849,NA,"Not Reported","Not Reported",0,0,0,1,874,1,"","No Prior TKI",0,"White",18931,1,"CM62999V","",1,1,"III",1,0,0,"",0,"",NA,NA,"Splice site SNV","Alive",1
"312",0,65,"",1,0,"",1,0,"","loss","NON-TKI",17709,17854,1,"","",2,"squamous",NA,17994,17840,"Nivolumab","anti-pd-1",1,1,1,0,0,0,"diarrhea","Early irAE","positive","Gastrointestinal","",18502,2,NA,"G1951R (VUS)",1,"","Foundation",1,662,7.5,18003,NA,"Not Reported","",0,0,0,0,163,1,"","No Prior TKI",0,"Asian",17754,1,"DK22678X","",1,1,"IV",0,0,1,"",0,"",NA,NA,"","Alive",0
"313",1,82,"",0,1,"P1175L (VUS)",0,0,"","","TKI",17977,NA,0,"E746_A750del","",NA,"adenocarcinoma",NA,18765,18732,"Atezolizumab","anti-pd-l1",0,0,0,0,0,0,"none reported",NA,"negative","No irae","",18998,4,1,"",0,"","Foundation",0,266,NA,18787,18291,"Not Reported","Not Reported",0,0,0,0,55,1,"","Prior TKI",1,"White",18030,0,"DL13440W","",0,0,"IV",0,0,1,"",1,"afatinib",18291,18039,"R248Q","Deceased",1
"314",1,76,"",1,0,"",1,0,"","","NON-TKI",17023,17967,0,"A767_S768insTLA","",NA,"adenocarcinoma",NA,17911,17897,"Nivolumab","anti-pd-1",0,0,0,1,1,1,"azotemia","Late irAE","positive","IRAE","",18477,3,NA,"",0,"","Onco48",1,580,NA,17981,NA,"Not Reported","Not Reported",0,0,0,0,84,1,"","No Prior TKI",0,"Asian",18010,0,"DL14688U","",0,0,"IV",0,0,1,"",1,"",NA,NA,"","Deceased",0
"315",0,74,"",0,1,"",0,0,"","","NON-TKI",18341,NA,0,"","",NA,"squamous",NA,18411,18369,"Atezolizumab","anti-pd-l1",0,0,0,0,0,0,"none reported",NA,"negative","No irae","",18635,2,NA,"",1,"","OncoComplete",0,266,136,18423,NA,"Negative","Negative",0,0,1,0,54,1,"","No Prior TKI",0,"White",18337,1,"DL65808X","",1,1,"I or II",0,1,0,"",1,"",NA,NA,"C176F","Deceased",1
"316",1,47,"",1,0,"",0,0,"","","NON-TKI",18318,NA,0,"","",NA,"adenocarcinoma",NA,18436,18374,"Pembrolizumab","anti-pd-1",0,0,0,0,0,0,"none reported",NA,"negative","No irae","",19062,1,NA,"",0,"","OncoComplete",1,688,10,18447,NA,">=50%","100%",0,1,0,0,73,1,"","No Prior TKI",0,"White",18339,0,"DL82708X","",1,0,"IV",0,0,1,"",1,"",NA,NA,"E285K","Deceased",1
"317",1,74,"",1,0,"",0,0,"","","NON-TKI",18497,NA,0,"","",NA,"adenocarcinoma",NA,18871,18703,"Pembrolizumab","anti-pd-1",0,0,0,0,0,0,"none reported",NA,"negative","No irae","",18932,2,NA,"",1,"","NeoGenomics (BRAF, ALK)",0,229,40,18871,NA,"1-49%","30%",1,0,0,0,168,1,"","No Prior TKI",0,"White",18466,1,"DM57805Y","",1,0,"IV",0,0,1,"",0,"",NA,NA,"","Alive",1
"318",0,67,"",1,0,"",0,0,"","","NON-TKI",18222,18424,0,"","",NA,"squamous",NA,18508,18354,"Pembrolizumab","anti-pd-1",1,1,1,0,0,0,"pneumonitis","Late irAE","positive","Respiratory","",18681,1,NA,"duplication exons 55-66",0,"","Foundation",0,327,75,18529,NA,"Negative","Negative",0,0,1,0,175,1,"","No Prior TKI",0,"White",18601,0,"DN29052S","E1252*",1,1,"IV",0,0,1,"",1,"",NA,NA,"Y234C","Deceased",1
"319",1,66,"",1,0,"",0,0,"","","NON-TKI",18387,NA,0,"","",NA,"adenocarcinoma",NA,18582,18449,"Pembrolizumab","anti-pd-1",0,0,0,0,0,0,"none reported",NA,"negative","No irae","",18643,1,NA,"",0,"","Foundation",0,194,10,18643,NA,">=50%","50%",0,1,0,1,194,1,"","No Prior TKI",0,"White",18411,0,"DN46202S","",1,0,"IV",0,0,1,"",1,"",NA,NA,"C242S","Deceased",1
"320",1,76,"",1,0,"S90fs*11-subclonal",0,0,"","p16INK4aS12*","NON-TKI",18187,18341,1,"","",NA,"adenocarcinoma",NA,18704,18340,"Nivolumab","anti-pd-1",0,0,0,1,1,1,"chills","Early irAE","positive","IRAE","",19271,2,NA,"",0,"","Foundation",1,931,NA,18716,NA,">=50%","70%",0,1,0,1,376,1,"","No Prior TKI",0,"White",18740,0,"DN55697R","",1,0,"IV",0,0,1,"",1,"",NA,NA,"E285K, G2455, R273H subclonal, S183*","Deceased",1
"321",1,81,"Negative",1,0,"",0,0,"","","NON-TKI",17774,18017,1,"Negative","",1,"adenocarcinoma",NA,18017,17961,"Nivolumab","anti-pd-1",0,0,0,1,1,1,"fatigue","Early irAE","positive","IRAE","Negative",18067,2,NA,"",0,"","OSH EGFR KRAS ALK ROS1 (All Negative)",0,106,NA,18043,NA,">=50%","60%",0,1,0,0,82,1,"","No Prior TKI",0,"White",17787,0,"DN83370Q","",0,0,"IV",0,0,1,"",1,"",NA,NA,"","Deceased",1
"322",1,63,"",0,1,"",0,0,"","","NON-TKI",18576,NA,0,"A822T (VUS), R986K (VUS)","",NA,"adenocarcinoma",NA,18733,18687,"Durvalumab","anti-pd-l1",0,0,0,0,0,0,"none reported",NA,"negative","No irae","",18753,1,NA,"",0,"","FoundationACT",0,66,20,18739,NA,"Not Reported","Not Reported",0,0,0,0,52,1,"","No Prior TKI",0,"Unknown or Other",18663,0,"EJ77564Y","",1,0,"III",1,0,0,"",1,"",NA,NA,"","Deceased",0
"323",0,78,"",1,0,"",0,0,"","Loss","NON-TKI",18418,18715,0,"","",NA,"squamous",NA,18673,18449,"Pembrolizumab","anti-pd-1",0,0,0,1,1,0,"severe arthralgias and myalgias","Late irAE","positive","IRAE","",19307,1,NA,"",1,"","Foundation",1,858,23.5,18715,NA,"1-49%","10%",1,0,0,1,266,1,"E542K","No Prior TKI",0,"White",19844,1,"EK68082V","",1,1,"IV",0,0,1,"",0,"",NA,NA,"S215I","Alive",1
"324",1,54,"",1,0,"Q944*",0,0,"","","NON-TKI",18701,18940,0,"","",2,"adenocarcinoma",NA,18961,18736,"Pembrolizumab","anti-pd-1",0,0,0,1,1,0,"fatigue","Late irAE","positive","IRAE","G12D",19115,1,NA,"",0,"","Foundation",1,379,NA,18984,NA,"Negative","Negative",0,0,1,1,248,1,"","No Prior TKI",0,"White",18732,0,"EL79542P","",0,0,"III",1,0,0,"",1,"",NA,NA,"","Deceased",1
"325",0,67,"",0,1,"",0,0,"","","NON-TKI",18463,NA,0,"","",NA,"squamous",NA,18782,18740,"Atezolizumab","anti-pd-l1",0,0,0,0,0,0,"none reported",NA,"negative","No irae","",19074,2,NA,"",1,"","Foundation",0,334,NA,18795,NA,"1-49%","10%",1,0,0,0,55,1,"","No Prior TKI",0,"Unknown or Other",18842,1,"EM24239S","",1,1,"IV",0,0,1,"",1,"",NA,NA,"H168L","Deceased",0
"326",1,69,"",1,0,"",0,0,"","","TKI",17170,NA,0,"L858R","",NA,"adenocarcinoma",NA,18724,18627,"Nivolumab","anti-pd-1",0,0,0,0,0,0,"none reported",NA,"negative","No irae","",18782,3,2,"",0,"","NeoGenomics EGFR",0,155,15,18737,18583,"Not Reported","Not Reported",0,0,0,0,110,1,"","Prior TKI",1,"Unknown or Other",18562,0,"EM24682R","",1,0,"III",1,0,0,"",1,"erlotinib",18585,18030,"","Deceased",0
"327",1,83,"I964N (VUS)",1,0,"",0,0,"","p16INK4a R58*, p14ARF P72L","NON-TKI",18473,18997,0,"","",NA,"adenocarcinoma",NA,NA,18638,"Pembrolizumab","anti-pd-1",1,1,0,0,0,0,"pruritus","Late irAE","positive","Skin","",19265,1,NA,"I1757V (VUS), L1894V (VUS)",1,"","Foundation",1,627,60,NA,NA,"Negative","Negative",0,0,1,1,NA,0,"E545K","No Prior TKI",0,"Unknown or Other",18617,1,"EM73051P","",1,0,"IV",0,0,1,"",0,"",NA,NA,"splice site 673-1G>A","Alive",0
"328",1,66,"",1,0,"",0,0,"","","NON-TKI",18514,18640,1,"","",2,"adenocarcinoma",NA,18668,18583,"Nivolumab","anti-pd-1",1,1,1,0,0,0,"cough and dyspnea","Early irAE","positive","Respiratory","G12A",18727,3,NA,"",0,"","Genoptix (ALK, BRAF, CD274, EGFR, ERBB2, KRAS, MET, RET, ROS1)",0,144,10,18727,NA,">=50%","85%",0,1,0,0,144,1,"","No Prior TKI",0,"White",18538,0,"EM84877X","",1,0,"IV",0,0,1,"",1,"",NA,NA,"","Deceased",1
"329",1,86,"",1,0,"",0,0,"","","NON-TKI",18109,NA,0,"","",NA,"adenocarcinoma",NA,18460,18397,"Pembrolizumab","anti-pd-1",0,0,0,0,0,0,"none reported",NA,"negative","No irae","",18530,2,NA,"",1,"","Foundation",0,133,60,18479,NA,"1-49%","5%",1,0,0,0,82,1,"","No Prior TKI",0,"White",18388,1,"EN86741S","",1,0,"I or II",0,1,0,"",0,"",NA,NA,"W53*","Alive",1
"330",1,80,"",1,0,"",0,0,"","","NON-TKI",18698,NA,0,"","",NA,"adenocarcinoma",NA,18745,18745,"Pembrolizumab","anti-pd-1",0,0,0,0,0,0,"none reported",NA,"negative","No irae","",18758,1,NA,"",1,"","Foundation",0,13,93,18758,NA,"Negative","Negative",0,0,1,0,13,1,"","No Prior TKI",0,"White",18735,1,"FK48168U","",1,0,"III",1,0,0,"",1,"",NA,NA,"Q192*","Deceased",1
"331",1,81,"",1,0,"",0,0,"","","NON-TKI",16331,NA,0,"","",NA,"adenocarcinoma",NA,17988,17946,"Nivolumab","anti-pd-1",0,0,0,0,0,0,"none reported",NA,"negative","No irae","",18002,2,NA,"",1,"","Onco48",0,56,50,18002,NA,"Not Reported","Not Reported",0,0,0,0,56,1,"1633G>A E545K","No Prior TKI",0,"White",17351,1,"FM86208W","",1,0,"IV",0,0,1,"",0,"",NA,NA,"","Alive",1
"332",1,76,"",1,0,"",0,0,"","","TKI",17954,18540,1,"E746_A750del","",NA,"adenocarcinoma",NA,18540,18540,"Pembrolizumab","anti-pd-1",0,0,0,1,1,1,"neutropenic fever and mucositis","Early irAE","positive","IRAE","",18572,3,1,"",0,"","OncoComplete",0,32,NA,18540,18399,">=50%","100%",0,1,0,0,0,1,"","Prior TKI",1,"White",18429,0,"FN23096T","",0,0,"IV",0,0,1,"",1,"afatinib",18399,17954,"Splice Site 376-2A>G","Deceased",1
"333",1,60,"",0,1,"",1,0,"","","TKI",17437,18247,1,"E746_A750del, T790M","",NA,"adenocarcinoma",NA,18270,18226,"Atezolizumab","anti-pd-l1",0,0,0,1,1,1,"stomatitis","Early irAE","positive","IRAE","",18419,4,1,"",0,"","Onco48",0,193,NA,18289,17822,">=50%","80%",0,1,0,0,63,1,"","Prior TKI",1,"Asian",17849,0,"GJ57993X","",0,0,"IV",0,0,1,"",1,"afatinib",17680,17496,"R273L","Deceased",0
"334",1,75,"",1,0,"",0,0,"","","NON-TKI",17690,18113,1,"","",2,"adenocarcinoma",NA,18155,18085,"Nivolumab","anti-pd-1",1,1,1,0,0,0,"constipation","Early irAE","positive","Gastrointestinal","G12C",18190,3,NA,"",0,"","OncoMutations",0,105,5,18171,NA,"Not Reported","",0,0,0,0,86,1,"","No Prior TKI",0,"White",18131,0,"GJ59578Q","",1,0,"IV",0,0,1,"",1,"",NA,NA,"","Deceased",1
"335",1,34,"",0,1,"G987fs*45",1,0,"","","TKI",17771,NA,0,"amplification, L858R","amplification",NA,"adenocarcinoma",NA,18166,18166,"Atezolizumab","anti-pd-l1",0,0,0,0,0,0,"none reported",NA,"negative","No irae","",18281,5,2,"H2341Y (VUS)",0,"amplification, G87V (VUS)","Foundation",0,115,NA,18179,17927,"Not Reported","Not Reported",0,0,0,0,13,1,"","Prior TKI",1,"Asian",18206,0,"GL10472S","",0,0,"IV",0,0,1,"",0,"crizotinib",17927,17899,"E258V","Alive",0
"336",1,79,"",1,0,"",0,0,"","","NON-TKI",17923,18155,1,"","",1,"adenocarcinoma",NA,18212,18109,"Nivolumab","anti-pd-1",1,1,1,0,0,0,"constipation","Early irAE","positive","Gastrointestinal","G12C",18286,2,NA,"",1,"","Foundation",0,177,120,18222,NA,"Not Reported","",0,0,0,0,113,1,"","No Prior TKI",0,"White",18225,1,"GL54366X","",1,0,"IV",0,0,1,"",1,"",NA,NA,"","Deceased",1
"337",1,76,"negative",0,1,"",0,0,"negative","","NON-TKI",18457,NA,0,"negative","",NA,"adenocarcinoma",NA,18640,18640,"Durvalumab","anti-pd-l1",0,0,0,0,0,0,"none reported",NA,"negative","No irae","negative",18663,2,NA,"",0,"","NeoGenomics",0,23,6,18645,NA,"Not Reported","Not Reported",0,0,0,0,5,1,"","No Prior TKI",0,"White",18472,0,"GL83918X","",1,0,"III",1,0,0,"",1,"",NA,NA,"","Deceased",1
"338",1,57,"",0,1,"",0,0,"","loss","NON-TKI",18135,NA,0,"","",NA,"adenocarcinoma",NA,18290,18269,"Atezolizumab","anti-pd-l1",0,0,0,0,0,0,"none reported",NA,"negative","No irae","G12C",18395,2,NA,"K3712T, L1205I (VUS)",1,"","Foundation",0,126,60,18299,NA,"Negative","Negative",0,0,1,0,30,1,"","No Prior TKI",0,"White",18222,1,"GM27441R","loss exons 12-29",1,0,"IV",0,0,1,"G242V",1,"",NA,NA,"","Deceased",1
"339",1,68,"rearrangment",1,0,"",0,0,"","","TKI",16349,18180,1,"","",NA,"adenocarcinoma",NA,18152,18138,"Nivolumab","anti-pd-1",1,1,1,0,0,0,"pneumonitis","Early irAE","positive","Respiratory","",18324,7,2,"",1,"","COH panel (EGFR, KRAS), ALK FISH",0,186,3,18187,17662,"Not Reported","Not Reported",0,0,0,0,49,1,"","Prior TKI",1,"White",16400,1,"GM70167V","",1,0,"IV",0,0,1,"",1,"crizotinib",17662,16462,"","Deceased",1
"340",1,80,"negative",1,0,"",0,0,"","","NON-TKI",18379,NA,0,"negative","",NA,"adenocarcinoma",NA,18796,18586,"Pembrolizumab","anti-pd-1",0,0,0,0,0,0,"none reported",NA,"negative","No irae","",18815,2,NA,"",0,"","Integrated Oncology (EGFR, ALK)",0,229,60,18815,NA,"1-49%","30%",1,0,0,1,229,1,"","No Prior TKI",0,"Unknown or Other",18344,0,"GM79544Y","",1,0,"IV",0,0,1,"",1,"",NA,NA,"","Deceased",0
"341",0,69,"",1,0,"",0,0,"","","NON-TKI",18682,NA,0,"","",NA,"squamous",NA,18731,18731,"Pembrolizumab","anti-pd-1",0,0,0,0,0,0,"none reported",NA,"negative","No irae","",18747,1,NA,"",1,"","Foundation Medicine (PD-L1 Only)",0,16,25,18747,NA,"1-49%","1%",1,0,0,0,16,1,"","No Prior TKI",0,"White",18692,1,"GM84101Q","",1,1,"IV",0,0,1,"",1,"",NA,NA,"","Deceased",1
"342",1,62,"",1,0,"",0,0,"","","NON-TKI",18010,18505,1,"","",NA,"adenocarcinoma",NA,18662,18464,"Nivolumab","anti-pd-1",1,1,1,0,0,0,"diarrhea","Early irAE","positive","Gastrointestinal","G12C",18763,2,NA,"",0,"","Guardant360",0,299,NA,18689,NA,"Not Reported","Not Reported",0,0,0,1,225,1,"","No Prior TKI",0,"Unknown or Other",18531,0,"GN66217T","",0,0,"IV",0,0,1,"",1,"",NA,NA,"R273C, D281E, L194F, C238G, S116C, I232S","Deceased",0
"343",1,66,"",1,0,"",0,0,"","p.W110*, c.330G>A","NON-TKI",18675,NA,0,"","",NA,"adenocarcinoma",NA,19060,18690,"Pembrolizumab","anti-pd-1",0,0,0,0,0,0,"none reported",NA,"negative","No irae","pG12D, c.35G>A",19275,2,NA,"",0,"","HopeSeq",1,585,50,19069,NA,"Not Reported","Not Reported",0,0,0,1,379,1,"","No Prior TKI",0,"Unknown or Other",18698,0,"GN76133Q","",1,0,"IV",0,0,1,"p.K44*, c.595G>T",0,"",NA,NA,"","Alive",0
"344",1,74,"",1,0,"",0,0,"","A76fs","NON-TKI",18150,NA,0,"","E1192D",NA,"adenocarcinoma",NA,18359,18332,"Nivolumab","anti-pd-1",0,0,0,0,0,0,"none reported",NA,"negative","No irae","",18369,2,NA,"",1,"","Guardant360",0,37,20,18365,NA,"Negative","Negative",0,0,1,0,33,1,"","No Prior TKI",0,"White",18321,1,"HJ44618U","",1,0,"IV",0,0,1,"S216F",1,"",NA,NA,"Y220C, H179D, G244S","Deceased",1
"345",0,56,"",1,0,"",0,0,"","","NON-TKI",18068,NA,0,"","",NA,"large cell or nos nslc",NA,18758,18716,"Pembrolizumab","anti-pd-1",0,0,0,0,0,0,"none reported",NA,"negative","No irae","",18947,2,NA,"",1,"","HopeSeq",0,231,45,18775,NA,"1-49%","30%",1,0,0,0,59,1,"","No Prior TKI",0,"White",18660,1,"HL90550U","",1,0,"IV",0,0,1,"",1,"",NA,NA,"p.Q317*, c.949C>T","Deceased",1
"346",1,60,"",1,0,"",0,0,"","","TKI",16272,NA,0,"","G776_V777>VCV",NA,"adenocarcinoma",NA,17891,17821,"Nivolumab","anti-pd-1",0,0,0,0,0,0,"none reported",NA,"negative","No irae","",17917,8,3,"",1,"","Foundation",0,96,NA,17903,17954,"Not Reported","Not Reported",0,0,0,0,82,1,"","Prior TKI",1,"White",16846,1,"HL92064X","",0,0,"IV",0,0,1,"",1,"erlotinib",17954,16766,"","Deceased",1
"347",1,70,"",0,1,"",1,0,"","","NON-TKI",17711,NA,0,"","Y772_A775dup",NA,"adenocarcinoma",NA,18473,18431,"Atezolizumab","anti-pd-l1",0,0,0,0,0,0,"none reported",NA,"negative","No irae","",18768,1,NA,"",0,"","Onco48",0,337,NA,18492,NA,"Not Reported","Not Reported",0,0,0,0,61,1,"","No Prior TKI",0,"Asian",17731,0,"HM86685Z","",0,0,"IV",0,0,1,"",0,"",NA,NA,"","Alive",0
"348",1,78,"",1,0,"",0,0,"","","NON-TKI",17984,NA,0,"","",NA,"adenocarcinoma",NA,18080,18065,"Nivolumab","anti-pd-1",0,0,0,0,0,0,"none reported",NA,"negative","No irae","",18144,3,NA,"",1,"","No Report",0,79,90,18144,NA,"Not Reported","",0,0,0,0,79,1,"","No Prior TKI",0,"White",NA,1,"AK54502U","",1,0,"IV",0,0,1,"",1,"",NA,NA,"","Deceased",1
"349",1,69,"",0,1,"",0,0,"","","NON-TKI",18463,18738,0,"","",NA,"adenocarcinoma",NA,18893,18642,"Durvalumab","anti-pd-l1",0,0,0,1,1,1,"normochromic normocytic anemia","Late irAE","positive","IRAE","",19307,2,NA,"",0,"","No Report",1,665,NA,18899,NA,"Negative","Negative",0,0,1,1,257,1,"","No Prior TKI",0,"Unknown or Other",NA,0,"AM14952X","",0,0,"III",1,0,0,"",0,"",NA,NA,"","Alive",0
"350",0,66,"",1,0,"",0,0,"","","NON-TKI",17088,17645,0,"","",NA,"squamous",NA,18080,17561,"Nivolumab","anti-pd-1",1,1,1,0,0,0,"elevated lfts","Late irAE","positive","Endocrine","",18235,2,NA,"",1,"","No Report",1,674,20,18094,NA,"Not Reported","Not Reported",0,0,0,1,533,1,"","No Prior TKI",0,"White",NA,1,"CM22404T","",1,1,"IV",0,0,1,"",0,"",NA,NA,"","Alive",1
"351",1,71,"",1,0,"",0,0,"","","NON-TKI",17913,NA,0,"","",NA,"adenocarcinoma",NA,18123,18123,"Nivolumab","anti-pd-1",0,0,0,0,0,0,"none reported",NA,"negative","No irae","",18272,2,NA,"",1,"","No Report",0,149,50,18137,NA,"Negative","Negative",0,0,1,0,14,1,"","No Prior TKI",0,"White",NA,1,"FJ34036R","",1,0,"IV",0,0,1,"",1,"",NA,NA,"","Deceased",1
"352",0,68,"",0,1,"",0,0,"","","NON-TKI",18460,NA,0,"","",NA,"squamous",NA,18710,18654,"Durvalumab","anti-pd-l1",0,0,0,0,0,0,"none reported",NA,"negative","No irae","",19275,2,NA,"",1,"","No Report",1,621,50,18769,NA,"Not Reported","Not Reported",0,0,0,0,115,1,"","No Prior TKI",0,"Unknown or Other",NA,1,"GL48269X","",1,1,"III",1,0,0,"",0,"",NA,NA,"","Alive",0
"353",0,65,"",1,0,"",0,0,"","","NON-TKI",18320,NA,0,"","",NA,"squamous",NA,18486,18445,"Pembrolizumab","anti-pd-1",0,0,0,0,0,0,"none reported",NA,"negative","No irae","",18978,2,NA,"",0,"","No Report",1,533,22,18500,NA,">=50%","90%",0,1,0,0,55,1,"","No Prior TKI",0,"Unknown or Other",NA,0,"GM27901R","",1,1,"IV",0,0,1,"",1,"",NA,NA,"","Deceased",0
"354",0,58,"",0,1,"",0,0,"","","NON-TKI",18257,NA,0,"","",NA,"squamous",NA,18326,18305,"Atezolizumab","anti-pd-l1",0,0,0,0,0,0,"none reported",NA,"negative","No irae","",19180,1,NA,"",1,"","No Report",1,875,60,NA,NA,"Not Reported","Not Reported",0,0,0,1,NA,0,"","No Prior TKI",0,"White",NA,1,"HK69051T","",1,1,"III",1,0,0,"",0,"",NA,NA,"","Alive",1
